KELLY KHUNTKELLY K HUNT8555HUNT, KELLY KProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson1400 Pressler StHouston77030-4008TXAuthorship 1651452Authorship 1656002Authorship 1661061Authorship 1664541Authorship 1664613Authorship 1668744Authorship 1677292Authorship 16805514Authorship 1681244Authorship 1683465Authorship 16932012Authorship 16942413Authorship 1694903Authorship 1698634Authorship 1698934Authorship 17020011Authorship 1702314Authorship 1703053Authorship 17040915Authorship 1706237Authorship 1707244Authorship 1707924Authorship 1709985Authorship 1714476Authorship 1714566Authorship 1715272Authorship 17178210Authorship 1718879Authorship 1719746Authorship 1724782Authorship 17248416Authorship 1725423Authorship 1725462Authorship 1727633Authorship 1728527Authorship 1729911Authorship 1731102Authorship 1735142Authorship 1735451Authorship 1735874Authorship 1735973Authorship 1736087Authorship 173640Authorship 1736842Authorship 1741589Authorship 17422315Authorship 1743043Authorship 17464410Authorship 1747343Authorship 17482814Authorship 17490512Authorship 1752493Authorship 17529812Authorship 1754958Authorship 1756554Authorship 17573810Authorship 1760506Authorship 1762903Authorship 1763312Authorship 1764245Authorship 17645010Authorship 1766975Authorship 1770265Authorship 17714710Authorship 1772022Authorship 1773117Authorship 1773236Authorship 17755010Authorship 17797710Authorship 1781043Authorship 17835311Authorship 17838513Authorship 1783989Authorship 17845111Authorship 1786167Authorship 17931110Authorship 1797313Authorship 17985210Authorship 1799318Authorship 1802727Authorship 1804648Authorship 18064710Authorship 1807546Authorship 1812782Authorship 1813212Authorship 1814499Authorship 1817935Authorship 18184210Authorship 1822382Authorship 1822777Authorship 1822796Authorship 1824316Authorship 1825018Authorship 1826339Authorship 1826488Authorship 1826559Authorship 1826705Authorship 1833466Authorship 18396610Authorship 18413514Authorship 1842223Authorship 1847549Authorship 1849462Authorship 1850026Authorship 1852322Authorship 1853822Authorship 1856144Authorship 18562512Authorship 18580216Authorship 1860867Authorship 1861464Authorship 18651010Authorship 18719519Authorship 1878835Authorship 18833812Authorship 18864411Authorship 1891339Authorship 1891619Authorship 18918410Authorship 1900862Authorship 1903299Authorship 19051036Authorship 1905413Authorship 1908293Authorship 19104010Authorship 19157815Authorship 1919181Authorship 1924797Authorship 19261412Authorship 1927682Authorship 1932317Authorship 19357611Authorship 1935877Authorship 1936391Authorship 1938617Authorship 1942122Authorship 19500812Authorship 19561477944038Swisher SG, Hunt KK, Schmit PJ, Hiyama DT, Bennion RS, Thompson JEThe American surgeonManagement of pancreatitis complicating pregnancy. Am Surg. 1994 Oct; 60(10):759-62.Am Surg1994-10-01T00:00:001994Management of pancreatitis complicating pregnancy.8050324Alvarez C, Hunt K, Ashley SW, Reber HADigestive diseases and sciencesEmphysematous cholecystitis after ERCP. Dig Dis Sci. 1994 Aug; 39(8):1719-23.Dig Dis Sci1994-08-01T00:00:001994Emphysematous cholecystitis after ERCP.8610271Hunt KK, Ames FC, Singletary SE, Buzdar AU, Hortobagyi GNThe Surgical clinics of North AmericaLocally advanced noninflammatory breast cancer. Surg Clin North Am. 1996 Apr; 76(2):393-410.Surg Clin North Am1996-04-01T00:00:001996Locally advanced noninflammatory breast cancer.8712904Swisher SG, Holmes EC, Hunt KK, Doty JE, Zinner MJ, McFadden DWArchives of surgery (Chicago, Ill. : 1960)The role of neoadjuvant therapy in surgically resectable esophageal cancer. Arch Surg. 1996 Aug; 131(8):819-24; discussion 824-5.Arch Surg1996-08-01T00:00:001996The role of neoadjuvant therapy in surgically resectable esophageal cancer.9926779Kuerer HM, Newman LA, Buzdar AU, Hunt KK, Dhingra K, Buchholz TA, Binkley SM, Ames FC, Feig BW, Ross MI, Hortobagyi GN, Singletary SEAmerican journal of surgeryResidual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg. 1998 Dec; 176(6):502-9.Am J Surg1998-12-01T00:00:001998Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer.10188058Pearlstone DB, Janjan NA, Feig BW, Yasko AW, Hunt KK, Pollock RE, Lawyer A, Horton J, Pisters PWThe cancer journal from Scientific AmericanRe-resection with brachytherapy for locally recurrent soft tissue sarcoma arising in a previously radiated field. Cancer J Sci Am. 1999 Jan-Feb; 5(1):26-33.Cancer J Sci Am1999-01-01T00:00:001999Re-resection with brachytherapy for locally recurrent soft tissue sarcoma arising in a previously radiated field.10550135Buzdar AU, Singletary SE, Theriault RL, Booser DJ, Valero V, Ibrahim N, Smith TL, Asmar L, Frye D, Manuel N, Kau SW, McNeese M, Strom E, Hunt K, Ames F, Hortobagyi GNJournal of clinical oncology : official journal of the American Society of Clinical OncologyProspective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. J Clin Oncol. 1999 Nov; 17(11):3412-7.J Clin Oncol1999-11-01T00:00:001999Prospective evaluation of paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer.11407517Vlastos G, Jean ME, Mirza AN, Mirza NQ, Kuerer HM, Ames FC, Hunt KK, Ross MI, Buchholz TA, Buzdar AU, Singletary SEAnnals of surgical oncologyFeasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases. Ann Surg Oncol. 2001 Jun; 8(5):425-31.Ann Surg Oncol2001-06-01T00:00:002001Feasibility of breast preservation in the treatment of occult primary carcinoma presenting with axillary metastases.11438265Newman LA, Kuerer HM, Fornage B, Mirza N, Hunt KK, Ross MI, Ames FC, Buzdar AU, Singletary SEAmerican journal of surgeryAdverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer. Am J Surg. 2001 Apr; 181(4):313-8.Am J Surg2001-04-01T00:00:002001Adverse prognostic significance of infraclavicular lymph nodes detected by ultrasonography in patients with locally advanced breast cancer.11773149Buchholz TA, Tucker SL, Masullo L, Kuerer HM, Erwin J, Salas J, Frye D, Strom EA, McNeese MD, Perkins G, Katz A, Singletary SE, Hunt KK, Buzdar AU, Hortobagyi GNJournal of clinical oncology : official journal of the American Society of Clinical OncologyPredictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol. 2002 Jan 01; 20(1):17-23.J Clin Oncol2002-01-01T00:00:002002Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation.11815977Porter GA, Cantor SB, Ahmad SA, Lenert JT, Ballo MT, Hunt KK, Feig BW, Patel SR, Benjamin RS, Pollock RE, Pisters PWCancerCost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas. Cancer. 2002 Jan 01; 94(1):197-204.Cancer2002-01-01T00:00:002002Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas.11932911Shmulevich I, Hunt K, El-Naggar A, Taylor E, Ramdas L, Labord? P, Hess KR, Pollock R, Zhang WCancerTumor specific gene expression profiles in human leiomyosarcoma: an evaluation of intratumor heterogeneity. Cancer. 2002 Apr 01; 94(7):2069-75.Cancer2002-04-01T00:00:002002Tumor specific gene expression profiles in human leiomyosarcoma: an evaluation of intratumor heterogeneity.11949754Meric F, Hung MC, Hortobagyi GN, Hunt KKJournal of the American College of SurgeonsHER2/neu in the management of invasive breast cancer. J Am Coll Surg. 2002 Apr; 194(4):488-501.J Am Coll Surg2002-04-01T00:00:002002HER2/neu in the management of invasive breast cancer.12095553Buchholz TA, Katz A, Strom EA, McNeese MD, Perkins GH, Hortobagyi GN, Thames HD, Kuerer HM, Singletary SE, Sahin AA, Hunt KK, Buzdar AU, Valero V, Sneige N, Tucker SLInternational journal of radiation oncology, biology, physicsPathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 2002 Jul 15; 53(4):880-8.Int J Radiat Oncol Biol Phys2002-07-15T00:00:002002Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy.12113134Buchholz TA, Crane C, Hunt KKExpert review of anticancer therapy1st annual oncology update: advances and controversies. Steamboat Springs, Colorado, USA, 13-17 February 2001. Expert Rev Anticancer Ther. 2001 Jun; 1(1):6-8.Expert Rev Anticancer Ther2001-06-01T00:00:0020011st annual oncology update: advances and controversies. Steamboat Springs, Colorado, USA, 13-17 February 2001.12209699Meric F, Hess KR, Varma DG, Hunt KK, Pisters PW, Milas KM, Patel SR, Benjamin RS, Plager C, Papadopoulos NE, Burgess MA, Pollock RE, Feig BWCancerRadiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas. Cancer. 2002 Sep 01; 95(5):1120-6.Cancer2002-09-01T00:00:002002Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.12569592Meric F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera GV, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins GH, McNeese MD, Strom EA, Valero V, Hunt KKCancerPositive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer. 2003 Feb 15; 97(4):926-33.Cancer2003-02-15T00:00:002003Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.12604895Diaz LK, Hunt K, Ames F, Meric F, Kuerer H, Babiera G, Ross M, Singletary E, Middleton LP, Symmans WF, Krishnamurthy S, Sahin A, Sneige N, Gilcrease MZThe American journal of surgical pathologyHistologic localization of sentinel lymph node metastases in breast cancer. Am J Surg Pathol. 2003 Mar; 27(3):385-9.Am J Surg Pathol2003-03-01T00:00:002003Histologic localization of sentinel lymph node metastases in breast cancer.12704689Krishnamurthy S, Sneige N, Thompson PA, Marcy SM, Singletary SE, Cristofanilli M, Hunt KK, Kuerer HMCancerNipple aspirate fluid cytology in breast carcinoma. Cancer. 2003 Apr 25; 99(2):97-104.Cancer2003-04-25T00:00:002003Nipple aspirate fluid cytology in breast carcinoma.12947058Woodward WA, Strom EA, Tucker SL, McNeese MD, Perkins GH, Schechter NR, Singletary SE, Theriault RL, Hortobagyi GN, Hunt KK, Buchholz TAJournal of clinical oncology : official journal of the American Society of Clinical OncologyChanges in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol. 2003 Sep 01; 21(17):3244-8.J Clin Oncol2003-09-01T00:00:002003Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival.14628425Le DT, Deavers M, Hunt K, Malpica A, Verschraegen CFCancer investigationCisplatin and irinotecan (CPT-11) for peritoneal mesothelioma. Cancer Invest. 2003; 21(5):682-9.Cancer Invest2003-01-01T00:00:002003Cisplatin and irinotecan (CPT-11) for peritoneal mesothelioma.14635089Evans RACancerPositive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer. 2003 Dec 01; 98(11):2522-3; author reply 2523-4.Cancer2003-12-01T00:00:002003Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.14672776Scaife CL, Hunt KK, Patel SR, Benjamin RS, Burgess MA, Chen LL, Trent J, Raymond AK, Cormier JN, Pisters PW, Pollock RE, Feig BWAmerican journal of surgeryIs there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate? Am J Surg. 2003 Dec; 186(6):665-9.Am J Surg2003-12-01T00:00:002003Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?15068954Yang WT, Whitman GJ, Johnson MM, Bolanos-Clark M, Kushwaha AC, Hunt KK, Dempsey PJRadiologyNeedle localization for excisional biopsy of breast lesions: comparison of effect of use of full-field digital versus screen-film mammographic guidance on procedure time. Radiology. 2004 Apr; 231(1):277-81.Radiology2004-04-01T00:00:002004Needle localization for excisional biopsy of breast lesions: comparison of effect of use of full-field digital versus screen-film mammographic guidance on procedure time.15093909Garg AK, Strom EA, McNeese MD, Buzdar AU, Hortobagyi GN, Kuerer HM, Perkins GH, Singletary SE, Hunt KK, Sahin A, Schechter N, Valero V, Tucker SL, Buchholz TAInternational journal of radiation oncology, biology, physicsT3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys. 2004 May 01; 59(1):138-45.Int J Radiat Oncol Biol Phys2004-05-01T00:00:002004T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.15122330Ding Y, Wang L, Su LK, Frey JA, Shao R, Hunt KK, Yan DHOncogeneAntitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer. Oncogene. 2004 Jun 03; 23(26):4556-66.Oncogene2004-06-03T00:00:002004Antitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer.15274063Cabioglu N, Krishnamurthy S, Kuerer HM, Hunt KK, Singletary SE, Meric-Bernstam F, Ross MI, Feig BW, Ames FC, Babiera GVCancerFeasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge. Cancer. 2004 Aug 01; 101(3):508-17.Cancer2004-08-01T00:00:002004Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge.15275718Buchholz TA, Huang EH, Berry D, Pusztai L, Strom EA, McNeese MD, Perkins GH, Schechter NR, Kuerer HM, Buzdar AU, Valero V, Hunt KK, Hortobagyi GN, Sahin AAInternational journal of radiation oncology, biology, physicsHer2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys. 2004 Aug 01; 59(5):1337-42.Int J Radiat Oncol Biol Phys2004-08-01T00:00:002004Her2/neu-positive disease does not increase risk of locoregional recurrence for patients treated with neoadjuvant doxorubicin-based chemotherapy, mastectomy, and radiotherapy.15310783Pisters PW, Patel SR, Prieto VG, Thall PF, Lewis VO, Feig BW, Hunt KK, Yasko AW, Lin PP, Jacobson MG, Burgess MA, Pollock RE, Zagars GK, Benjamin RS, Ballo MTJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas. J Clin Oncol. 2004 Aug 15; 22(16):3375-80.J Clin Oncol2004-08-15T00:00:002004Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas.15316905Shen J, Hunt KK, Mirza NQ, Krishnamurthy S, Singletary SE, Kuerer HM, Meric-Bernstam F, Feig B, Ross MI, Ames FC, Babiera GVCancerIntramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Cancer. 2004 Sep 15; 101(6):1330-7.Cancer2004-09-15T00:00:002004Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma.15492568Berman RS, Feig BW, Hunt KK, Mansfield PF, Pollock REAnnals of surgeryPlatelet kinetics and decreased transfusion requirements after splenectomy for hematologic malignancy. Ann Surg. 2004 Nov; 240(5):852-7.Ann Surg2004-11-01T00:00:002004Platelet kinetics and decreased transfusion requirements after splenectomy for hematologic malignancy.15747375Chagpar A, Middleton LP, Sahin AA, Meric-Bernstam F, Kuerer HM, Feig BW, Ross MI, Ames FC, Singletary SE, Buchholz TA, Valero V, Hunt KKCancerClinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer. 2005 Apr 15; 103(8):1581-6.Cancer2005-04-15T00:00:002005Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.15851010Pataer A, Vorburger SA, Chada S, Balachandran S, Barber GN, Roth JA, Hunt KK, Swisher SGMolecular therapy : the journal of the American Society of Gene TherapyMelanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR. Mol Ther. 2005 May; 11(5):717-23.Mol Ther2005-05-01T00:00:002005Melanoma differentiation-associated gene-7 protein physically associates with the double-stranded RNA-activated protein kinase PKR.15915373Kawase K, Dimaio DJ, Tucker SL, Buchholz TA, Ross MI, Feig BW, Kuerer HM, Meric-Bernstam F, Babiera G, Ames FC, Singletary SE, Hunt KKAnnals of surgical oncologyPaget's disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol. 2005 May; 12(5):391-7.Ann Surg Oncol2005-03-29T00:00:002005Paget's disease of the breast: there is a role for breast-conserving therapy.15968686Shen J, Hunt KK, Mirza NQ, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Ross MI, Ames FC, Feig BW, Singletary SE, Cristofanilli M, Meric-Bernstam FCancerPredictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence. Cancer. 2005 Aug 01; 104(3):479-90.Cancer2005-08-01T00:00:002005Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence.16041472Hunt KK, Buchholz TA, Hortobagyi GNAnnals of surgical oncologyNow and later? The sticky question of lymph node management in patients receiving preoperative chemotherapy. Ann Surg Oncol. 2005 Sep; 12(9):683-5.Ann Surg Oncol2005-07-25T00:00:002005Now and later? The sticky question of lymph node management in patients receiving preoperative chemotherapy.16104028Tez M, Tez SCancerClinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer. 2005 Oct 15; 104(8):1779-80; author reply 1780.Cancer2005-10-15T00:00:002005Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.16288486Vorburger SA, Xing Y, Hunt KK, Lakin GE, Benjamin RS, Feig BW, Pisters PW, Ballo MT, Chen L, Trent J, Burgess M, Patel S, Pollock RE, Cormier JNCancerAngiosarcoma of the breast. Cancer. 2005 Dec 15; 104(12):2682-8.Cancer2005-12-15T00:00:002005Angiosarcoma of the breast.16333852Adepoju LJ, Symmans WF, Babiera GV, Singletary SE, Arun B, Sneige N, Pusztai L, Buchholz TA, Sahin A, Hunt KK, Meric-Bernstam F, Ross MI, Ames FC, Kuerer HMCancerImpact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy. Cancer. 2006 Jan 01; 106(1):42-50.Cancer2006-01-01T00:00:002006Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.16710719Zheng M, Bocangel D, Doneske B, Mhashilkar A, Ramesh R, Hunt KK, Ekmekcioglu S, Sutton RB, Poindexter N, Grimm EA, Chada SCancer immunology, immunotherapy : CIIHuman interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10. Cancer Immunol Immunother. 2007 Feb; 56(2):205-15.Cancer Immunol Immunother2006-05-19T00:00:002006Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10.16948128Rouzier R, Pusztai L, Garbay JR, Delaloge S, Hunt KK, Hortobagyi GN, Berry D, Kuerer HMCancerDevelopment and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer. Cancer. 2006 Oct 01; 107(7):1459-66.Cancer2006-10-01T00:00:002006Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer.16978971Rosenkranz KM, Bedrosian I, Feng L, Hunt KK, Hartman K, Lucci A, Meric-Bernstam F, Kuerer HM, Singletary ES, Hwang R, Feig B, Ross M, Ames F, Babiera GVAmerican journal of surgeryBreast cancer in the very elderly: treatment patterns and complications in a tertiary cancer center. Am J Surg. 2006 Oct; 192(4):541-4.Am J Surg2006-10-01T00:00:002006Breast cancer in the very elderly: treatment patterns and complications in a tertiary cancer center.16978974Vo TN, Meric-Bernstam F, Yi M, Buchholz TA, Ames FC, Kuerer HM, Bedrosian I, Hunt KKAmerican journal of surgeryOutcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma. Am J Surg. 2006 Oct; 192(4):552-5.Am J Surg2006-10-01T00:00:002006Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.17039501Jeruss JS, Hunt KK, Xing Y, Krishnamurthy S, Meric-Bernstam F, Cantor SB, Ross MI, Cormier JNCancerIs intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective? Cancer. 2006 Nov 15; 107(10):2328-36.Cancer2006-11-15T00:00:002006Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective?17072676Andtbacka RH, Ng CS, Scaife CL, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Benjamin RS, Burgess MA, Chen LL, Trent J, Patel SR, Raymond K, Feig BWAnnals of surgical oncologySurgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol. 2007 Jan; 14(1):14-24.Ann Surg Oncol2007-01-01T00:00:002007Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.17200359Buzdar AU, Valero V, Ibrahim NK, Francis D, Broglio KR, Theriault RL, Pusztai L, Green MC, Singletary SE, Hunt KK, Sahin AA, Esteva F, Symmans WF, Ewer MS, Buchholz TA, Hortobagyi GNClinical cancer research : an official journal of the American Association for Cancer ResearchNeoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen. Clin Cancer Res. 2007 Jan 01; 13(1):228-33.Clin Cancer Res2007-01-01T00:00:002007Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen.17280496Boughey JC, Hunt KKFuture oncology (London, England)Expanding the indications for sentinel lymph node surgery in breast cancer. Future Oncol. 2007 Feb; 3(1):9-14.Future Oncol2007-02-01T00:00:002007Expanding the indications for sentinel lymph node surgery in breast cancer.18029860Yang WT, Hennessy B, Broglio K, Mills C, Sneige N, Davis WG, Valero V, Hunt KK, Gilcrease MZAJR. American journal of roentgenologyImaging differences in metaplastic and invasive ductal carcinomas of the breast. AJR Am J Roentgenol. 2007 Dec; 189(6):1288-93.AJR Am J Roentgenol2007-12-01T00:00:002007Imaging differences in metaplastic and invasive ductal carcinomas of the breast.18206436Boughey JC, Buzdar AU, Hunt KKCurrent problems in surgeryRecent advances in the hormonal treatment of breast cancer. Curr Probl Surg. 2008 Jan; 45(1):13-55.Curr Probl Surg2008-01-01T00:00:002008Recent advances in the hormonal treatment of breast cancer.18306370Al-Refaie WB, Andtbacka RH, Ensor J, Pisters PW, Ellis TL, Shrout A, Hunt KK, Cormier JN, Pollock RE, Feig BWCancerLymphadenectomy for isolated lymph node metastasis from extremity soft-tissue sarcomas. Cancer. 2008 Apr 15; 112(8):1821-6.Cancer2008-04-15T00:00:002008Lymphadenectomy for isolated lymph node metastasis from extremity soft-tissue sarcomas.18442039Jeruss JS, Newman LA, Ayers GD, Cristofanilli M, Broglio KR, Meric-Bernstam F, Yi M, Waljee JF, Ross MI, Hunt KKCancerFactors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy. Cancer. 2008 Jun 15; 112(12):2646-54.Cancer2008-06-15T00:00:002008Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy.18632641Wang-Johanning F, Radvanyi L, Rycaj K, Plummer JB, Yan P, Sastry KJ, Piyathilake CJ, Hunt KK, Johanning GLCancer researchHuman endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients. Cancer Res. 2008 Jul 15; 68(14):5869-77.Cancer Res2008-07-15T00:00:002008Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients.18649996Yang J, Du X, Chen K, Ylip?? A, Lazar AJ, Trent J, Lev D, Pollock R, Hao X, Hunt K, Zhang WCancer lettersGenetic aberrations in soft tissue leiomyosarcoma. Cancer Lett. 2009 Mar 08; 275(1):1-8.Cancer Lett2008-07-22T00:00:002008Genetic aberrations in soft tissue leiomyosarcoma.18671247Yang J, Du X, Lazar AJ, Pollock R, Hunt K, Chen K, Hao X, Trent J, Zhang WCancerGenetic aberrations of gastrointestinal stromal tumors. Cancer. 2008 Oct 01; 113(7):1532-43.Cancer2008-10-01T00:00:002008Genetic aberrations of gastrointestinal stromal tumors.18953611McAuliffe JC, Hunt KK, Lazar AJ, Choi H, Qiao W, Thall P, Pollock RE, Benjamin RS, Trent JCAnnals of surgical oncologyA randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis. Ann Surg Oncol. 2009 Apr; 16(4):910-9.Ann Surg Oncol2008-10-25T00:00:002008A randomized, phase II study of preoperative plus postoperative imatinib in GIST: evidence of rapid radiographic response and temporal induction of tumor cell apoptosis.19047121Moulder SL, Symmans WF, Booser DJ, Madden TL, Lipsanen C, Yuan L, Brewster AM, Cristofanilli M, Hunt KK, Buchholz TA, Zwiebel J, Valero V, Hortobagyi GN, Esteva FJClinical cancer research : an official journal of the American Association for Cancer ResearchPhase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer. Clin Cancer Res. 2008 Dec 01; 14(23):7909-16.Clin Cancer Res2008-12-01T00:00:002008Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer.19351758Lahat G, Lazar A, Wang X, Wang WL, Zhu QS, Hunt KK, Pollock RE, Lev DClinical cancer research : an official journal of the American Association for Cancer ResearchIncreased vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomas. Clin Cancer Res. 2009 Apr 15; 15(8):2637-46.Clin Cancer Res2009-04-07T00:00:002009Increased vascular endothelial growth factor-C expression is insufficient to induce lymphatic metastasis in human soft-tissue sarcomas.19624418Boughey JC, Goravanchi F, Parris RN, Kee SS, Frenzel JC, Hunt KK, Ames FC, Kuerer HM, Lucci AThe breast journalImproved postoperative pain control using thoracic paravertebral block for breast operations. Breast J. 2009 Sep-Oct; 15(5):483-8.Breast J2009-07-13T00:00:002009Improved postoperative pain control using thoracic paravertebral block for breast operations.20530685Bagheri-Yarmand R, Biernacka A, Hunt KK, Keyomarsi KCancer researchLow molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification. Cancer Res. 2010 Jun 15; 70(12):5074-84.Cancer Res2010-06-08T00:00:002010Low molecular weight cyclin E overexpression shortens mitosis, leading to chromosome missegregation and centrosome amplification.20647335Yi M, Hunt KK, Arun BK, Bedrosian I, Barrera AG, Do KA, Kuerer HM, Babiera GV, Mittendorf EA, Ready K, Litton J, Meric-Bernstam FCancer prevention research (Philadelphia, Pa.)Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Phila). 2010 Aug; 3(8):1026-34.Cancer Prev Res (Phila)2010-07-20T00:00:002010Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.20823156Caruso JA, Hunt KK, Keyomarsi KCancer researchThe neutrophil elastase inhibitor elafin triggers rb-mediated growth arrest and caspase-dependent apoptosis in breast cancer. Cancer Res. 2010 Sep 15; 70(18):7125-36.Cancer Res2010-09-07T00:00:002010The neutrophil elastase inhibitor elafin triggers rb-mediated growth arrest and caspase-dependent apoptosis in breast cancer.21979111Wagner JL, Fearmonti R, Hunt KK, Hwang RF, Meric-Bernstam F, Kuerer HM, Bedrosian I, Crosby MA, Baumann DP, Ross MI, Feig BW, Krishnamurthy S, Hernandez M, Babiera GVAnnals of surgical oncologyProspective evaluation of the nipple-areola complex sparing mastectomy for risk reduction and for early-stage breast cancer. Ann Surg Oncol. 2012 Apr; 19(4):1137-44.Ann Surg Oncol2011-10-07T00:00:002011Prospective evaluation of the nipple-areola complex sparing mastectomy for risk reduction and for early-stage breast cancer.22621334Caudle AS, Yu TK, Tucker SL, Bedrosian I, Litton JK, Gonzalez-Angulo AM, Hoffman K, Meric-Bernstam F, Hunt KK, Buchholz TA, Mittendorf EABreast cancer research : BCRLocal-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy. Breast Cancer Res. 2012 May 23; 14(3):R83.Breast Cancer Res2012-05-23T00:00:002012Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy.22622473Alvarado R, Lari SA, Roses RE, Smith BD, Yang W, Mittendorf EA, Arun BK, Lucci A, Babiera GV, Wagner JL, Caudle AS, Meric-Bernstam F, Hwang RF, Bedrosian I, Hunt KK, Kuerer HMAnnals of surgical oncologyBiology, treatment, and outcome in very young and older women with DCIS. Ann Surg Oncol. 2012 Nov; 19(12):3777-84.Ann Surg Oncol2012-05-24T00:00:002012Biology, treatment, and outcome in very young and older women with DCIS.23002684Hunt K, Kohman L, Nelson HBulletin of the American College of SurgeonsAnnouncing the surgical standards manual project: a call for volunteers. Bull Am Coll Surg. 2012 Sep; 97(9):67-8.Bull Am Coll Surg2012-09-01T00:00:002012Announcing the surgical standards manual project: a call for volunteers.23337751Bayraktar S, Gutierrez Barrera AM, Liu D, Pusztai L, Litton J, Valero V, Hunt K, Hortobagyi GN, Wu Y, Symmans F, Arun BCancer journal (Sudbury, Mass.)USP-11 as a predictive and prognostic factor following neoadjuvant therapy in women with breast cancer. Cancer J. 2013 Jan-Feb; 19(1):10-7.Cancer J2013-01-01T00:00:002013USP-11 as a predictive and prognostic factor following neoadjuvant therapy in women with breast cancer.23562929Kim MM, Allen P, Gonzalez-Angulo AM, Woodward WA, Meric-Bernstam F, Buzdar AU, Hunt KK, Kuerer HM, Litton JK, Hortobagyi GN, Buchholz TA, Mittendorf EAAnnals of oncology : official journal of the European Society for Medical OncologyPathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer. Ann Oncol. 2013 Aug; 24(8):1999-2004.Ann Oncol2013-04-05T00:00:002013Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer.24473644Hunt KK, Smith BD, Mittendorf EAAnnals of surgical oncologyThe controversy regarding margin width in breast cancer: enough is enough. Ann Surg Oncol. 2014 Mar; 21(3):701-3.Ann Surg Oncol2014-01-29T00:00:002014The controversy regarding margin width in breast cancer: enough is enough.25004649Mittendorf EA, Hunt KKOncology (Williston Park, N.Y.)Following the data: past, present, and future management of the axilla in breast cancer patients. Oncology (Williston Park). 2014 May; 28(5):378, 380, 382.Oncology (Williston Park)2014-05-01T00:00:002014Following the data: past, present, and future management of the axilla in breast cancer patients.Experimental Radiation OncologyInvestigational Cancer TherapeuticsLeukemiaRadiation OncologyMD AndersonHENRY MARKKUERERHENRY MARK KUERER8727KUERER, HENRY MARKProfessorTHOMAS ABUCHHOLZTHOMAS A BUCHHOLZ8732BUCHHOLZ, THOMAS AProfessorHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessor15.95660.003053871415research areas12.21830.0113143293coauthor of690.88135.0660similar to11897selected publicationsELIZABETH ANNMITTENDORFELIZABETH ANN MITTENDORF9277MITTENDORF, ELIZABETH ANNAssociate ProfessorFUNDAMERIC-BERNSTAMFUNDA MERIC-BERNSTAM8778MERIC-BERNSTAM, FUNDAProfessorKHANDANKEYOMARSIKHANDAN KEYOMARSI8908KEYOMARSI, KHANDANProfessorAuthorship 2120641Authorship 2146063Authorship 2157381Authorship 2166494Authorship 2168733Authorship 2172809Authorship 2173023Authorship 2174342Authorship 2175473Authorship 2176812Authorship 2176894Authorship 21812113Authorship 2182334Authorship 2184073Authorship 2185864Authorship 2186264Authorship 21863510Authorship 21865410Authorship 2186592Authorship 2186789Authorship 2187406Authorship 2188139Authorship 2188913Authorship 2188994Authorship 21896015Authorship 21906813Authorship 21912714Authorship 21925413Authorship 21935716Authorship 2198198Authorship 2201189Authorship 2201943Authorship 2202535Authorship 2208007Authorship 2208488Authorship 2208814Authorship 22114612Authorship 2213404Authorship 2214309Authorship 2215632Authorship 2215875Authorship 2217502Authorship 2219087Authorship 2219248Authorship 2219976Authorship 2220826Authorship 2221253Authorship 2222785Authorship 2224825Authorship 2228674Authorship 22289110Authorship 2229702Authorship 2230654Authorship 2239927Authorship 2241155Authorship 2241725Authorship 2241757Authorship 2243623Authorship 2244596Authorship 2244927Authorship 2245705Authorship 2247905Authorship 2247934Authorship 22483510Authorship 2250376Authorship 2253359Authorship 2254094Authorship 2254152Authorship 2255412Authorship 2256352Authorship 22645611Authorship 22654410Authorship 2270859Authorship 2272288Authorship 22756420Authorship 2278172Authorship 2279485Authorship 22810210Authorship 2282002Authorship 2284172Authorship 22843610Authorship 2285692Authorship 2286182Authorship 2287678Authorship 2288723Authorship 2290562Authorship 2290594Authorship 2291613Authorship 2293605Authorship 2294496Authorship 2295949Authorship 2296171Authorship 2297098Authorship 22975613Authorship 2299363Authorship 2301026Authorship 2301589Authorship 2302218Authorship 2303077Authorship 2303598Authorship 23053522Authorship 2306239Authorship 23119411Authorship 23143213Authorship 2315438Authorship 2316064Authorship 2319612Authorship 2319912Authorship 23237515Authorship 2324752Authorship 2327703Authorship 2328189Authorship 2347101Authorship 23475012Authorship 2348229Authorship 23487791563014Hunt KK, Shibata M, Gupta RK, Morton DLCancer immunology, immunotherapy : CIIComplement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen. Cancer Immunol Immunother. 1992; 34(6):377-82.Cancer Immunol Immunother1992-01-01T00:00:001992Complement-dependent lysis of tumor cells by a baboon IgM antibody to a tumor-associated antigen.7977999Swisher SG, Schmit PJ, Hunt KK, Hiyama DT, Bennion RS, Swisher EM, Thompson JEAmerican journal of surgeryBiliary disease during pregnancy. Am J Surg. 1994 Dec; 168(6):576-9; discussion 580-1.Am J Surg1994-12-01T00:00:001994Biliary disease during pregnancy.9416413Bouvet M, Ollila DW, Hunt KK, Babiera GV, Spitz FR, Giuliano AE, Strom EA, Ames FC, Ross MI, Singletary SEAnnals of surgical oncologyRole of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997 Dec; 4(8):650-4.Ann Surg Oncol1997-12-01T00:00:001997Role of conservation therapy for invasive lobular carcinoma of the breast.9865717Hunt KK, Fleming JB, Abramian A, Zhang L, Evans DB, Chiao PJCancer researchOverexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells. Cancer Res. 1998 Dec 15; 58(24):5656-61.Cancer Res1998-12-15T00:00:001998Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells.10373666Steck K, Hunt K, Tucker S, Singletary S, El-Naggar AKOncology reportsFlow cytometric analysis of Ki-67 in invasive ductal carcinoma of the breast: correlation with tumor and patient characteristics. Oncol Rep. 1999 Jul-Aug; 6(4):835-8.Oncol Rep1999-07-01T00:00:001999Flow cytometric analysis of Ki-67 in invasive ductal carcinoma of the breast: correlation with tumor and patient characteristics.10440767Newman LA, Kuerer HM, Harper T, Hunt KK, Laronga C, Breslin T, Singletary SEJournal of surgical oncologySpecial considerations in breast cancer risk and survival. J Surg Oncol. 1999 Aug; 71(4):250-60.J Surg Oncol1999-08-01T00:00:001999Special considerations in breast cancer risk and survival.10455913Feig BW, Lu X, Hunt KK, Shan Q, Yu D, Pollock R, Chiao PSurgeryInhibition of the transcription factor nuclear factor-kappa B by adenoviral-mediated expression of I kappa B alpha M results in tumor cell death. Surgery. 1999 Aug; 126(2):399-405.Surgery1999-08-01T00:00:001999Inhibition of the transcription factor nuclear factor-kappa B by adenoviral-mediated expression of I kappa B alpha M results in tumor cell death.10622504Lenert JT, Vlastos G, Mirza NQ, Winchester DJ, Binkley SM, Ames FC, Ross MI, Feig BW, Hunt KK, Strom E, Buzdar AU, Hortobagyi GN, Singletary SEAnnals of surgical oncologyPrimary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients. Ann Surg Oncol. 1999 Dec; 6(8):762-7.Ann Surg Oncol1999-12-01T00:00:001999Primary tumor response to induction chemotherapy as a predictor of histological status of axillary nodes in operable breast cancer patients.10703863Kuerer HM, Hunt KK, Newman LA, Ross MI, Ames FC, Singletary SEJournal of the American College of SurgeonsNeoadjuvant chemotherapy in women with invasive breast carcinoma: conceptual basis and fundamental surgical issues. J Am Coll Surg. 2000 Mar; 190(3):350-63.J Am Coll Surg2000-03-01T00:00:002000Neoadjuvant chemotherapy in women with invasive breast carcinoma: conceptual basis and fundamental surgical issues.10797292Peng H, Xu F, Pershad R, Hunt KK, Frazier ML, Berchuck A, Gray JW, Hogg D, Bast RC, Yu YInternational journal of cancerARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers. Int J Cancer. 2000 Jun 01; 86(5):690-4.Int J Cancer2000-06-01T00:00:002000ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancers.10894139Meric F, Mirza NQ, Buzdar AU, Hunt KK, Ames FC, Ross MI, Pollock RE, Newman LA, Feig BW, Strom EA, Buchholz TA, McNeese MD, Hortobagyi GN, Singletary SEAnnals of surgical oncologyPrognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer. Ann Surg Oncol. 2000 Jul; 7(6):435-40.Ann Surg Oncol2000-07-01T00:00:002000Prognostic implications of pathological lymph node status after preoperative chemotherapy for operable T3N0M0 breast cancer.10989906Newman LA, Kuerer HM, Hung KK, Vlastos G, Ames FC, Ross MI, Singletary SEJournal of the American College of SurgeonsProphylactic mastectomy. J Am Coll Surg. 2000 Sep; 191(3):322-30.J Am Coll Surg2000-09-01T00:00:002000Prophylactic mastectomy.11034242Mirza NQ, Vlastos G, Meric F, Sahin AA, Singletary SE, Newman LA, Kuerer HM, Ames FC, Ross MI, Feig BW, Pollock RE, Buchholz TA, McNeese MD, Strom EA, Hortobagyi GN, Hunt KKAnnals of surgical oncologyDuctal carcinoma-in-situ: long-term results of breast-conserving therapy. Ann Surg Oncol. 2000 Oct; 7(9):656-64.Ann Surg Oncol2000-10-01T00:00:002000Ductal carcinoma-in-situ: long-term results of breast-conserving therapy.11072150Freedman LM, Buchholz TA, Thames HD, Strom EA, McNeese MD, Hortobagyi GN, Singletary SE, Heaton KM, Hunt KKInternational journal of radiation oncology, biology, physicsLocal-regional control in breast cancer patients with a possible genetic predisposition. Int J Radiat Oncol Biol Phys. 2000 Nov 01; 48(4):951-7.Int J Radiat Oncol Biol Phys2000-11-01T00:00:002000Local-regional control in breast cancer patients with a possible genetic predisposition.11169942Portera CA, Ho V, Patel SR, Hunt KK, Feig BW, Respondek PM, Yasko AW, Benjamin RS, Pollock RE, Pisters PWCancerAlveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer. 2001 Feb 01; 91(3):585-91.Cancer2001-02-01T00:00:002001Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution.11352312Newman LA, Kuerer HM, Hunt KK, Vlastos G, Ames FC, Ross MI, Singletary SEAnnals of surgical oncologyEducational review: role of the surgeon in hereditary breast cancer. Ann Surg Oncol. 2001 May; 8(4):368-78.Ann Surg Oncol2001-05-01T00:00:002001Educational review: role of the surgeon in hereditary breast cancer.11550159Fleming JB, Cantor SB, Varma DG, Holst D, Feig BW, Hunt KK, Patel SR, Benjamin RS, Pollock RE, Pisters PWCancerUtility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas. Cancer. 2001 Aug 15; 92(4):863-8.Cancer2001-08-15T00:00:002001Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas.11597808Schlembach PJ, Buchholz TA, Ross MI, Kirsner SM, Salas GJ, Strom EA, McNeese MD, Perkins GH, Hunt KKInternational journal of radiation oncology, biology, physicsRelationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys. 2001 Nov 01; 51(3):671-8.Int J Radiat Oncol Biol Phys2001-11-01T00:00:002001Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation.11720678Albo D, Wayne JD, Hunt KK, Rahlfs TF, Singletary SE, Ames FC, Feig BW, Ross MI, Kuerer HMAmerican journal of surgeryAnaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer. Am J Surg. 2001 Oct; 182(4):393-8.Am J Surg2001-10-01T00:00:002001Anaphylactic reactions to isosulfan blue dye during sentinel lymph node biopsy for breast cancer.11745249Cristofanilli M, Buzdar AU, Sneige N, Smith T, Wasaff B, Ibrahim N, Booser D, Rivera E, Murray JL, Valero V, Ueno N, Singletary ES, Hunt K, Strom E, McNeese M, Stelling C, Hortobagyi GNCancerPaclitaxel in the multimodality treatment for inflammatory breast carcinoma. Cancer. 2001 Oct 01; 92(7):1775-82.Cancer2001-10-01T00:00:002001Paclitaxel in the multimodality treatment for inflammatory breast carcinoma.11800340Keleher AJ, Theriault RL, Gwyn KM, Hunt KK, Stelling CB, Singletary SE, Ames FC, Buchholz TA, Sahin AA, Kuerer HMJournal of the American College of SurgeonsMultidisciplinary management of breast cancer concurrent with pregnancy. J Am Coll Surg. 2002 Jan; 194(1):54-64.J Am Coll Surg2002-01-01T00:00:002002Multidisciplinary management of breast cancer concurrent with pregnancy.11839324Kuerer HM, Singletary SE, Buzdar AU, Ames FC, Valero V, Buchholz TA, Ross MI, Pusztai L, Hortobagyi GN, Hunt KKAmerican journal of surgerySurgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma. Am J Surg. 2001 Dec; 182(6):601-8.Am J Surg2001-12-01T00:00:002001Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma.11854546Vorburger SA, Hunt KKThe oncologistAdenoviral gene therapy. Oncologist. 2002; 7(1):46-59.Oncologist2002-01-01T00:00:002002Adenoviral gene therapy.11884322Meric F, Bernstam EV, Mirza NQ, Hunt KK, Ames FC, Ross MI, Kuerer HM, Pollock RE, Musen MA, Singletary SEBMJ (Clinical research ed.)Breast cancer on the world wide web: cross sectional survey of quality of information and popularity of websites. BMJ. 2002 Mar 09; 324(7337):577-81.BMJ2002-03-09T00:00:002002Breast cancer on the world wide web: cross sectional survey of quality of information and popularity of websites.11923128Newman LA, Buzdar AU, Singletary SE, Kuerer HM, Buchholz T, Ames FC, Ross MI, Hunt KKAnnals of surgical oncologyA prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility. Ann Surg Oncol. 2002 Apr; 9(3):228-34.Ann Surg Oncol2002-04-01T00:00:002002A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility.11923132Mirza NQ, Vlastos G, Meric F, Buchholz TA, Esnaola N, Singletary SE, Kuerer HM, Newman LA, Ames FC, Ross MI, Feig BW, Pollock RE, McNeese M, Strom E, Hunt KKAnnals of surgical oncologyPredictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol. 2002 Apr; 9(3):256-65.Ann Surg Oncol2002-04-01T00:00:002002Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy.11999950Singletary SE, Fornage BD, Sneige N, Ross MI, Simmons R, Giuliano A, Hansen N, Kuerer HM, Newman LA, Ames FC, Babiera G, Meric F, Hunt KK, Edeiken B, Mirza ANCancer journal (Sudbury, Mass.)Radiofrequency ablation of early-stage invasive breast tumors: an overview. Cancer J. 2002 Mar-Apr; 8(2):177-80.Cancer J2002-03-01T00:00:002002Radiofrequency ablation of early-stage invasive breast tumors: an overview.12015769Bilimoria MM, Holtz DJ, Mirza NQ, Feig BW, Pisters PW, Patel S, Pollock RE, Benjamin RS, Papadopoulos NE, Plager C, Murphy A, Griffin JR, Burgess MA, Hunt KKCancerTumor volume as a prognostic factor for sarcomatosis. Cancer. 2002 May 01; 94(9):2441-6.Cancer2002-05-01T00:00:002002Tumor volume as a prognostic factor for sarcomatosis.12209680Krishnamurthy S, Sneige N, Bedi DG, Edieken BS, Fornage BD, Kuerer HM, Singletary SE, Hunt KKCancerRole of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer. 2002 Sep 01; 95(5):982-8.Cancer2002-09-01T00:00:002002Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma.12214268Vorburger SA, Pataer A, Yoshida K, Barber GN, Xia W, Chiao P, Ellis LM, Hung MC, Swisher SG, Hunt KKOncogeneRole for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis. Oncogene. 2002 Sep 12; 21(41):6278-88.Oncogene2002-09-12T00:00:002002Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis.12412158Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, Feig BW, Kuerer HM, Ross MI, Singletary SE, McNeese MD, Strom EA, Hunt KKCancerClassifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer. 2002 Nov 15; 95(10):2059-67.Cancer2002-11-15T00:00:002002Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences.12646190Yan DH, Abramian A, Li Z, Ding Y, Wen Y, Liu TJ, Hunt KBiochemical and biophysical research communicationsP202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells. Biochem Biophys Res Commun. 2003 Mar 28; 303(1):219-22.Biochem Biophys Res Commun2003-03-28T00:00:002003P202, an interferon-inducible protein, inhibits E2F1-mediated apoptosis in prostate cancer cells.12909225Chagpar A, Kuerer HM, Hunt KK, Strom EA, Buchholz TAInternational journal of radiation oncology, biology, physicsOutcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: implications for post-mastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 2003 Sep 01; 57(1):128-35.Int J Radiat Oncol Biol Phys2003-09-01T00:00:002003Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: implications for post-mastectomy radiation therapy.12957243Woodward WA, Strom EA, Tucker SL, Katz A, McNeese MD, Perkins GH, Buzdar AU, Hortobagyi GN, Hunt KK, Sahin A, Meric F, Sneige N, Buchholz TAInternational journal of radiation oncology, biology, physicsLocoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2003 Oct 01; 57(2):336-44.Int J Radiat Oncol Biol Phys2003-10-01T00:00:002003Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation.14553853Chagpar A, Yen T, Sahin A, Hunt KK, Whitman GJ, Ames FC, Ross MI, Meric-Bernstam F, Babiera GV, Singletary SE, Kuerer HMAmerican journal of surgeryIntraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. Am J Surg. 2003 Oct; 186(4):371-7.Am J Surg2003-10-01T00:00:002003Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery.14745864Pawlik TM, Perry A, Strom EA, Babiera GV, Buchholz TA, Singletary E, Perkins GH, Ross MI, Schecter NR, Meric-Bernstam F, Ames FC, Hunt KK, Kuerer HMCancerPotential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma. Cancer. 2004 Feb 01; 100(3):490-8.Cancer2004-02-01T00:00:002004Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.15024716Koh JS, Trent J, Chen L, El-Naggar A, Hunt K, Pollock R, Zhang WHistology and histopathologyGastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate. Histol Histopathol. 2004 04; 19(2):565-74.Histol Histopathol2004-04-01T00:00:002004Gastrointestinal stromal tumors: overview of pathologic features, molecular biology, and therapy with imatinib mesylate.15120650Chada S, Sutton RB, Ekmekcioglu S, Ellerhorst J, Mumm JB, Leitner WW, Yang HY, Sahin AA, Hunt KK, Fuson KL, Po?ndexter N, Roth JA, Ramesh R, Grimm EA, Mhashilkar AMInternational immunopharmacologyMDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family. Int Immunopharmacol. 2004 May; 4(5):649-67.Int Immunopharmacol2004-05-01T00:00:002004MDA-7/IL-24 is a unique cytokine--tumor suppressor in the IL-10 family.15234041Shahar KH, Hunt KK, Thames HD, Ross MI, Perkins GH, Kuerer HM, Strom EA, McNeese MD, Meric F, Schechter NR, Sahin AA, Middleton LP, Buchholz TAInternational journal of radiation oncology, biology, physicsFactors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields. Int J Radiat Oncol Biol Phys. 2004 Jul 15; 59(4):1074-9.Int J Radiat Oncol Biol Phys2004-07-15T00:00:002004Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields.15376199Krishnamurthy S, Zhao L, Hayes K, Glassman AB, Cristofanilli M, Singletary SE, Hunt KK, Kuerer HM, Sneige NCancerFeasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study. Cancer. 2004 Oct 25; 102(5):322-7.Cancer2004-10-25T00:00:002004Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study.15454152Newman LA, Hurd T, Leitch M, Kuerer HM, Diehl K, Lucci A, Giuliano A, Hunt KK, Putnam W, Wells SAJournal of the American College of SurgeonsA report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group. J Am Coll Surg. 2004 Oct; 199(4):644-51.J Am Coll Surg2004-10-01T00:00:002004A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.15564176Xing Y, Cormier JN, Kuerer HM, Hunt KKAsian journal of surgerySentinel lymph node biopsy following neoadjuvant chemotherapy: review of the literature and recommendations for use in patient management. Asian J Surg. 2004 Oct; 27(4):262-7.Asian J Surg2004-10-01T00:00:002004Sentinel lymph node biopsy following neoadjuvant chemotherapy: review of the literature and recommendations for use in patient management.15641036Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Babiera G, Hortobagyi GN, Buchholz TACancerBreast conservation after neoadjuvant chemotherapy. Cancer. 2005 Feb 15; 103(4):689-95.Cancer2005-02-15T00:00:002005Breast conservation after neoadjuvant chemotherapy.15692757Pawlik TM, Fritsche H, Coombes KR, Xiao L, Krishnamurthy S, Hunt KK, Pusztai L, Chen JN, Clarke CH, Arun B, Hung MC, Kuerer HMBreast cancer research and treatmentSignificant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry. Breast Cancer Res Treat. 2005 Jan; 89(2):149-57.Breast Cancer Res Treat2005-01-01T00:00:002005Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry.15912514Cabioglu N, Hunt KK, Buchholz TA, Mirza N, Singletary SE, Kuerer HM, Babiera GV, Ames FC, Sahin AA, Meric-Bernstam FCancerImproving local control with breast-conserving therapy: a 27-year single-institution experience. Cancer. 2005 Jul 01; 104(1):20-9.Cancer2005-07-01T00:00:002005Improving local control with breast-conserving therapy: a 27-year single-institution experience.15993550Nguyen KH, Hachem P, Khor LY, Salem N, Hunt KK, Calkins PR, Pollack AInternational journal of radiation oncology, biology, physicsAdenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells. Int J Radiat Oncol Biol Phys. 2005 Sep 01; 63(1):238-46.Int J Radiat Oncol Biol Phys2005-09-01T00:00:002005Adenoviral-E2F-1 radiosensitizes p53wild-type and p53null human prostate cancer cells.16164930Khakpour N, Hunt KK, Kuerer HM, Yi M, Meric-Bernstam F, Ross MI, Lucci AAmerican journal of surgerySentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node. Am J Surg. 2005 Oct; 190(4):598-601.Am J Surg2005-10-01T00:00:002005Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.16329089Xing Y, Foy M, Cox DD, Kuerer HM, Hunt KK, Cormier JNThe British journal of surgeryMeta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg. 2006 May; 93(5):539-46.Br J Surg2006-05-01T00:00:002006Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.16371742Andtbacka RH, Babiera G, Singletary SE, Hunt KK, Meric-Bernstam F, Feig BW, Ames FC, Ross MI, Dejesus Y, Kuerer HMAnnals of surgeryIncidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg. 2006 Jan; 243(1):96-101.Ann Surg2006-01-01T00:00:002006Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways.16432360Chagpar AB, Middleton LP, Sahin AA, Dempsey P, Buzdar AU, Mirza AN, Ames FC, Babiera GV, Feig BW, Hunt KK, Kuerer HM, Meric-Bernstam F, Ross MI, Singletary SEAnnals of surgeryAccuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg. 2006 Feb; 243(2):257-64.Ann Surg2006-02-01T00:00:002006Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy.16491338Pawlik TM, Pisters PW, Mikula L, Feig BW, Hunt KK, Cormier JN, Ballo MT, Catton CN, Jones JJ, O'Sullivan B, Pollock RE, Swallow CJAnnals of surgical oncologyLong-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol. 2006 Apr; 13(4):508-17.Ann Surg Oncol2006-02-24T00:00:002006Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma.16542425Pawlik TM, Hawke DH, Liu Y, Krishnamurthy S, Fritsche H, Hunt KK, Kuerer HMBMC cancerProteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer. 2006 Mar 16; 6:68.BMC Cancer2006-03-16T00:00:002006Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein.16628227Pataer A, Fanale MA, Roth JA, Swisher SG, Hunt KKCancer gene therapyInduction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53. Cancer Gene Ther. 2006 Aug; 13(8):806-14.Cancer Gene Ther2006-04-21T00:00:002006Induction of apoptosis in human lung cancer cells following treatment with amifostine and an adenoviral vector containing wild-type p53.16862596Peintinger F, Symmans WF, Gonzalez-Angulo AM, Boughey JC, Buzdar AU, Yu TK, Hunt KK, Singletary SE, Babiera GV, Lucci A, Meric-Bernstam F, Kuerer HMCancerThe safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer. 2006 Sep 15; 107(6):1248-54.Cancer2006-09-15T00:00:002006The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy.16926572Boughey JC, Peintinger F, Meric-Bernstam F, Perry AC, Hunt KK, Babiera GV, Singletary SE, Bedrosian I, Lucci A, Buzdar AU, Pusztai L, Kuerer HMAnnals of surgeryImpact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer. Ann Surg. 2006 Sep; 244(3):464-70.Ann Surg2006-09-01T00:00:002006Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer.16986125Trent JC, Ramdas L, Dupart J, Hunt K, Macapinlac H, Taylor E, Hu L, Salvado A, Abbruzzese JL, Pollock R, Benjamin RS, Zhang WCancerEarly effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor. Cancer. 2006 Oct 15; 107(8):1898-908.Cancer2006-10-15T00:00:002006Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor.17024233Pataer A, Bocangel D, Chada S, Roth JA, Hunt KK, Swisher SGCancer gene therapyEnhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 17-allyl- amino-17-demethoxy analogue. Cancer Gene Ther. 2007 Jan; 14(1):12-8.Cancer Gene Ther2006-10-06T00:00:002006Enhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 17-allyl- amino-17-demethoxy analogue.17028770Peintinger F, Kuerer HM, Anderson K, Boughey JC, Meric-Bernstam F, Singletary SE, Hunt KK, Whitman GJ, Stephens T, Buzdar AU, Green MC, Symmans WFAnnals of surgical oncologyAccuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy. Ann Surg Oncol. 2006 Nov; 13(11):1443-9.Ann Surg Oncol2006-09-21T00:00:002006Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.17084545Ballo MT, Zagars GK, Pollock RE, Benjamin RS, Feig BW, Cormier JN, Hunt KK, Patel SR, Trent JC, Beddar S, Pisters PWInternational journal of radiation oncology, biology, physicsRetroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007 Jan 01; 67(1):158-63.Int J Radiat Oncol Biol Phys2006-11-02T00:00:002006Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment.17260108Cabioglu N, Hunt KK, Sahin AA, Kuerer HM, Babiera GV, Singletary SE, Whitman GJ, Ross MI, Ames FC, Feig BW, Buchholz TA, Meric-Bernstam FAnnals of surgical oncologyRole for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol. 2007 Apr; 14(4):1458-71.Ann Surg Oncol2007-01-28T00:00:002007Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.17360660Price ND, Trent J, El-Naggar AK, Cogdell D, Taylor E, Hunt KK, Pollock RE, Hood L, Shmulevich I, Zhang WProceedings of the National Academy of Sciences of the United States of AmericaHighly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas. Proc Natl Acad Sci U S A. 2007 Feb 27; 104(9):3414-9.Proc Natl Acad Sci U S A2007-02-21T00:00:002007Highly accurate two-gene classifier for differentiating gastrointestinal stromal tumors and leiomyosarcomas.17485711Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE, American College of Surgeons Oncology GroupJournal of clinical oncology : official journal of the American Society of Clinical OncologySurgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol. 2007 Aug 20; 25(24):3657-63.J Clin Oncol2007-05-07T00:00:002007Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.17582626Williams SA, Ehlers RA, Hunt KK, Yi M, Kuerer HM, Singletary SE, Ross MI, Feig BW, Symmans WF, Meric-Bernstam FCancerMetastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival. Cancer. 2007 Aug 15; 110(4):731-7.Cancer2007-08-15T00:00:002007Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival.17587208Hwang RF, Gonzalez-Angulo AM, Yi M, Buchholz TA, Meric-Bernstam F, Kuerer HM, Babiera GV, Tereffe W, Liu DD, Hunt KKCancerLow locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer. 2007 Aug 15; 110(4):723-30.Cancer2007-08-15T00:00:002007Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection.17826054Boughey JC, Middleton LP, Harker L, Garrett B, Fornage B, Hunt KK, Babiera GV, Dempsey P, Bedrosian IAmerican journal of surgeryUtility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast. Am J Surg. 2007 Oct; 194(4):450-5.Am J Surg2007-10-01T00:00:002007Utility of ultrasound and fine-needle aspiration biopsy of the axilla in the assessment of invasive lobular carcinoma of the breast.17941034Oh JL, Nguyen G, Whitman GJ, Hunt KK, Yu TK, Woodward WA, Tereffe W, Strom EA, Perkins GH, Buchholz TACancerPlacement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy. Cancer. 2007 Dec 01; 110(11):2420-7.Cancer2007-12-01T00:00:002007Placement of radiopaque clips for tumor localization in patients undergoing neoadjuvant chemotherapy and breast conservation therapy.17944569Mittendorf EA, Hunt KKExpert review of anticancer therapySignificance and management of micrometastases in patients with breast cancer. Expert Rev Anticancer Ther. 2007 Oct; 7(10):1451-61.Expert Rev Anticancer Ther2007-10-01T00:00:002007Significance and management of micrometastases in patients with breast cancer.18056453Yokota T, Bui T, Liu Y, Yi M, Hunt KK, Keyomarsi KCancer researchDifferential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta. Cancer Res. 2007 Dec 01; 67(23):11272-83.Cancer Res2007-12-01T00:00:002007Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.18059175Pataer A, Chada S, Roth JA, Hunt KK, Swisher SGCancer biology & therapyDevelopment of Ad-mda7/IL-24-resistant lung cancer cell lines. Cancer Biol Ther. 2008 Jan; 7(1):103-8.Cancer Biol Ther2007-10-13T00:00:002007Development of Ad-mda7/IL-24-resistant lung cancer cell lines.18427152Badgwell BD, Giordano SH, Duan ZZ, Fang S, Bedrosian I, Kuerer HM, Singletary SE, Hunt KK, Hortobagyi GN, Babiera GJournal of clinical oncology : official journal of the American Society of Clinical OncologyMammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol. 2008 May 20; 26(15):2482-8.J Clin Oncol2008-04-21T00:00:002008Mammography before diagnosis among women age 80 years and older with breast cancer.18436181Yi M, Krishnamurthy S, Kuerer HM, Meric-Bernstam F, Bedrosian I, Ross MI, Ames FC, Lucci A, Hwang RF, Hunt KKAmerican journal of surgeryRole of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg. 2008 Jul; 196(1):81-7.Am J Surg2008-04-23T00:00:002008Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer.18640934Olson JA, McCall LM, Beitsch P, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE, American College of Surgeons Oncology Group Trials Z0010 and Z0011Journal of clinical oncology : official journal of the American Society of Clinical OncologyImpact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011. J Clin Oncol. 2008 Jul 20; 26(21):3530-5.J Clin Oncol2008-07-20T00:00:002008Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group Trials Z0010 and Z0011.18815841Mittendorf EA, Sahin AA, Tucker SL, Meric-Bernstam F, Yi M, Nayeemuddin KM, Babiera GV, Ross MI, Feig BW, Kuerer HM, Hunt KKAnnals of surgical oncologyLymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients. Ann Surg Oncol. 2008 Dec; 15(12):3369-77.Ann Surg Oncol2008-09-25T00:00:002008Lymphovascular invasion and lobular histology are associated with increased incidence of isolated tumor cells in sentinel lymph nodes from early-stage breast cancer patients.19318554Delk NA, Hunt KK, Keyomarsi KCancer researchAltered subcellular localization of tumor-specific cyclin E isoforms affects cyclin-dependent kinase 2 complex formation and proteasomal regulation. Cancer Res. 2009 Apr 01; 69(7):2817-25.Cancer Res2009-03-24T00:00:002009Altered subcellular localization of tumor-specific cyclin E isoforms affects cyclin-dependent kinase 2 complex formation and proteasomal regulation.19536326Lott ST, Chen N, Chandler DS, Yang Q, Wang L, Rodriguez M, Xie H, Balasenthil S, Buchholz TA, Sahin AA, Chaung K, Zhang B, Olufemi SE, Chen J, Adams H, Band V, El-Naggar AK, Frazier ML, Keyomarsi K, Hunt KK, Sen S, Haffty B, Hewitt SM, Krahe R, Killary AMPLoS medicineDEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer. PLoS Med. 2009 May 26; 6(5):e1000068.PLoS Med2009-05-05T00:00:002009DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.19680729Fearmonti RM, Gayed IW, Kim E, Bedrosian I, Hunt KK, Meric-Bernstam F, Feig B, Ghonimi E, Warneke C, Babiera GVAnnals of surgical oncologyIntra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancer. Ann Surg Oncol. 2010 Jan; 17(1):220-7.Ann Surg Oncol2009-08-13T00:00:002009Intra-individual comparison of lymphatic drainage patterns using subareolar and peritumoral isotope injection for breast cancer.20154588Nguyen CV, Falc?n-Escobedo R, Hunt KK, Nayeemuddin KM, Lester TR, Harrell RK, Bassett RL, Gilcrease MZThe American journal of surgical pathologyPleomorphic ductal carcinoma of the breast: predictors of decreased overall survival. Am J Surg Pathol. 2010 Apr; 34(4):486-93.Am J Surg Pathol2010-04-01T00:00:002010Pleomorphic ductal carcinoma of the breast: predictors of decreased overall survival.20224366Rourke LL, Hunt KKAnnals of surgeryAvoiding radiation after breast-conserving surgery for ductal carcinoma in situ of the breast: beyond the margin. Ann Surg. 2010 Apr; 251(4):592-4.Ann Surg2010-04-01T00:00:002010Avoiding radiation after breast-conserving surgery for ductal carcinoma in situ of the breast: beyond the margin.20237430Sun B, Wingate H, Swisher SG, Keyomarsi K, Hunt KKCell cycle (Georgetown, Tex.)Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cells. Cell Cycle. 2010 Mar 15; 9(6):1122-30.Cell Cycle2010-03-15T00:00:002010Absence of pRb facilitates E2F1-induced apoptosis in breast cancer cells.20309640Wilke LG, Ballman KV, McCall LM, Giuliano AE, Whitworth PW, Blumencranz PW, Reintgen DS, Burak WE, Leitch AM, Hunt KKAnnals of surgical oncologyAdherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010. Ann Surg Oncol. 2010 Aug; 17(8):1989-94.Ann Surg Oncol2010-03-23T00:00:002010Adherence to the National Quality Forum (NQF) breast cancer measures within cancer clinical trials: a review from ACOSOG Z0010.20426606Rourke LL, Hunt KK, Cormier JNWomen's health (London, England)Breast cancer and lymphedema: a current overview for the healthcare provider. Womens Health (Lond). 2010 May; 6(3):399-406.Womens Health (Lond)2010-05-01T00:00:002010Breast cancer and lymphedema: a current overview for the healthcare provider.20453888Mittendorf EA, Liu Y, Tucker SL, McKenzie T, Qiao N, Akli S, Biernacka A, Liu Y, Meijer L, Keyomarsi K, Hunt KKOncogeneA novel interaction between HER2/neu and cyclin E in breast cancer. Oncogene. 2010 Jul 08; 29(27):3896-907.Oncogene2010-05-10T00:00:002010A novel interaction between HER2/neu and cyclin E in breast cancer.20559739Hall C, Krishnamurthy S, Lodhi A, Mosalpuria K, Kuerer HM, Meric-Bernstam F, Bedrosian I, Hunt KK, Lucci AAnnals of surgical oncologyDisseminated tumor cells in biologic subtypes of stage I-III breast cancer patients. Ann Surg Oncol. 2010 Dec; 17(12):3252-8.Ann Surg Oncol2010-06-18T00:00:002010Disseminated tumor cells in biologic subtypes of stage I-III breast cancer patients.20564394Brown AS, Hunt KK, Shen J, Huo L, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Boughey JC, Ching CD, Gilcrease MZCancerHistologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment. Cancer. 2010 Jun 15; 116(12):2878-83.Cancer2010-06-15T00:00:002010Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatment.20655242Van Leeuwen BL, Rosenkranz KM, Feng LL, Bedrosian I, Hartmann K, Hunt KK, Kuerer HM, Ross M, Singletary SE, Babiera GV, Department of Surgical Oncology, MD Anderson Cancer CenterCritical reviews in oncology/hematologyThe effect of under-treatment of breast cancer in women 80 years of age and older. Crit Rev Oncol Hematol. 2011 Sep; 79(3):315-20.Crit Rev Oncol Hematol2010-07-23T00:00:002010The effect of under-treatment of breast cancer in women 80 years of age and older.20739842Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman KAnnals of surgeryLocoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010 Sep; 252(3):426-32; discussion 432-3.Ann Surg2010-09-01T00:00:002010Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.20740500Kuerer HM, Buzdar AU, Mittendorf EA, Esteva FJ, Lucci A, Vence LM, Radvanyi L, Meric-Bernstam F, Hunt KK, Symmans WFCancerBiologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast. Cancer. 2011 Jan 01; 117(1):39-47.Cancer2010-08-24T00:00:002010Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast.20818650Ylip?? A, Hunt KK, Yang J, Lazar AJ, Torres KE, Lev DC, Nykter M, Pollock RE, Trent J, Zhang WCancerIntegrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors. Cancer. 2011 Jan 15; 117(2):380-9.Cancer2010-09-03T00:00:002010Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors.20853057Yi M, Giordano SH, Meric-Bernstam F, Mittendorf EA, Kuerer HM, Hwang RF, Bedrosian I, Rourke L, Hunt KKAnnals of surgical oncologyTrends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database. Ann Surg Oncol. 2010 Oct; 17 Suppl 3:343-51.Ann Surg Oncol2010-09-19T00:00:002010Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database.21061075Caudle AS, Gonzalez-Angulo AM, Hunt KK, Pusztai L, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam FAnnals of surgical oncologyImpact of progression during neoadjuvant chemotherapy on surgical management of breast cancer. Ann Surg Oncol. 2011 Apr; 18(4):932-8.Ann Surg Oncol2011-04-01T00:00:002011Impact of progression during neoadjuvant chemotherapy on surgical management of breast cancer.21147692Valero V, Kong AL, Hunt KK, Yi M, Hwang RF, Meric-Bernstam F, Bedrosian I, Ross MI, Babiera GV, Litton JK, Mittendorf EAClinical breast cancerSentinel lymph node dissection is technically feasible in older breast cancer patients. Clin Breast Cancer. 2010 Dec 01; 10(6):477-82.Clin Breast Cancer2010-12-01T00:00:002010Sentinel lymph node dissection is technically feasible in older breast cancer patients.21246524Wray CJ, Benjamin RS, Hunt KK, Cormier JN, Ross MI, Feig BWCancerIsolated limb perfusion for unresectable extremity sarcoma: results of 2 single-institution phase 2 trials. Cancer. 2011 Jul 15; 117(14):3235-41.Cancer2011-01-18T00:00:002011Isolated limb perfusion for unresectable extremity sarcoma: results of 2 single-institution phase 2 trials.21304082Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow MJAMAAxillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011 Feb 09; 305(6):569-75.JAMA2011-02-09T00:00:002011Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.21321294Hsu C, Vega F, Grimes LM, Hunt KKJournal of clinical oncology : official journal of the American Society of Clinical OncologyFollicular dendritic cell sarcoma and associated myasthenia gravis: true, true, related? J Clin Oncol. 2011 May 01; 29(13):e369-71.J Clin Oncol2011-02-14T00:00:002011Follicular dendritic cell sarcoma and associated myasthenia gravis: true, true, related?21327455Caudle AS, Hunt KK, Kuerer HM, Meric-Bernstam F, Lucci A, Bedrosian I, Babiera GV, Hwang RF, Ross MI, Feig BW, Hoffman K, Litton JK, Sahin AA, Yang W, Hortobagyi GN, Buchholz TA, Mittendorf EAAnnals of surgical oncologyMultidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial. Ann Surg Oncol. 2011 Sep; 18(9):2407-12.Ann Surg Oncol2011-09-01T00:00:002011Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 study: a practice-changing trial.21472707Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Tereffe W, Woodward WA, Strom EA, Hunt KK, Tucker SL, Buchholz TACancerPatients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer. Cancer. 2011 Apr 15; 117(8):1595-601.Cancer2010-11-08T00:00:002010Patients with only 1 positive hormone receptor have increased locoregional recurrence compared with patients with estrogen receptor-positive progesterone receptor-positive disease in very early stage breast cancer.21494124Wagner JL, Warneke CL, Mittendorf EA, Bedrosian I, Babiera GV, Kuerer HM, Hunt KK, Yang W, Sahin AA, Meric-Bernstam FAnnals of surgeryDelays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients. Ann Surg. 2011 Jul; 254(1):119-24.Ann Surg2011-07-01T00:00:002011Delays in primary surgical treatment are not associated with significant tumor size progression in breast cancer patients.21546925Valero V, Wingate H, Chada S, Liu Y, Palalon F, Mills G, Keyomarsi K, Hunt KKCancer gene therapyMDA-7 results in downregulation of AKT concomitant with apoptosis and cell cycle arrest in breast cancer cells. Cancer Gene Ther. 2011 Jul; 18(7):510-9.Cancer Gene Ther2011-05-06T00:00:002011MDA-7 results in downregulation of AKT concomitant with apoptosis and cell cycle arrest in breast cancer cells.21558518Hatzis C, Pusztai L, Valero V, Booser DJ, Esserman L, Lluch A, Vidaurre T, Holmes F, Souchon E, Wang H, Martin M, Cotrina J, Gomez H, Hubbard R, Chac?n JI, Ferrer-Lozano J, Dyer R, Buxton M, Gong Y, Wu Y, Ibrahim N, Andreopoulou E, Ueno NT, Hunt K, Yang W, Nazario A, DeMichele A, O'Shaughnessy J, Hortobagyi GN, Symmans WFJAMAA genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA. 2011 May 11; 305(18):1873-81.JAMA2011-05-11T00:00:002011A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.21778330Euhus D, Bu D, Xie XJ, Sarode V, Ashfaq R, Hunt K, Xia W, O'Shaughnessy J, Grant M, Arun B, Dooley W, Miller A, Flockhart D, Lewis CCancer prevention research (Philadelphia, Pa.)Tamoxifen downregulates ets oncogene family members ETV4 and ETV5 in benign breast tissue: implications for durable risk reduction. Cancer Prev Res (Phila). 2011 Nov; 4(11):1852-62.Cancer Prev Res (Phila)2011-07-21T00:00:002011Tamoxifen downregulates ets oncogene family members ETV4 and ETV5 in benign breast tissue: implications for durable risk reduction.21791687Giuliano AE, Hawes D, Ballman KV, Whitworth PW, Blumencranz PW, Reintgen DS, Morrow M, Leitch AM, Hunt KK, McCall LM, Abati A, Cote RJAMAAssociation of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer. JAMA. 2011 Jul 27; 306(4):385-93.JAMA2011-07-27T00:00:002011Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer.22042942Haffty BG, Hunt KK, Harris JR, Buchholz TAJournal of clinical oncology : official journal of the American Society of Clinical OncologyPositive sentinel nodes without axillary dissection: implications for the radiation oncologist. J Clin Oncol. 2011 Dec 01; 29(34):4479-81.J Clin Oncol2011-10-31T00:00:002011Positive sentinel nodes without axillary dissection: implications for the radiation oncologist.22084362Yi M, Mittendorf EA, Cormier JN, Buchholz TA, Bilimoria K, Sahin AA, Hortobagyi GN, Gonzalez-Angulo AM, Luo S, Buzdar AU, Crow JR, Kuerer HM, Hunt KKJournal of clinical oncology : official journal of the American Society of Clinical OncologyNovel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system. J Clin Oncol. 2011 Dec 10; 29(35):4654-61.J Clin Oncol2011-11-14T00:00:002011Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.22247020Wang-Johanning F, Rycaj K, Plummer JB, Li M, Yin B, Frerich K, Garza JG, Shen J, Lin K, Yan P, Glynn SA, Dorsey TH, Hunt KK, Ambs S, Johanning GLJournal of the National Cancer InstituteImmunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors. J Natl Cancer Inst. 2012 Feb 08; 104(3):189-210.J Natl Cancer Inst2012-01-12T00:00:002012Immunotherapeutic potential of anti-human endogenous retrovirus-K envelope protein antibodies in targeting breast tumors.22331946Kelly CM, Green MC, Broglio K, Thomas ES, Brewster AM, Valero V, Ibrahim NK, Gonzalez-Angulo AM, Booser DJ, Walters RS, Hunt KK, Hortobagyi GN, Buzdar AUJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer. J Clin Oncol. 2012 Mar 20; 30(9):930-5.J Clin Oncol2012-02-13T00:00:002012Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer.22392043Kuerer HM, Lari SA, Arun BK, Hu CY, Brewster A, Mittendorf EA, Albarracin CT, Babiera GV, Caudle AS, Wagner JL, Litton JK, Bedrosian I, Meric-Bernstam F, Lucci A, Hunt KKBreast cancer research and treatmentBiologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass. Breast Cancer Res Treat. 2012 Jun; 133(3):1131-41.Breast Cancer Res Treat2012-03-04T00:00:002012Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass.22409461Chawla A, Hunt KK, Mittendorf EAFuture oncology (London, England)Surgical considerations in patients receiving neoadjuvant systemic therapy. Future Oncol. 2012 Mar; 8(3):239-50.Future Oncol2012-03-01T00:00:002012Surgical considerations in patients receiving neoadjuvant systemic therapy.22511276Kim MM, Dawood S, Allen P, Sahin AA, Woodward WA, Smith BD, Strom EA, Hunt KK, Meric-Bernstam F, Gonzalez-Angulo AM, Buchholz TACancerHormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer. Cancer. 2012 Oct 15; 118(20):4936-43.Cancer2012-04-17T00:00:002012Hormone receptor status influences the locoregional benefit of trastuzumab in patients with nonmetastatic breast cancer.22820938Gainer SM, Hunt KK, Beitsch P, Caudle AS, Mittendorf EA, Lucci AAnnals of surgical oncologyChanging behavior in clinical practice in response to the ACOSOG Z0011 trial: a survey of the American Society of Breast Surgeons. Ann Surg Oncol. 2012 Oct; 19(10):3152-8.Ann Surg Oncol2012-07-21T00:00:002012Changing behavior in clinical practice in response to the ACOSOG Z0011 trial: a survey of the American Society of Breast Surgeons.22996169Luo S, Yi M, Huang X, Hunt KKStatistics in medicineA Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer. Stat Med. 2013 Jun 15; 32(13):2320-34.Stat Med2012-09-21T00:00:002012A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer.23030225Bednarski BK, Pisters PW, Hunt KKExpert review of anticancer therapyThe role of surgery in the multidisciplinary management of patients with localized gastrointestinal stromal tumors. Expert Rev Anticancer Ther. 2012 Aug; 12(8):1069-78.Expert Rev Anticancer Ther2012-08-01T00:00:002012The role of surgery in the multidisciplinary management of patients with localized gastrointestinal stromal tumors.23122536Yi M, Kuerer HM, Mittendorf EA, Hwang RF, Caudle AS, Bedrosian I, Meric-Bernstam F, Wagner JL, Hunt KKJournal of the American College of SurgeonsImpact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population. J Am Coll Surg. 2013 Jan; 216(1):105-13.J Am Coll Surg2012-11-02T00:00:002012Impact of the american college of surgeons oncology group Z0011 criteria applied to a contemporary patient population.24510381Akay CL, Ueno NT, Chisholm GB, Hortobagyi GN, Woodward WA, Alvarez RH, Bedrosian I, Kuerer HM, Hunt KK, Huo L, Babiera GVCancerPrimary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer. Cancer. 2014 May 01; 120(9):1319-28.Cancer2014-02-07T00:00:002014Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer.24687821Hunt KK, Sahin AAJournal of clinical oncology : official journal of the American Society of Clinical OncologyToo much, too little, or just right? Tumor margins in women undergoing breast-conserving surgery. J Clin Oncol. 2014 May 10; 32(14):1401-6.J Clin Oncol2014-03-31T00:00:002014Too much, too little, or just right? Tumor margins in women undergoing breast-conserving surgery.24721590McBride A, Allen P, Woodward W, Kim M, Kuerer HM, Drinka EK, Sahin A, Strom EA, Buzdar A, Valero V, Hortobagyi GN, Hunt KK, Buchholz TAInternational journal of radiation oncology, biology, physicsLocoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment. Int J Radiat Oncol Biol Phys. 2014 Jun 01; 89(2):392-8.Int J Radiat Oncol Biol Phys2014-04-07T00:00:002014Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment.25203877Boughey JC, McCall LM, Ballman KV, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Flippo-Morton T, Hunt KKAnnals of surgeryTumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial. Ann Surg. 2014 Oct; 260(4):608-14; discussion 614-6.Ann Surg2014-10-01T00:00:002014Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.Authorship 2396722Authorship 2405432Authorship 2406253Authorship 2406362Authorship 2407181Authorship 2409383Authorship 2411273Authorship 2411483Authorship 2412715Authorship 2413835Authorship 2414215Authorship 2415542Authorship 2421155Authorship 2422792Authorship 2424892Authorship 2428224Authorship 2430197Authorship 24326611Authorship 2444063Authorship 2444868Authorship 24475016Authorship 2447851Authorship 24483510Authorship 2453182Authorship 2453583Authorship 2453902Authorship 2454654Authorship 2457633Authorship 2458652Authorship 2460986Authorship 2462323Authorship 2462385Authorship 24634611Authorship 2464052Authorship 2465318Authorship 2467502Authorship 2467987Authorship 2468015Authorship 2470865Authorship 24718910Authorship 2472951Authorship 24733914Authorship 2473577Authorship 2474296Authorship 2474339Authorship 2474474Authorship 2475537Authorship 2476196Authorship 2476578Authorship 2478653Authorship 24827610Authorship 2484214Authorship 24843913Authorship 2485449Authorship 2486243Authorship 24894210Authorship 2491029Authorship 2491372Authorship 2494245Authorship 24943310Authorship 2497806Authorship 2500477Authorship 2507506Authorship 25087412Authorship 2512046Authorship 25151311Authorship 2516089Authorship 2517638Authorship 2517978Authorship 2518214Authorship 2518953Authorship 2519129Authorship 2519629Authorship 2519932Authorship 25213210Authorship 2523975Authorship 2525478Authorship 2527544Authorship 2530751Authorship 2532063Authorship 2532764Authorship 25337110Authorship 2534251Authorship 2534436Authorship 25364212Authorship 2536765Authorship 2542306Authorship 2547131Authorship 2550076Authorship 25518115Authorship 2553219Authorship 2556481Authorship 25573412Authorship 2558292Authorship 25614311Authorship 2563677Authorship 2565472Authorship 2565937Authorship 25667910Authorship 2570427Authorship 2573902Authorship 2574016Authorship 2585552Authorship 2588398Authorship 2588768Authorship 2590462Authorship 2591131Authorship 25914812Authorship 2594646Authorship 2597308Authorship 25978613Authorship 2608369Authorship 26088121Authorship 2612813Authorship 26138016Authorship 26147687809018Swisher SG, Cates JA, Hunt KK, Robert ME, Bennion RS, Thompson JE, Roslyn JJ, Reber HAPancreasPancreatitis associated with adult choledochal cysts. Pancreas. 1994 Sep; 9(5):633-7.Pancreas1994-09-01T00:00:001994Pancreatitis associated with adult choledochal cysts.7838341Badie B, Hunt K, Economou JS, Black KLNeurosurgeryStereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model. Neurosurgery. 1994 Nov; 35(5):910-5; discussion 915-6.Neurosurgery1994-11-01T00:00:001994Stereotactic delivery of a recombinant adenovirus into a C6 glioma cell line in a rat brain tumor model.8985520Toloza EM, Hunt K, Miller AR, McBride W, Lau R, Swisher S, Rhoades K, Arthur J, Choi J, Chen L, Chang P, Chen A, Glaspy J, Economou JSAnnals of surgical oncologyTransduction of murine and human tumors using recombinant adenovirus vectors. Ann Surg Oncol. 1997 Jan; 4(1):70-9.Ann Surg Oncol1997-01-01T00:00:001997Transduction of murine and human tumors using recombinant adenovirus vectors.9259963Hunt KK, Baldwin BJ, Strom EA, Ames FC, McNeese MD, Kroll SS, Singletary SEAnnals of surgical oncologyFeasibility of postmastectomy radiation therapy after TRAM flap breast reconstruction. Ann Surg Oncol. 1997 Jul-Aug; 4(5):377-84.Ann Surg Oncol1997-07-01T00:00:001997Feasibility of postmastectomy radiation therapy after TRAM flap breast reconstruction.9367084Mansfield PF, Hunt KKCancer treatment and researchClassification, staging, and management of non-Hodgkin's lymphomas. Cancer Treat Res. 1997; 90:203-11.Cancer Treat Res1997-01-01T00:00:001997Classification, staging, and management of non-Hodgkin's lymphomas.9689981Kuerer HM, Newman LA, Buzdar AU, Dhingra K, Hunt KK, Buchholz TA, Binkley SM, Strom EA, Ames FC, Ross MI, Feig BW, McNeese MD, Hortobagyi GN, Singletary SEThe cancer journal from Scientific AmericanPathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status. Cancer J Sci Am. 1998 Jul-Aug; 4(4):230-6.Cancer J Sci Am1998-07-01T00:00:001998Pathologic tumor response in the breast following neoadjuvant chemotherapy predicts axillary lymph node status.9831111Newman LA, Kuerer HM, Hunt KK, Kroll SS, Ames FC, Ross MI, Feig BW, Singletary SEAnnals of surgical oncologyPresentation, treatment, and outcome of local recurrence afterskin-sparing mastectomy and immediate breast reconstruction. Ann Surg Oncol. 1998 Oct-Nov; 5(7):620-6.Ann Surg Oncol1998-10-01T00:00:001998Presentation, treatment, and outcome of local recurrence afterskin-sparing mastectomy and immediate breast reconstruction.9921978Pearlstone DB, Pisters PW, Bold RJ, Feig BW, Hunt KK, Yasko AW, Patel S, Pollack A, Benjamin RS, Pollock RECancerPatterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer. 1999 Jan 01; 85(1):85-92.Cancer1999-01-01T00:00:001999Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up.10080583McMasters KM, Hunt KKJournal of clinical oncology : official journal of the American Society of Clinical OncologyNeoadjuvant chemotherapy, locally advanced breast cancer, and quality of life. J Clin Oncol. 1999 Feb; 17(2):441-4.J Clin Oncol1999-02-01T00:00:001999Neoadjuvant chemotherapy, locally advanced breast cancer, and quality of life.10340882Newman LA, Kuerer HM, Hunt KK, Singh G, Ames FC, Feig BW, Ross MI, Taylor S, Singletary SEAnnals of surgical oncologyLocal recurrence and survival among black women with early-stage breast cancer treated with breast-conservation therapy or mastectomy. Ann Surg Oncol. 1999 Apr-May; 6(3):241-8.Ann Surg Oncol1999-04-01T00:00:001999Local recurrence and survival among black women with early-stage breast cancer treated with breast-conservation therapy or mastectomy.10400039Kuerer HM, Sahin AA, Hunt KK, Newman LA, Breslin TM, Ames FC, Ross MI, Buzdar AU, Hortobagyi GN, Singletary SEAnnals of surgeryIncidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy. Ann Surg. 1999 Jul; 230(1):72-8.Ann Surg1999-07-01T00:00:001999Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.10415848Chiao PJ, Hunt KK, Grau AM, Abramian A, Fleming J, Zhang W, Breslin T, Abbruzzese JL, Evans DBAnnals of the New York Academy of SciencesTumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle. Ann N Y Acad Sci. 1999 Jun 30; 880:31-7.Ann N Y Acad Sci1999-06-30T00:00:001999Tumor suppressor gene Smad4/DPC4, its downstream target genes, and regulation of cell cycle.10706081Pataer A, Fang B, Yu R, Kagawa S, Hunt KK, McDonnell TJ, Roth JA, Swisher SGCancer researchAdenoviral Bak overexpression mediates caspase-dependent tumor killing. Cancer Res. 2000 Feb 15; 60(4):788-92.Cancer Res2000-02-15T00:00:002000Adenoviral Bak overexpression mediates caspase-dependent tumor killing.10976701Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AAThe American journal of surgical pathologyIdentification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy. Am J Surg Pathol. 2000 Sep; 24(9):1266-72.Am J Surg Pathol2000-09-01T00:00:002000Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.11004328Vlastos G, Fornage BD, Mirza NQ, Bedi D, Lenert JT, Winchester DJ, Tolley SM, Ames FC, Ross MI, Feig BW, Hunt KK, Buzdar AU, Singletary SEAmerican journal of surgeryThe correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy. Am J Surg. 2000 Jun; 179(6):446-52.Am J Surg2000-06-01T00:00:002000The correlation of axillary ultrasonography with histologic breast cancer downstaging after induction chemotherapy.11113430Newman LA, Hunt KK, Buchholz T, Kuerer HM, Vlastos G, Mirza N, Ames FC, Ross MI, Singletary SEAmerican journal of surgeryPresentation, management and outcome of axillary recurrence from breast cancer. Am J Surg. 2000 Oct; 180(4):252-6.Am J Surg2000-10-01T00:00:002000Presentation, management and outcome of axillary recurrence from breast cancer.11571720Vlastos G, Mirza NQ, Meric F, Hunt KK, Kuerer HM, Ames FC, Ross MI, Buchholz TA, Hortobagyi GN, Singletary SECancerBreast conservation therapy as a treatment option for the elderly. The M. D. Anderson experience. Cancer. 2001 Sep 01; 92(5):1092-100.Cancer2001-09-01T00:00:002001Breast conservation therapy as a treatment option for the elderly. The M. D. Anderson experience.11906446Baker TP, Lenert JT, Parker J, Kemp B, Kushwaha A, Evans G, Hunt KKThe breast journalLactating adenoma: a diagnosis of exclusion. Breast J. 2001 Sep-Oct; 7(5):354-7.Breast J2001-09-01T00:00:002001Lactating adenoma: a diagnosis of exclusion.12095969Meric F, Buchholz TA, Mirza NQ, Vlastos G, Ames FC, Ross MI, Pollock RE, Singletary SE, Feig BW, Kuerer HM, Newman LA, Perkins GH, Strom EA, McNeese MD, Hortobagyi GN, Hunt KKAnnals of surgical oncologyLong-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol. 2002 Jul; 9(6):543-9.Ann Surg Oncol2002-07-01T00:00:002002Long-term complications associated with breast-conservation surgery and radiotherapy.12128124Huang E, McNeese MD, Strom EA, Perkins GH, Katz A, Hortobagyi GN, Valero V, Kuerer HM, Singletary SE, Hunt KK, Buzdar AU, Buchholz TAInternational journal of radiation oncology, biology, physicsLocoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. Int J Radiat Oncol Biol Phys. 2002 Aug 01; 53(5):1225-33.Int J Radiat Oncol Biol Phys2002-08-01T00:00:002002Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer.12130788Hunt KK, Vorburger SAScience (New York, N.Y.)Tech.Sight. Gene therapy. Hurdles and hopes for cancer treatment. Science. 2002 Jul 19; 297(5580):415-6.Science2002-07-19T00:00:002002Tech.Sight. Gene therapy. Hurdles and hopes for cancer treatment.12648684Cabioglu N, Hunt KK, Singletary SE, Stephens TW, Marcy S, Meric F, Ross MI, Babiera GV, Ames FC, Kuerer HMJournal of the American College of SurgeonsSurgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge. J Am Coll Surg. 2003 Mar; 196(3):354-64.J Am Coll Surg2003-03-01T00:00:002003Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge.12830052Pataer A, Chada S, Hunt KK, Roth JA, Swisher SGThe Journal of thoracic and cardiovascular surgeryAdenoviral melanoma differentiation-associated gene 7 induces apoptosis in lung cancer cells through mitochondrial permeability transition-independent cytochrome c release. J Thorac Cardiovasc Surg. 2003 Jun; 125(6):1328-35.J Thorac Cardiovasc Surg2003-06-01T00:00:002003Adenoviral melanoma differentiation-associated gene 7 induces apoptosis in lung cancer cells through mitochondrial permeability transition-independent cytochrome c release.12839847Chagpar A, Meric-Bernstam F, Hunt KK, Ross MI, Cristofanilli M, Singletary SE, Buchholz TA, Ames FC, Marcy S, Babiera GV, Feig BW, Hortobagyi GN, Kuerer HMAnnals of surgical oncologyChest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol. 2003 Jul; 10(6):628-34.Ann Surg Oncol2003-07-01T00:00:002003Chest wall recurrence after mastectomy does not always portend a dismal outcome.12907143Mhashilkar AM, Stewart AL, Sieger K, Yang HY, Khimani AH, Ito I, Saito Y, Hunt KK, Grimm EA, Roth JA, Meyn RE, Ramesh R, Chada SMolecular therapy : the journal of the American Society of Gene TherapyMDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells. Mol Ther. 2003 Aug; 8(2):207-19.Mol Ther2003-08-01T00:00:002003MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells.12916466Hwang RF, Hunt KKSurgical oncology clinics of North AmericaExperimental approaches to treatment of soft tissue sarcoma. Surg Oncol Clin N Am. 2003 Apr; 12(2):499-521.Surg Oncol Clin N Am2003-04-01T00:00:002003Experimental approaches to treatment of soft tissue sarcoma.12973838Buchholz TA, Hunt KK, Whitman GJ, Sahin AA, Hortobagyi GNCancerNeoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks. Cancer. 2003 Sep 15; 98(6):1150-60.Cancer2003-09-15T00:00:002003Neoadjuvant chemotherapy for breast carcinoma: multidisciplinary considerations of benefits and risks.14983489Yen TW, Hunt KK, Mirza NQ, Thomas ES, Singletary SE, Babiera GV, Meric-Bernstam F, Buchholz TA, Feig BW, Ross MI, Ames FC, Theriault RL, Kuerer HMCancerPhysician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. Cancer. 2004 Mar 01; 100(5):942-9.Cancer2004-03-01T00:00:002004Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ.15174900Vorburger SA, Pataer A, Swisher SG, Hunt KKAmerican journal of pharmacogenomics : genomics-related research in drug development and clinical practiceGenetically targeted cancer therapy: tumor destruction by PKR activation. Am J Pharmacogenomics. 2004; 4(3):189-98.Am J Pharmacogenomics2004-01-01T00:00:002004Genetically targeted cancer therapy: tumor destruction by PKR activation.15197191Chen AM, Meric-Bernstam F, Hunt KK, Thames HD, Oswald MJ, Outlaw ED, Strom EA, McNeese MD, Kuerer HM, Ross MI, Singletary SE, Ames FC, Feig BW, Sahin AA, Perkins GH, Schechter NR, Hortobagyi GN, Buchholz TAJournal of clinical oncology : official journal of the American Society of Clinical OncologyBreast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol. 2004 Jun 15; 22(12):2303-12.J Clin Oncol2004-06-15T00:00:002004Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.15197795Chagpar A, Evelegh M, Fritsche HA, Krishnamurthy S, Hunt KK, Kuerer HMCancerProspective evaluation of a novel approach for the use of a quantitative galactose oxidase-Schiff reaction in ductal fluid samples from women with breast carcinoma. Cancer. 2004 Jun 15; 100(12):2549-54.Cancer2004-06-15T00:00:002004Prospective evaluation of a novel approach for the use of a quantitative galactose oxidase-Schiff reaction in ductal fluid samples from women with breast carcinoma.15217509Poindexter NJ, Sahin A, Hunt KK, Grimm EABreast cancer research : BCRAnalysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer. Breast Cancer Res. 2004; 6(4):R408-15.Breast Cancer Res2004-06-04T00:00:002004Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer.15300212McKenzie T, Liu Y, Fanale M, Swisher SG, Chada S, Hunt KKSurgeryCombination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells. Surgery. 2004 Aug; 136(2):437-42.Surgery2004-08-01T00:00:002004Combination therapy of Ad-mda7 and trastuzumab increases cell death in Her-2/neu-overexpressing breast cancer cells.15342366Chen LL, Trent JC, Wu EF, Fuller GN, Ramdas L, Zhang W, Raymond AK, Prieto VG, Oyedeji CO, Hunt KK, Pollock RE, Feig BW, Hayes KJ, Choi H, Macapinlac HA, Hittelman W, Velasco MA, Patel S, Burgess MA, Benjamin RS, Frazier MLCancer researchA missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res. 2004 Sep 01; 64(17):5913-9.Cancer Res2004-09-01T00:00:002004A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors.15374553Daley MD, Norman PH, Leak JA, Nguyen DT, Bui TP, Kowalski AM, Srejic U, Popat K, Arens JF, Gershenwald JE, Hunt KK, Kuerer HMJournal of clinical anesthesiaAdverse events associated with the intraoperative injection of isosulfan blue. J Clin Anesth. 2004 Aug; 16(5):332-41.J Clin Anesth2004-08-01T00:00:002004Adverse events associated with the intraoperative injection of isosulfan blue.15804465Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW, Ames FC, Kuerer HMJournal of the American College of SurgeonsPredictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg. 2005 Apr; 200(4):516-26.J Am Coll Surg2005-04-01T00:00:002005Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.15849517Swisher SG, Hofstetter W, Wu TT, Correa AM, Ajani JA, Komaki RR, Chirieac L, Hunt KK, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Roth JAAnnals of surgeryProposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg. 2005 May; 241(5):810-7; discussion 817-20.Ann Surg2005-05-01T00:00:002005Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT).15912050Martin RC, Chagpar A, Scoggins CR, Edwards MJ, Hagendoorn L, Stromberg AJ, McMasters KM, University of Louisville Breast Cancer Sentinel Lymph Node StudyAnnals of surgeryClinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer. Ann Surg. 2005 Jun; 241(6):1005-12; discussion 1012-5.Ann Surg2005-06-01T00:00:002005Clinicopathologic factors associated with false-negative sentinel lymph-node biopsy in breast cancer.16043362Hunt KK, Keyomarsi KSeminars in cancer biologyCyclin E as a prognostic and predictive marker in breast cancer. Semin Cancer Biol. 2005 Aug; 15(4):319-26.Semin Cancer Biol2005-08-01T00:00:002005Cyclin E as a prognostic and predictive marker in breast cancer.16087943Green MC, Buzdar AU, Smith T, Ibrahim NK, Valero V, Rosales MF, Cristofanilli M, Booser DJ, Pusztai L, Rivera E, Theriault RL, Carter C, Frye D, Hunt KK, Symmans WF, Strom EA, Sahin AA, Sikov W, Hortobagyi GNJournal of clinical oncology : official journal of the American Society of Clinical OncologyWeekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks. J Clin Oncol. 2005 Sep 01; 23(25):5983-92.J Clin Oncol2005-08-08T00:00:002005Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks.16153435von Holzen U, Bocangel D, Pataer A, Vorburger SA, Liu Y, Lu X, Hunt KK, Swisher SGSurgeryRole for the double-stranded RNA-activated protein kinase PKR in Ad-TNF-alpha gene therapy in esophageal cancer. Surgery. 2005 Aug; 138(2):261-8.Surgery2005-08-01T00:00:002005Role for the double-stranded RNA-activated protein kinase PKR in Ad-TNF-alpha gene therapy in esophageal cancer.16158053Lu Z, Luo RZ, Peng H, Huang M, Nishmoto A, Hunt KK, Helin K, Liao WS, Yu YOncogeneE2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer. Oncogene. 2006 Jan 12; 25(2):230-9.Oncogene2006-01-12T00:00:002006E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.16164916Leitch AM, Beitsch PD, McCall LM, Posther K, Newman LA, Herndon JE, Hunt KK, Giuliano AEAmerican journal of surgeryPatterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer. Am J Surg. 2005 Oct; 190(4):539-42.Am J Surg2005-10-01T00:00:002005Patterns of participation and successful patient recruitment to American College of Surgeons Oncology Group Z0010, a phase II trial for patients with early-stage breast cancer.16164931Al-Refaie W, Kuerer HM, Khuwaja A, Perry A, Hunt KK, Feig B, Ames F, Ross M, Singletary SE, Meric-Bernstam F, Babiera GVAmerican journal of surgeryDeterminants of mastectomy in breast conservation therapy candidates. Am J Surg. 2005 Oct; 190(4):602-5.Am J Surg2005-10-01T00:00:002005Determinants of mastectomy in breast conservation therapy candidates.16192820Posther KE, McCall LM, Blumencranz PW, Burak WE, Beitsch PD, Hansen NM, Morrow M, Wilke LG, Herndon JE, Hunt KK, Giuliano AEAnnals of surgerySentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer. Ann Surg. 2005 Oct; 242(4):593-9; discussion 599-602.Ann Surg2005-10-01T00:00:002005Sentinel node skills verification and surgeon performance: data from a multicenter clinical trial for early-stage breast cancer.16224212Davis WG, Hennessy B, Babiera G, Hunt K, Valero V, Buchholz TA, Sneige N, Gilcrease MZThe American journal of surgical pathologyMetaplastic sarcomatoid carcinoma of the breast with absent or minimal overt invasive carcinomatous component: a misnomer. Am J Surg Pathol. 2005 Nov; 29(11):1456-63.Am J Surg Pathol2005-11-01T00:00:002005Metaplastic sarcomatoid carcinoma of the breast with absent or minimal overt invasive carcinomatous component: a misnomer.16275992Vorburger SA, Hetrakul N, Xia W, Wilson-Heiner M, Mirza N, Pollock RE, Feig B, Swisher SG, Hunt KKMolecular cancer therapeuticsGene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo. Mol Cancer Ther. 2005 Nov; 4(11):1710-6.Mol Cancer Ther2005-11-01T00:00:002005Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo.16282987Chada S, Mhashilkar AM, Liu Y, Nishikawa T, Bocangel D, Zheng M, Vorburger SA, Pataer A, Swisher SG, Ramesh R, Kawase K, Meyn RE, Hunt KKCancer gene therapymda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies and radiotherapy: correlation with expression of bcl-2 family members. Cancer Gene Ther. 2006 May; 13(5):490-502.Cancer Gene Ther2006-05-01T00:00:002006mda-7 gene transfer sensitizes breast carcinoma cells to chemotherapy, biologic therapies and radiotherapy: correlation with expression of bcl-2 family members.16378156Rivers AK, Griffith KA, Hunt KK, Degnim AC, Sabel MS, Diehl KM, Cimmino VM, Chang AE, Lucas PC, Newman LAAnnals of surgical oncologyClinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann Surg Oncol. 2006 Jan; 13(1):36-44.Ann Surg Oncol2006-01-01T00:00:002006Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.16463073Lambert LA, Ayers GD, Hwang RF, Hunt KK, Ross MI, Kuerer HM, Singletary SE, Babiera GV, Ames FC, Feig B, Lucci A, Krishnamurthy S, Meric-Bernstam FAnnals of surgical oncologyValidation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol. 2006 Mar; 13(3):310-20.Ann Surg Oncol2006-02-10T00:00:002006Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy.16627052You YN, Hunt KK, Posner MC, Putnam JB, Nelson H, Ota DM, Pisters PWSurgeryOperative trials: the opportunity beckons-an update on the American College of Surgeons Oncology Group. Surgery. 2006 Apr; 139(4):455-9.Surgery2006-04-01T00:00:002006Operative trials: the opportunity beckons-an update on the American College of Surgeons Oncology Group.16783343Bocangel D, Zheng M, Mhashilkar A, Liu Y, Ramesh R, Hunt KK, Chada SCancer gene therapyCombinatorial synergy induced by adenoviral-mediated mda-7 and Herceptin in Her-2+ breast cancer cells. Cancer Gene Ther. 2006 Oct; 13(10):958-68.Cancer Gene Ther2006-06-16T00:00:002006Combinatorial synergy induced by adenoviral-mediated mda-7 and Herceptin in Her-2+ breast cancer cells.16887286Huang EH, Strom EA, Perkins GH, Oh JL, Chen AM, Meric-Bernstam F, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TAInternational journal of radiation oncology, biology, physicsComparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score. Int J Radiat Oncol Biol Phys. 2006 Oct 01; 66(2):352-7.Int J Radiat Oncol Biol Phys2006-08-02T00:00:002006Comparison of risk of local-regional recurrence after mastectomy or breast conservation therapy for patients treated with neoadjuvant chemotherapy and radiation stratified according to a prognostic index score.16942642Boughey JC, Ross MI, Babiera GV, Bedrosian I, Feig BW, Hwang RF, Kuerer HM, Hunt KKClinical breast cancerSentinel lymph node surgery in locally recurrent breast cancer. Clin Breast Cancer. 2006 Aug; 7(3):248-53.Clin Breast Cancer2006-08-01T00:00:002006Sentinel lymph node surgery in locally recurrent breast cancer.16952046Tseng JF, Ballo MT, Langstein HN, Wayne JD, Cormier JN, Hunt KK, Feig BW, Yasko AW, Lewis VO, Lin PP, Cannon CP, Zagars GK, Pollock RE, Pisters PWAnnals of surgical oncologyThe effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol. 2006 Sep; 13(9):1209-15.Ann Surg Oncol2006-09-03T00:00:002006The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas.16955504Boughey JC, Khakpour N, Meric-Bernstam F, Ross MI, Kuerer HM, Singletary SE, Babiera GV, Arun B, Hunt KK, Bedrosian ICancerSelective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer. 2006 Oct 01; 107(7):1440-7.Cancer2006-10-01T00:00:002006Selective use of sentinel lymph node surgery during prophylactic mastectomy.16977650Huo L, Sneige N, Hunt KK, Albarracin CT, Lopez A, Resetkova ECancerPredictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer. 2006 Oct 15; 107(8):1760-8.Cancer2006-10-15T00:00:002006Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ.17075114Oh JL, Dryden MJ, Woodward WA, Yu TK, Tereffe W, Strom EA, Perkins GH, Middleton L, Hunt KK, Giordano SH, Oswald MJ, Domain D, Buchholz TAJournal of clinical oncology : official journal of the American Society of Clinical OncologyLocoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy. J Clin Oncol. 2006 Nov 01; 24(31):4971-5.J Clin Oncol2006-11-01T00:00:002006Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy.17236970Huang EH, Strom EA, Valero V, Fornage B, Perkins GH, Oh JL, Yu TK, Tereffe W, Woodward WA, Hunt KK, Meric-Bernstam F, Sahin AA, Bedrosian I, Hortobagyi GN, Buchholz TAInternational journal of radiation oncology, biology, physicsLocoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis. Int J Radiat Oncol Biol Phys. 2007 Feb 01; 67(2):490-6.Int J Radiat Oncol Biol Phys2007-02-01T00:00:002007Locoregional treatment outcomes for breast cancer patients with ipsilateral supraclavicular metastases at diagnosis.17325063Yang WT, Hennessy BT, Dryden MJ, Valero V, Hunt KK, Krishnamurthy SRadiologyMammary angiosarcomas: imaging findings in 24 patients. Radiology. 2007 Mar; 242(3):725-34.Radiology2007-03-01T00:00:002007Mammary angiosarcomas: imaging findings in 24 patients.17330229Shen J, Gilcrease MZ, Babiera GV, Ross MI, Meric-Bernstam F, Feig BW, Kuerer HM, Francis A, Ames FC, Hunt KKCancerFeasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer. 2007 Apr 01; 109(7):1255-63.Cancer2007-04-01T00:00:002007Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.17541936Sher T, Hennessy BT, Valero V, Broglio K, Woodward WA, Trent J, Hunt KK, Hortobagyi GN, Gonzalez-Angulo AMCancerPrimary angiosarcomas of the breast. Cancer. 2007 Jul 01; 110(1):173-8.Cancer2007-07-01T00:00:002007Primary angiosarcomas of the breast.17893504Pisters PW, Pollock RE, Lewis VO, Yasko AW, Cormier JN, Respondek PM, Feig BW, Hunt KK, Lin PP, Zagars G, Wei C, Ballo MTAnnals of surgeryLong-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas. Ann Surg. 2007 Oct; 246(4):675-81; discussion 681-2.Ann Surg2007-10-01T00:00:002007Long-term results of prospective trial of surgery alone with selective use of radiation for patients with T1 extremity and trunk soft tissue sarcomas.17932905Boughey JC, Cormier JN, Xing Y, Hunt KK, Meric-Bernstam F, Babiera GV, Ross MI, Kuerer HM, Singletary SE, Bedrosian ICancerDecision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy. Cancer. 2007 Dec 01; 110(11):2542-50.Cancer2007-12-01T00:00:002007Decision analysis to assess the efficacy of routine sentinel lymphadenectomy in patients undergoing prophylactic mastectomy.17947465von Holzen U, Pataer A, Raju U, Bocangel D, Vorburger SA, Liu Y, Lu X, Roth JA, Aggarwal BB, Barber GN, Keyomarsi K, Hunt KK, Swisher SGClinical cancer research : an official journal of the American Association for Cancer ResearchThe double-stranded RNA-activated protein kinase mediates radiation resistance in mouse embryo fibroblasts through nuclear factor kappaB and Akt activation. Clin Cancer Res. 2007 Oct 15; 13(20):6032-9.Clin Cancer Res2007-10-15T00:00:002007The double-stranded RNA-activated protein kinase mediates radiation resistance in mouse embryo fibroblasts through nuclear factor kappaB and Akt activation.18439768Bristol IJ, Woodward WA, Strom EA, Cristofanilli M, Domain D, Singletary SE, Perkins GH, Oh JL, Yu TK, Terrefe W, Sahin AA, Hunt KK, Hortobagyi GN, Buchholz TAInternational journal of radiation oncology, biology, physicsLocoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 2008 Oct 01; 72(2):474-84.Int J Radiat Oncol Biol Phys2008-04-24T00:00:002008Locoregional treatment outcomes after multimodality management of inflammatory breast cancer.18488000Chen LL, Holden JA, Choi H, Zhu J, Wu EF, Jones KA, Ward JH, Andtbacka RH, Randall RL, Scaife CL, Hunt KK, Prieto VG, Raymond AK, Zhang W, Trent JC, Benjamin RS, Frazier MLModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncEvolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression. Mod Pathol. 2008 Jul; 21(7):826-36.Mod Pathol2008-05-16T00:00:002008Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression.18535617Roh V, Laemmle A, Von Holzen U, Stroka D, Dufour JF, Hunt KK, Candinas D, Vorburger SACancer gene therapyDual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma. Cancer Gene Ther. 2008 Oct; 15(10):636-44.Cancer Gene Ther2008-06-06T00:00:002008Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma.18701468Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KKCancer researchStaging of breast cancer in the neoadjuvant setting. Cancer Res. 2008 Aug 15; 68(16):6477-81.Cancer Res2008-08-15T00:00:002008Staging of breast cancer in the neoadjuvant setting.18723497Pataer A, Hu W, Xiaolin L, Chada S, Roth JA, Hunt KK, Swisher SGMolecular cancer therapeuticsAdenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing. Mol Cancer Ther. 2008 Aug; 7(8):2528-35.Mol Cancer Ther2008-08-01T00:00:002008Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing.18829554Lambert LA, Qiao N, Hunt KK, Lambert DH, Mills GB, Meijer L, Keyomarsi KCancer researchAutophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model. Cancer Res. 2008 Oct 01; 68(19):7966-74.Cancer Res2008-10-01T00:00:002008Autophagy: a novel mechanism of synergistic cytotoxicity between doxorubicin and roscovitine in a sarcoma model.19047898Downs-Kelly E, Nayeemuddin KM, Albarracin C, Wu Y, Hunt KK, Gilcrease MZThe American journal of surgical pathologyMatrix-producing carcinoma of the breast: an aggressive subtype of metaplastic carcinoma. Am J Surg Pathol. 2009 Apr; 33(4):534-41.Am J Surg Pathol2009-04-01T00:00:002009Matrix-producing carcinoma of the breast: an aggressive subtype of metaplastic carcinoma.19107593Shaye A, Sahin A, Hao Q, Hunt K, Keyomarsi K, Bedrosian IBreast cancer research and treatmentCyclin E deregulation is an early event in the development of breast cancer. Breast Cancer Res Treat. 2009 Jun; 115(3):651-9.Breast Cancer Res Treat2008-12-24T00:00:002008Cyclin E deregulation is an early event in the development of breast cancer.19172584Yi M, Meric-Bernstam F, Middleton LP, Arun BK, Bedrosian I, Babiera GV, Hwang RF, Kuerer HM, Yang W, Hunt KKCancerPredictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer. 2009 Mar 01; 115(5):962-71.Cancer2009-03-01T00:00:002009Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.19195040Krishnamurthy S, Meric-Bernstam F, Lucci A, Hwang RF, Kuerer HM, Babiera G, Ames FC, Feig BW, Ross MI, Singletary E, Hunt KK, Bedrosian ICancerA prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer. 2009 Apr 01; 115(7):1555-62.Cancer2009-04-01T00:00:002009A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer.19205875Hunt KK, Askew R, Cormier JNBreast cancer research and treatmentMeasuring lymphedema in patients with breast cancer: go with the flow? Breast Cancer Res Treat. 2009 Oct; 117(3):559-60.Breast Cancer Res Treat2009-02-10T00:00:002009Measuring lymphedema in patients with breast cancer: go with the flow?19280264Boughey JC, Wagner J, Garrett BJ, Harker L, Middleton LP, Babiera GV, Meric-Bernstam F, Lucci A, Hunt KK, Bedrosian IAnnals of surgical oncologyNeoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation. Ann Surg Oncol. 2009 Jun; 16(6):1606-11.Ann Surg Oncol2009-03-12T00:00:002009Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation.19352776Mittendorf EA, Hunt KKAnnals of surgical oncologyLymphatic interrupted: do we really understand the risks and consequences? Ann Surg Oncol. 2009 Jul; 16(7):1768-70.Ann Surg Oncol2009-04-08T00:00:002009Lymphatic interrupted: do we really understand the risks and consequences?19362281Wagner J, Boughey JC, Garrett B, Babiera G, Kuerer H, Meric-Bernstam F, Singletary E, Hunt KK, Middleton LP, Bedrosian IAmerican journal of surgeryMargin assessment after neoadjuvant chemotherapy in invasive lobular cancer. Am J Surg. 2009 Sep; 198(3):387-91.Am J Surg2009-04-10T00:00:002009Margin assessment after neoadjuvant chemotherapy in invasive lobular cancer.19402173Blazer DG, Lazar AJ, Xing Y, Askew RL, Feig BW, Pisters PW, Pollock RE, Lev D, Hunt KK, Cormier JNCancerClinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registry. Cancer. 2009 Jul 01; 115(13):2971-9.Cancer2009-07-01T00:00:002009Clinical outcomes of molecularly confirmed clear cell sarcoma from a single institution and in comparison with data from the Surveillance, Epidemiology, and End Results registry.19427625Boughey JC, Goravanchi F, Parris RN, Kee SS, Kowalski AM, Frenzel JC, Bedrosian I, Meric-Bernstam F, Hunt KK, Ames FC, Kuerer HM, Lucci AAmerican journal of surgeryProspective randomized trial of paravertebral block for patients undergoing breast cancer surgery. Am J Surg. 2009 Nov; 198(5):720-5.Am J Surg2009-05-09T00:00:002009Prospective randomized trial of paravertebral block for patients undergoing breast cancer surgery.19565301Wagner M, Roh V, Strehlen M, Laemmle A, Stroka D, Egger B, Trochsler M, Hunt KK, Candinas D, Vorburger SAJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractEffective treatment of advanced colorectal cancer by rapamycin and 5-FU/oxaliplatin monitored by TIMP-1. J Gastrointest Surg. 2009 Oct; 13(10):1781-90.J Gastrointest Surg2009-06-30T00:00:002009Effective treatment of advanced colorectal cancer by rapamycin and 5-FU/oxaliplatin monitored by TIMP-1.19730235Hunt KK, Yi M, Mittendorf EA, Guerrero C, Babiera GV, Bedrosian I, Hwang RF, Kuerer HM, Ross MI, Meric-Bernstam FAnnals of surgerySentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients. Ann Surg. 2009 Oct; 250(4):558-66.Ann Surg2009-10-01T00:00:002009Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients.19735388Fearmonti RM, Batista LI, Meric-Bernstam F, Bedrosian I, Kuerer HM, Hunt KK, Eva Singletary S, Babiera GVThe breast journalFalse negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burden. Breast J. 2009 Nov-Dec; 15(6):645-8.Breast J2009-09-07T00:00:002009False negative rate of sentinel lymph node biopsy in multicentric and multifocal breast cancers may be higher in cases with large additive tumor burden.20024613Sparano JA, Pisano ED, White JR, Hunt KK, Mamounas EP, Perez EA, Hortobagyi GN, Gralow JR, Comis RLBreast cancer research and treatmentRecommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy. Breast Cancer Res Treat. 2010 Apr; 120(2):273-84.Breast Cancer Res Treat2009-12-19T00:00:002009Recommendations for research priorities in breast cancer by the coalition of cancer cooperative groups scientific leadership council: imaging and local therapy.20231683Caudle AS, Gonzalez-Angulo AM, Hunt KK, Liu P, Pusztai L, Symmans WF, Kuerer HM, Mittendorf EA, Hortobagyi GN, Meric-Bernstam FJournal of clinical oncology : official journal of the American Society of Clinical OncologyPredictors of tumor progression during neoadjuvant chemotherapy in breast cancer. J Clin Oncol. 2010 Apr 10; 28(11):1821-8.J Clin Oncol2010-03-15T00:00:002010Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer.20336790Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, Krishnamurthy S, Meric-Bernstam FCancerA phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer. 2010 Jun 01; 116(11):2543-8.Cancer2010-06-01T00:00:002010A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients.20564117Walker GV, Smith GL, Perkins GH, Oh JL, Woodward W, Yu TK, Hunt KK, Hoffman K, Strom EA, Buchholz TACancerPopulation-based analysis of occult primary breast cancer with axillary lymph node metastasis. Cancer. 2010 Sep 01; 116(17):4000-6.Cancer2010-09-01T00:00:002010Population-based analysis of occult primary breast cancer with axillary lymph node metastasis.20564395Dominici LS, Negron Gonzalez VM, Buzdar AU, Lucci A, Mittendorf EA, Le-Petross HT, Babiera GV, Meric-Bernstam F, Hunt KK, Kuerer HMCancerCytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer. Cancer. 2010 Jun 15; 116(12):2884-9.Cancer2010-06-15T00:00:002010Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer.20651304Yang J, Eddy JA, Pan Y, Hategan A, Tabus I, Wang Y, Cogdell D, Price ND, Pollock RE, Lazar AJ, Hunt KK, Trent JC, Zhang WMolecular & cellular proteomics : MCPIntegrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug. Mol Cell Proteomics. 2010 Nov; 9(11):2405-13.Mol Cell Proteomics2010-07-22T00:00:002010Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of slug.20719576Bloom ES, Kirsner S, Mason BE, Nelson CL, Hunt KK, Baumann DP, Gifford KABrachytherapyAccelerated partial breast irradiation using the strut-adjusted volume implant single-entry hybrid catheter in brachytherapy for breast cancer in the setting of breast augmentation. Brachytherapy. 2011 May-Jun; 10(3):178-83.Brachytherapy2010-08-17T00:00:002010Accelerated partial breast irradiation using the strut-adjusted volume implant single-entry hybrid catheter in brachytherapy for breast cancer in the setting of breast augmentation.21121095Hunt KK, Cormier JNArchives of surgery (Chicago, Ill. : 1960)Risky business: Identifying risk factors associated with lymphedema after breast cancer: Comment on "Risk factors for lymphedema in a prospective breast cancer survivorship study". Arch Surg. 2010 Nov; 145(11):1063-4.Arch Surg2010-11-01T00:00:002010Risky business: Identifying risk factors associated with lymphedema after breast cancer: Comment on "Risk factors for lymphedema in a prospective breast cancer survivorship study".21209588Yi M, Buchholz TA, Meric-Bernstam F, Bedrosian I, Hwang RF, Ross MI, Kuerer HM, Luo S, Gonzalez-Angulo AM, Buzdar AU, Symmans WF, Feig BW, Lucci A, Huang EH, Hunt KKAnnals of surgeryClassification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Ann Surg. 2011 Mar; 253(3):572-9.Ann Surg2011-03-01T00:00:002011Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning.21331622Lester TR, Hunt KK, Nayeemuddin KM, Bassett RL, Gonzalez-Angulo AM, Feig BW, Huo L, Rourke LL, Davis WG, Valero V, Gilcrease MZBreast cancer research and treatmentMetaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers. Breast Cancer Res Treat. 2012 Jan; 131(1):41-8.Breast Cancer Res Treat2011-02-18T00:00:002011Metaplastic sarcomatoid carcinoma of the breast appears more aggressive than other triple receptor-negative breast cancers.21476105Roses RE, Arun BK, Lari SA, Mittendorf EA, Lucci A, Hunt KK, Kuerer HMAnnals of surgical oncologyDuctal carcinoma-in-situ of the breast with subsequent distant metastasis and death. Ann Surg Oncol. 2011 Oct; 18(10):2873-8.Ann Surg Oncol2011-04-08T00:00:002011Ductal carcinoma-in-situ of the breast with subsequent distant metastasis and death.21482989Mittendorf EA, Jeruss JS, Tucker SL, Kolli A, Newman LA, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KKJournal of clinical oncology : official journal of the American Society of Clinical OncologyValidation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy. J Clin Oncol. 2011 May 20; 29(15):1956-62.J Clin Oncol2011-04-11T00:00:002011Validation of a novel staging system for disease-specific survival in patients with breast cancer treated with neoadjuvant chemotherapy.21548471Hunt KK, Woodward WAOncology (Williston Park, N.Y.)Have we made progress in inflammatory breast cancer? Not so fast. Oncology (Williston Park). 2011 Mar; 25(3):276, 278.Oncology (Williston Park)2011-03-01T00:00:002011Have we made progress in inflammatory breast cancer? Not so fast.21695458Nanos-Webb A, Jabbour NA, Multani AS, Wingate H, Oumata N, Galons H, Joseph B, Meijer L, Hunt KK, Keyomarsi KBreast cancer research and treatmentTargeting low molecular weight cyclin E (LMW-E) in breast cancer. Breast Cancer Res Treat. 2012 Apr; 132(2):575-88.Breast Cancer Res Treat2011-06-22T00:00:002011Targeting low molecular weight cyclin E (LMW-E) in breast cancer.21725683Caudle AS, Hunt KK, Mittendorf EAAnnals of surgical oncologyResponse to the letter to the editor: Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: a practice-changing trial. Ann Surg Oncol. 2011 Dec; 18 Suppl 3:S283.Ann Surg Oncol2011-07-02T00:00:002011Response to the letter to the editor: Multidisciplinary considerations in the implementation of the findings from the American College of Surgeons Oncology Group (ACOSOG) Z0011 Study: a practice-changing trial.21726347Durak MG, Gonzalez-Angulo AM, Hanrahan EO, Broglio KR, Valero V, Hortobagyi GN, Hunt KK, Sahin AAThe breast journalAge and associated fibrocystic changes are prognostically significant in patients with small node-negative (T1a,bN0) invasive breast cancer. Breast J. 2011 Sep-Oct; 17(5):462-9.Breast J2011-07-05T00:00:002011Age and associated fibrocystic changes are prognostically significant in patients with small node-negative (T1a,bN0) invasive breast cancer.22167004Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, Yi M, Meric-Bernstam F, Ross MI, Babiera GV, Kuerer HM, Hwang RFAnnals of surgeryIncorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node. Ann Surg. 2012 Jan; 255(1):109-15.Ann Surg2012-01-01T00:00:002012Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.22253459Yi M, Meric-Bernstam F, Kuerer HM, Mittendorf EA, Bedrosian I, Lucci A, Hwang RF, Crow JR, Luo S, Hunt KKJournal of clinical oncology : official journal of the American Society of Clinical OncologyEvaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision. J Clin Oncol. 2012 Feb 20; 30(6):600-7.J Clin Oncol2012-01-17T00:00:002012Evaluation of a breast cancer nomogram for predicting risk of ipsilateral breast tumor recurrences in patients with ductal carcinoma in situ after local excision.22621306Dominici LS, Mittendorf EA, Wang X, Liu J, Kuerer HM, Hunt KK, Brewster A, Babiera GV, Buchholz TA, Meric-Bernstam F, Bedrosian IBreast cancer research : BCRImplications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy. Breast Cancer Res. 2012 May 23; 14(3):R82.Breast Cancer Res2012-05-23T00:00:002012Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy.22847123Caudle AS, Hunt KK, Tucker SL, Hoffman K, Gainer SM, Lucci A, Kuerer HM, Meric-Bernstam F, Shah R, Babiera GV, Sahin AA, Mittendorf EAAnnals of surgical oncologyAmerican College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns. Ann Surg Oncol. 2012 Oct; 19(10):3144-51.Ann Surg Oncol2012-07-31T00:00:002012American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns.22868365Hunt KK, Ballman KV, McCall LM, Boughey JC, Mittendorf EA, Cox CE, Whitworth PW, Beitsch PD, Leitch AM, Buchholz TA, Morrow MA, Giuliano AEAnnals of surgeryFactors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial. Ann Surg. 2012 Sep; 256(3):428-36.Ann Surg2012-09-01T00:00:002012Factors associated with local-regional recurrence after a negative sentinel node dissection: results of the ACOSOG Z0010 trial.22963676Huo L, Zhang J, Gilcrease MZ, Gong Y, Wu Y, Zhang H, Resetkova E, Hunt KK, Deavers MTHistopathologyGross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer. Histopathology. 2013 Jan; 62(2):267-74.Histopathology2012-09-11T00:00:002012Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer.23164142Henteleff HJ, Hunt KK, Quan ML, Evidence-Based Reviews in Surgery GroupJournal of the American College of SurgeonsComparative effectiveness of magnetic resonance imaging in breast cancer. J Am Coll Surg. 2012 Dec; 215(6):894-6; discussion 895-6.J Am Coll Surg2012-12-01T00:00:002012Comparative effectiveness of magnetic resonance imaging in breast cancer.23224828Torres KE, Ravi V, Kin K, Yi M, Guadagnolo BA, May CD, Arun BK, Hunt KK, Lam R, Lahat G, Hoffman A, Cormier JN, Feig BW, Lazar AJ, Lev D, Pollock REAnnals of surgical oncologyLong-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer. Ann Surg Oncol. 2013 Apr; 20(4):1267-74.Ann Surg Oncol2012-12-06T00:00:002012Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer.23291658Mittendorf EA, Buchholz TA, Tucker SL, Meric-Bernstam F, Kuerer HM, Gonzalez-Angulo AM, Bedrosian I, Babiera GV, Hoffman K, Yi M, Ross MI, Hortobagyi GN, Hunt KKAnnals of surgeryImpact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy. Ann Surg. 2013 Feb; 257(2):173-9.Ann Surg2013-02-01T00:00:002013Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy.23470470Yi M, Xu J, Liu P, Chang GJ, Du XL, Hu CY, Song Y, He J, Ren Y, Wei Y, Yang J, Hunt KK, Li XBritish journal of cancerComparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer. Br J Cancer. 2013 Apr 16; 108(7):1508-14.Br J Cancer2013-03-07T00:00:002013Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer.23720073Weksberg DC, Allen PK, Hoffman KE, Litton JK, Strom EA, Shah RR, Kuerer HM, Hunt KK, Buchholz TA, Mittendorf EAAnnals of surgical oncologyOutcomes and predictive factors for salvage therapy after local--regional recurrence following neoadjuvant chemotherapy and breast conserving therapy. Ann Surg Oncol. 2013 Oct; 20(11):3430-7.Ann Surg Oncol2013-05-30T00:00:002013Outcomes and predictive factors for salvage therapy after local--regional recurrence following neoadjuvant chemotherapy and breast conserving therapy.23722650Murray MM, Bui T, Smith M, Bagheri-Yarmand R, Wingate H, Hunt KK, Keyomarsi KCarcinogenesisStaurosporine is chemoprotective by inducing G1 arrest in a Chk1- and pRb-dependent manner. Carcinogenesis. 2013 Oct; 34(10):2244-52.Carcinogenesis2013-05-30T00:00:002013Staurosporine is chemoprotective by inducing G1 arrest in a Chk1- and pRb-dependent manner.23975313Fitzsullivan E, Lari SA, Smith B, Caudle AS, Krishnamurthy S, Lucci A, Mittendorf EA, Babiera GV, Black DM, Wagner JL, Bedrosian I, Woodward W, Gainer SM, Hwang R, Meric-Bernstam F, Hunt KK, Kuerer HMAnnals of surgical oncologyIncidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted? Ann Surg Oncol. 2013 Dec; 20(13):4103-12.Ann Surg Oncol2013-08-23T00:00:002013Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?24046126Caudle AS, Yi M, Hoffman KE, Mittendorf EA, Babiera GV, Hwang RF, Meric-Bernstam F, Sahin AA, Hunt KKAnnals of surgical oncologyImpact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients. Ann Surg Oncol. 2014 Jan; 21(1):60-5.Ann Surg Oncol2013-09-18T00:00:002013Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients.24101169Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Kuerer HM, Bowling M, Flippo-Morton TS, Byrd DR, Ollila DW, Julian TB, McLaughlin SA, McCall L, Symmans WF, Le-Petross HT, Haffty BG, Buchholz TA, Nelson H, Hunt KK, Alliance for Clinical Trials in OncologyJAMASentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013 Oct 09; 310(14):1455-61.JAMA2013-10-09T00:00:002013Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.24291235Yang J, Du X, Wang G, Sun Y, Chen K, Zhu X, Lazar AJ, Hunt KK, Pollock RE, Zhang WEuropean journal of cancer (Oxford, England : 1990)Mesenchymal to epithelial transition in sarcomas. Eur J Cancer. 2014 Feb; 50(3):593-601.Eur J Cancer2013-11-28T00:00:002013Mesenchymal to epithelial transition in sarcomas.25076741Mittendorf EA, Boughey JC, Hunt KKBulletin of the American College of SurgeonsSLN surgery for clinically node-positive breast cancer patients treated with neoadjuvant therapy. Bull Am Coll Surg. 2014 Jul; 99(7):52-4.Bull Am Coll Surg2014-07-01T00:00:002014SLN surgery for clinically node-positive breast cancer patients treated with neoadjuvant therapy.25551582Caruso JA, Karakas C, Zhang J, Yi M, Albarracin C, Sahin A, Bondy M, Liu J, Hunt KK, Keyomarsi KBreast cancer research : BCRElafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence. Breast Cancer Res. 2014; 16(6):3417.Breast Cancer Res2014-01-01T00:00:002014Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.Authorship 2636325Authorship 2637663Authorship 26391210Authorship 2639245Authorship 2643595Authorship 2643922Authorship 2644842Authorship 2648222Authorship 26500419Authorship 2651003Authorship 2651037Authorship 2652405Authorship 26570510Authorship 2657664Authorship 26581310Authorship 2658264Authorship 26584210Authorship 2660492Authorship 26607114Authorship 2662527Authorship 2664345Authorship 26692010Authorship 26698511Authorship 2673082Authorship 2673404Authorship 26759910Authorship 26780010Authorship 2689217Authorship 2689283Authorship 2690254Authorship 2690613Authorship 2691306Authorship 2691369Authorship 26967510Authorship 2697262Authorship 2698917Authorship 2704859Authorship 2704922Authorship 270908117771626Swisher SG, Hunt KK, Holmes EC, Zinner MJ, McFadden DWAmerican journal of surgeryChanges in the surgical management of esophageal cancer from 1970 to 1993. Am J Surg. 1995 Jun; 169(6):609-14.Am J Surg1995-06-01T00:00:001995Changes in the surgical management of esophageal cancer from 1970 to 1993.7850546Miller AR, McBride WH, Hunt K, Economou JSAnnals of surgical oncologyCytokine-mediated gene therapy for cancer. Ann Surg Oncol. 1994 Sep; 1(5):436-50.Ann Surg Oncol1994-09-01T00:00:001994Cytokine-mediated gene therapy for cancer.9753717McMasters KM, Giuliano AE, Ross MI, Reintgen DS, Hunt KK, Byrd DR, Klimberg VS, Whitworth PW, Tafra LC, Edwards MJThe New England journal of medicineSentinel-lymph-node biopsy for breast cancer--not yet the standard of care. N Engl J Med. 1998 Oct 01; 339(14):990-5.N Engl J Med1998-10-01T00:00:001998Sentinel-lymph-node biopsy for breast cancer--not yet the standard of care.10030422Heaton KM, Peoples GE, Singletary SE, Feig BW, Ross MI, Ames FC, Buchholz TA, Strom EA, McNeese MD, Hunt KKAnnals of surgical oncologyFeasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer. Ann Surg Oncol. 1999 Jan-Feb; 6(1):102-8.Ann Surg Oncol1999-01-01T00:00:001999Feasibility of breast conservation therapy in metachronous or synchronous bilateral breast cancer.10080586Kuerer HM, Newman LA, Smith TL, Ames FC, Hunt KK, Dhingra K, Theriault RL, Singh G, Binkley SM, Sneige N, Buchholz TA, Ross MI, McNeese MD, Buzdar AU, Hortobagyi GN, Singletary SEJournal of clinical oncology : official journal of the American Society of Clinical OncologyClinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. J Clin Oncol. 1999 Feb; 17(2):460-9.J Clin Oncol1999-02-01T00:00:001999Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.10367172Buchholz TA, Hunt KK, Amosson CM, Tucker SL, Strom EA, McNeese MD, Buzdar AU, Singletary SE, Hortobagyi GNThe cancer journal from Scientific AmericanSequencing of chemotherapy and radiation in lymph node-negative breast cancer. Cancer J Sci Am. 1999 May-Jun; 5(3):159-64.Cancer J Sci Am1999-05-01T00:00:001999Sequencing of chemotherapy and radiation in lymph node-negative breast cancer.10561352Fleming JB, Berman RS, Cheng SC, Chen NP, Hunt KK, Feig BW, Respondek PM, Yasko AW, Pollack A, Patel SR, Burgess MA, Papadopoulos NE, Plager C, Zagars G, Benjamin RS, Pollock RE, Pisters PWJournal of clinical oncology : official journal of the American Society of Clinical OncologyLong-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol. 1999 Sep; 17(9):2772-80.J Clin Oncol1999-09-01T00:00:001999Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas.11013278Meric F, Milas M, Hunt KK, Hess KR, Pisters PW, Hildebrandt G, Patel SR, Benjamin RS, Plager C, Papadopolous NE, Burgess MA, Pollock RE, Feig BWJournal of clinical oncology : official journal of the American Society of Clinical OncologyImpact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol. 2000 Oct 01; 18(19):3378-83.J Clin Oncol2000-10-01T00:00:002000Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas.11013364Chaney AW, Pollack A, McNeese MD, Zagars GK, Pisters PW, Pollock RE, Hunt KKCancerPrimary treatment of cystosarcoma phyllodes of the breast. Cancer. 2000 Oct 01; 89(7):1502-11.Cancer2000-10-01T00:00:002000Primary treatment of cystosarcoma phyllodes of the breast.11956076Pataer A, Vorburger SA, Barber GN, Chada S, Mhashilkar AM, Zou-Yang H, Stewart AL, Balachandran S, Roth JA, Hunt KK, Swisher SGCancer researchAdenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR). Cancer Res. 2002 Apr 15; 62(8):2239-43.Cancer Res2002-04-15T00:00:002002Adenoviral transfer of the melanoma differentiation-associated gene 7 (mda7) induces apoptosis of lung cancer cells via up-regulation of the double-stranded RNA-dependent protein kinase (PKR).12006521Buzdar AU, Singletary SE, Valero V, Booser DJ, Ibrahim NK, Rahman Z, Theriault RL, Walters R, Rivera E, Smith TL, Holmes FA, Hoy E, Frye DK, Manuel N, Kau SW, McNeese MD, Strom E, Thomas E, Hunt K, Ames F, Berry D, Hortobagyi GNClinical cancer research : an official journal of the American Association for Cancer ResearchEvaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial. Clin Cancer Res. 2002 May; 8(5):1073-9.Clin Cancer Res2002-05-01T00:00:002002Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.12209664Lee A, Krishnamurthy S, Sahin A, Symmans WF, Hunt K, Sneige NCancerIntraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients. Cancer. 2002 Aug 25; 96(4):225-31.Cancer2002-08-25T00:00:002002Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients.12417515Vlastos G, Mirza NQ, Meric F, Hunt KK, Mirza AN, Newman LA, Ames FC, Kuerer HM, Ross MI, Feig B, Babiera G, Buchholz TA, Hortobagyi GN, Singletary SEAnnals of surgical oncologyBreast-conservation therapy in early-stage breast cancer patients with a positive family history. Ann Surg Oncol. 2002 Nov; 9(9):912-9.Ann Surg Oncol2002-11-01T00:00:002002Breast-conservation therapy in early-stage breast cancer patients with a positive family history.12481419Meric F, Hunt KKMolecular cancer therapeuticsTranslation initiation in cancer: a novel target for therapy. Mol Cancer Ther. 2002 Sep; 1(11):971-9.Mol Cancer Ther2002-09-01T00:00:002002Translation initiation in cancer: a novel target for therapy.12576424Kuerer HM, Thompson PA, Krishnamurthy S, Fritsche HA, Marcy SM, Babiera GV, Singletary SE, Cristofanilli M, Sneige N, Hunt KKClinical cancer research : an official journal of the American Association for Cancer ResearchHigh and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer. Clin Cancer Res. 2003 Feb; 9(2):601-5.Clin Cancer Res2003-02-01T00:00:002003High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer.12679318Vorburger SA, Pataer A, Yoshida K, Liu Y, Lu X, Swisher SG, Hunt KKAnnals of surgical oncologyThe mitochondrial apoptosis-inducing factor plays a role in E2F-1-induced apoptosis in human colon cancer cells. Ann Surg Oncol. 2003 Apr; 10(3):314-22.Ann Surg Oncol2003-04-01T00:00:002003The mitochondrial apoptosis-inducing factor plays a role in E2F-1-induced apoptosis in human colon cancer cells.12915599Pisters PW, Ballo MT, Fenstermacher MJ, Feig BW, Hunt KK, Raymond KA, Burgess MA, Zagars GK, Pollock RE, Benjamin RS, Patel SRJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol. 2003 Aug 15; 21(16):3092-7.J Clin Oncol2003-08-15T00:00:002003Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma.15050324Ballo MT, Zagars GK, Cormier JN, Hunt KK, Feig BW, Patel SR, Pisters PWInternational journal of radiation oncology, biology, physicsInterval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1461-7.Int J Radiat Oncol Biol Phys2004-04-01T00:00:002004Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma.15389473Goldflam K, Hunt KK, Gershenwald JE, Singletary SE, Mirza N, Kuerer HM, Babiera GV, Ames FC, Ross MI, Feig BW, Sahin AA, Arun B, Meric-Bernstam FCancerContralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer. 2004 Nov 01; 101(9):1977-86.Cancer2004-11-01T00:00:002004Contralateral prophylactic mastectomy. Predictors of significant histologic findings.15570071Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Hortobagyi GN, Buchholz TAJournal of clinical oncology : official journal of the American Society of Clinical OncologyPostmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol. 2004 Dec 01; 22(23):4691-9.J Clin Oncol2004-12-01T00:00:002004Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy.15738535Buzdar AU, Ibrahim NK, Francis D, Booser DJ, Thomas ES, Theriault RL, Pusztai L, Green MC, Arun BK, Giordano SH, Cristofanilli M, Frye DK, Smith TL, Hunt KK, Singletary SE, Sahin AA, Ewer MS, Buchholz TA, Berry D, Hortobagyi GNJournal of clinical oncology : official journal of the American Society of Clinical OncologySignificantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol. 2005 Jun 01; 23(16):3676-85.J Clin Oncol2005-02-28T00:00:002005Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer.15890574Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Hortobagyi GN, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Buchholz TAInternational journal of radiation oncology, biology, physicsPredictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Jun 01; 62(2):351-7.Int J Radiat Oncol Biol Phys2005-06-01T00:00:002005Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.16514477Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, Gabram SG, Lucci A, Cox CE, Hunt KK, Herndon JE, Giuliano AEAnnals of surgical oncologySurgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol. 2006 Apr; 13(4):491-500.Ann Surg Oncol2006-03-02T00:00:002006Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial.16551137Nykter M, Hunt KK, Pollock RE, El-Naggar AK, Taylor E, Shmulevich I, Yli-Harja O, Zhang WTechnology in cancer research & treatmentUnsupervised analysis uncovers changes in histopathologic diagnosis in supervised genomic studies. Technol Cancer Res Treat. 2006 Apr; 5(2):177-82.Technol Cancer Res Treat2006-04-01T00:00:002006Unsupervised analysis uncovers changes in histopathologic diagnosis in supervised genomic studies.17541691Lim SJ, Cormier JN, Feig BW, Mansfield PF, Benjamin RS, Griffin JR, Chase JL, Pisters PW, Pollock RE, Hunt KKAnnals of surgical oncologyToxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis. Ann Surg Oncol. 2007 Aug; 14(8):2309-18.Ann Surg Oncol2007-05-31T00:00:002007Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis.17985187Lim SJ, Feig BW, Wang H, Hunt KK, Rodriguez-Bigas MA, Skibber JM, Ellis V, Cleary K, Chang GJAnnals of surgical oncologySentinel lymph node evaluation does not improve staging accuracy in colon cancer. Ann Surg Oncol. 2008 Jan; 15(1):46-51.Ann Surg Oncol2007-11-06T00:00:002007Sentinel lymph node evaluation does not improve staging accuracy in colon cancer.18056680Jeruss JS, Mittendorf EA, Tucker SL, Gonzalez-Angulo AM, Buchholz TA, Sahin AA, Cormier JN, Buzdar AU, Hortobagyi GN, Hunt KKJournal of clinical oncology : official journal of the American Society of Clinical OncologyCombined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy. J Clin Oncol. 2008 Jan 10; 26(2):246-52.J Clin Oncol2007-12-03T00:00:002007Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy.19492879Sahin AA, Guray M, Hunt KKArchives of pathology & laboratory medicineIdentification and biologic significance of micrometastases in axillary lymph nodes in patients with invasive breast cancer. Arch Pathol Lab Med. 2009 Jun; 133(6):869-78.Arch Pathol Lab Med2009-06-01T00:00:002009Identification and biologic significance of micrometastases in axillary lymph nodes in patients with invasive breast cancer.19551444Lahat G, Dhuka AR, Lahat S, Smith KD, Pollock RE, Hunt KK, Ravi V, Lazar AJ, Lev DAnnals of surgical oncologyOutcome of locally recurrent and metastatic angiosarcoma. Ann Surg Oncol. 2009 Sep; 16(9):2502-9.Ann Surg Oncol2009-06-24T00:00:002009Outcome of locally recurrent and metastatic angiosarcoma.19557478Lahat G, Dhuka AR, Lahat S, Lazar AJ, Lewis VO, Lin PP, Feig B, Cormier JN, Hunt KK, Pisters PW, Pollock RE, Lev DAnnals of surgical oncologyComplete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Ann Surg Oncol. 2009 Sep; 16(9):2579-86.Ann Surg Oncol2009-06-26T00:00:002009Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients.20145171Akli S, Bui T, Wingate H, Biernacka A, Moulder S, Tucker SL, Hunt KK, Keyomarsi KClinical cancer research : an official journal of the American Association for Cancer ResearchLow-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors. Clin Cancer Res. 2010 Feb 15; 16(4):1179-90.Clin Cancer Res2010-02-09T00:00:002010Low-molecular-weight cyclin E can bypass letrozole-induced G1 arrest in human breast cancer cells and tumors.20218739Yang D, Ylipaa A, Yang J, Hunt K, Pollock R, Trent J, Yli-Harja O, Shmulevich I, Nykter M, Zhang WTechnology in cancer research & treatmentAn integrated study of aberrant gene copy number and gene expression in GIST and LMS. Technol Cancer Res Treat. 2010 Apr; 9(2):171-8.Technol Cancer Res Treat2010-04-01T00:00:002010An integrated study of aberrant gene copy number and gene expression in GIST and LMS.20853047Kang T, Yi M, Hunt KK, Mittendorf EA, Babiera GV, Kuerer H, Bedrosian I, Hwang RF, Lucci A, Meric-Bernstam FAnnals of surgical oncologyDoes blue dye contribute to success of sentinel node mapping for breast cancer? Ann Surg Oncol. 2010 Oct; 17 Suppl 3:280-5.Ann Surg Oncol2010-09-19T00:00:002010Does blue dye contribute to success of sentinel node mapping for breast cancer?21124221Caudle AS, Hunt KKCurrent opinion in obstetrics & gynecologyThe neoadjuvant approach in breast cancer treatment: it is not just about chemotherapy anymore. Curr Opin Obstet Gynecol. 2011 Feb; 23(1):31-6.Curr Opin Obstet Gynecol2011-02-01T00:00:002011The neoadjuvant approach in breast cancer treatment: it is not just about chemotherapy anymore.21553292Albert JM, Buzdar AU, Guzman R, Allen PK, Strom EA, Perkins GH, Woodward WA, Hoffman KE, Tereffe W, Hunt KK, Buchholz TA, Oh JLBreast cancer research and treatmentProspective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control. Breast Cancer Res Treat. 2011 Jul; 128(2):421-7.Breast Cancer Res Treat2011-05-08T00:00:002011Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control.21725688Bilimoria KY, Wayne JD, Merkow RP, Abbott DE, Cormier JN, Feig BW, Hunt KK, Pisters PW, Pollock R, Bentrem DJAnnals of surgical oncologyIncorporation of adjuvant therapy into the multimodality management of gastrointestinal stromal tumors of the stomach in the United States. Ann Surg Oncol. 2012 Jan; 19(1):184-91.Ann Surg Oncol2011-07-02T00:00:002011Incorporation of adjuvant therapy into the multimodality management of gastrointestinal stromal tumors of the stomach in the United States.21885207Nagar H, Mittendorf EA, Strom EA, Perkins GH, Oh JL, Tereffe W, Woodward WA, Gonzalez-Angulo AM, Hunt KK, Buchholz TA, Yu TKInternational journal of radiation oncology, biology, physicsLocal-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer. Int J Radiat Oncol Biol Phys. 2011 Nov 01; 81(3):782-7.Int J Radiat Oncol Biol Phys2011-08-30T00:00:002011Local-regional recurrence with and without radiation therapy after neoadjuvant chemotherapy and mastectomy for clinically staged T3N0 breast cancer.21899648Buchholz TA, Hunt KKThe breast journalBreast conservation therapy in the 21st century. Breast J. 2011 Sep-Oct; 17(5):445-7.Breast J2011-09-01T00:00:002011Breast conservation therapy in the 21st century.23224829Yi M, Cormier JN, Xing Y, Giordano SH, Chai C, Meric-Bernstam F, Vlastos G, Kuerer HM, Mirza NQ, Buchholz TA, Hunt KKAnnals of surgical oncologyOther primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy. Ann Surg Oncol. 2013 May; 20(5):1514-21.Ann Surg Oncol2012-12-06T00:00:002012Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy.Authorship 27270210Authorship 27283311Authorship 2728967Authorship 2729248Authorship 2732037Authorship 2735906Authorship 2737705Authorship 2741353Authorship 2741409Authorship 2743784Authorship 2743828Authorship 2745048Authorship 2745945Authorship 2748433Authorship 2750919Authorship 2752519Authorship 2764984Authorship 2766725Authorship 2767455Authorship 2768951Authorship 27696913Authorship 2770704Authorship 2772321Authorship 2773223Authorship 2774003Authorship 2776947Authorship 27772388751501Swisher SG, Holmes EC, Hunt KK, Gornbein JA, Zinner MJ, McFadden DWThe Journal of thoracic and cardiovascular surgeryPerioperative blood transfusions and decreased long-term survival in esophageal cancer. J Thorac Cardiovasc Surg. 1996 Aug; 112(2):341-8.J Thorac Cardiovasc Surg1996-08-01T00:00:001996Perioperative blood transfusions and decreased long-term survival in esophageal cancer.9367083Hunt KK, Ross MICancer treatment and researchChanging trends in the diagnosis and treatment of early breast cancer. Cancer Treat Res. 1997; 90:171-201.Cancer Treat Res1997-01-01T00:00:001997Changing trends in the diagnosis and treatment of early breast cancer.9869512Kuerer HM, Newman LA, Fornage BD, Dhingra K, Hunt KK, Buzdar AU, Ames FC, Ross MI, Feig BW, Hortobagyi GN, Singletary SEAnnals of surgical oncologyRole of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer. Ann Surg Oncol. 1998 Dec; 5(8):673-80.Ann Surg Oncol1998-12-01T00:00:001998Role of axillary lymph node dissection after tumor downstaging with induction chemotherapy for locally advanced breast cancer.10402641Hunt KK, Feig BWSeminars in surgical oncologyPreclinical experimental therapeutic approaches in soft tissue sarcoma. Semin Surg Oncol. 1999 Jul-Aug; 17(1):78-82.Semin Surg Oncol1999-07-01T00:00:001999Preclinical experimental therapeutic approaches in soft tissue sarcoma.10717625Vlastos G, Mirza NQ, Lenert JT, Hunt KK, Ames FC, Feig BW, Ross MI, Buzdar AU, Singletary SECancerThe feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy. Cancer. 2000 Mar 15; 88(6):1417-24.Cancer2000-03-15T00:00:002000The feasibility of minimally invasive surgery for stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapy.10889372Liao Z, Strom EA, Buzdar AU, Singletary SE, Hunt K, Allen PK, McNeese MDInternational journal of radiation oncology, biology, physicsLocoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence. Int J Radiat Oncol Biol Phys. 2000 Jul 15; 47(5):1191-200.Int J Radiat Oncol Biol Phys2000-07-15T00:00:002000Locoregional irradiation for inflammatory breast cancer: effectiveness of dose escalation in decreasing recurrence.11304777Buchholz TA, Tucker SL, Erwin J, Mathur D, Strom EA, McNeese MD, Hortobagyi GN, Cristofanilli M, Esteva FJ, Newman L, Singletary SE, Buzdar AU, Hunt KKJournal of clinical oncology : official journal of the American Society of Clinical OncologyImpact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol. 2001 Apr 15; 19(8):2240-6.J Clin Oncol2001-04-15T00:00:002001Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy.11745234Cormier JN, Patel SR, Herzog CE, Ballo MT, Burgess MA, Feig BW, Hunt KK, Raney RB, Zagars GK, Benjamin RS, Pisters PWCancerConcurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma. Cancer. 2001 Sep 15; 92(6):1550-5.Cancer2001-09-15T00:00:002001Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma.11786582Ahmad SA, Patel SR, Ballo MT, Baker TP, Yasko AW, Wang X, Feig BW, Hunt KK, Lin PP, Weber KL, Chen LL, Zagars GK, Pollock RE, Benjamin RS, Pisters PWJournal of clinical oncology : official journal of the American Society of Clinical OncologyExtraosseous osteosarcoma: response to treatment and long-term outcome. J Clin Oncol. 2002 Jan 15; 20(2):521-7.J Clin Oncol2002-01-15T00:00:002002Extraosseous osteosarcoma: response to treatment and long-term outcome.12383904Solorzano CC, Middleton LP, Hunt KK, Mirza N, Meric F, Kuerer HM, Ross MI, Ames FC, Feig BW, Pollock RE, Singletary SE, Babiera GAmerican journal of surgeryTreatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg. 2002 Oct; 184(4):364-8.Am J Surg2002-10-01T00:00:002002Treatment and outcome of patients with intracystic papillary carcinoma of the breast.12875602Buchholz TA, Strom EA, McNeese MD, Hunt KKThe Surgical clinics of North AmericaRadiation therapy as an adjuvant treatment after sentinel lymph node surgery for breast cancer. Surg Clin North Am. 2003 Aug; 83(4):911-30, x.Surg Clin North Am2003-08-01T00:00:002003Radiation therapy as an adjuvant treatment after sentinel lymph node surgery for breast cancer.15313733Shen J, Valero V, Buchholz TA, Singletary SE, Ames FC, Ross MI, Cristofanilli M, Babiera GV, Meric-Bernstam F, Feig B, Hunt KK, Kuerer HMAnnals of surgical oncologyEffective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol. 2004 Sep; 11(9):854-60.Ann Surg Oncol2004-08-16T00:00:002004Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy.15523402Kuerer HM, Coombes KR, Chen JN, Xiao L, Clarke C, Fritsche H, Krishnamurthy S, Marcy S, Hung MC, Hunt KKSurgeryAssociation between ductal fluid proteomic expression profiles and the presence of lymph node metastases in women with breast cancer. Surgery. 2004 Nov; 136(5):1061-9.Surgery2004-11-01T00:00:002004Association between ductal fluid proteomic expression profiles and the presence of lymph node metastases in women with breast cancer.16213894Suh YJ, Chada S, McKenzie T, Liu Y, Swisher SG, Lucci A, Hunt KKSurgerySynergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells. Surgery. 2005 Sep; 138(3):422-30.Surgery2005-09-01T00:00:002005Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery of mda-7 in human breast cancer cells.16614878Babiera GV, Rao R, Feng L, Meric-Bernstam F, Kuerer HM, Singletary SE, Hunt KK, Ross MI, Gwyn KM, Feig BW, Ames FC, Hortobagyi GNAnnals of surgical oncologyEffect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol. 2006 Jun; 13(6):776-82.Ann Surg Oncol2006-04-17T00:00:002006Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor.16684318Khakpour N, Zager JS, Yen T, Stephens T, Kuerer HM, Singletary ES, Ross MI, Hunt KK, Babiera GVThe breast journalThe role of ultrasound in the surgical management of patients diagnosed with ductal carcinoma in situ of the breast. Breast J. 2006 May-Jun; 12(3):212-5.Breast J2006-05-01T00:00:002006The role of ultrasound in the surgical management of patients diagnosed with ductal carcinoma in situ of the breast.18357493Rao R, Feng L, Kuerer HM, Singletary SE, Bedrosian I, Hunt KK, Ross MI, Hortobagyi GN, Feig BW, Ames FC, Babiera GVAnnals of surgical oncologyTiming of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol. 2008 Jun; 15(6):1696-702.Ann Surg Oncol2008-03-21T00:00:002008Timing of surgical intervention for the intact primary in stage IV breast cancer patients.19920100Mittendorf EA, Wu Y, Scaltriti M, Meric-Bernstam F, Hunt KK, Dawood S, Esteva FJ, Buzdar AU, Chen H, Eksambi S, Hortobagyi GN, Baselga J, Gonzalez-Angulo AMClinical cancer research : an official journal of the American Association for Cancer ResearchLoss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes. Clin Cancer Res. 2009 Dec 01; 15(23):7381-8.Clin Cancer Res2009-11-17T00:00:002009Loss of HER2 amplification following trastuzumab-based neoadjuvant systemic therapy and survival outcomes.20472353Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Strom EA, Tereffe W, Woodward WA, Tucker SL, Hunt KK, Hortobagyi GN, Buchholz TAInternational journal of radiation oncology, biology, physicsEstrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer. Int J Radiat Oncol Biol Phys. 2010 Aug 01; 77(5):1296-302.Int J Radiat Oncol Biol Phys2010-05-14T00:00:002010Estrogen/progesterone receptor negativity and HER2 positivity predict locoregional recurrence in patients with T1a,bN0 breast cancer.21698015Langsner RJ, Middleton LP, Sun J, Meric-Bernstam F, Hunt KK, Drezek RA, Yu TKBiomedical optics expressWide-field imaging of fluorescent deoxy-glucose in ex vivo malignant and normal breast tissue. Biomed Opt Express. 2011 Jun 01; 2(6):1514-23.Biomed Opt Express2011-05-11T00:00:002011Wide-field imaging of fluorescent deoxy-glucose in ex vivo malignant and normal breast tissue.21861223Akay CL, Meric-Bernstam F, Hunt KK, Grubbs EG, Bedrosian I, Tucker SL, Kuerer HM, Hoffman KE, Babiera GV, Strom EA, Buchholz TA, Mittendorf EAAnnals of surgical oncologyEvaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy. Ann Surg Oncol. 2012 Mar; 19(3):901-7.Ann Surg Oncol2011-08-23T00:00:002011Evaluation of the MD Anderson Prognostic Index for local-regional recurrence after breast conserving therapy in patients receiving neoadjuvant chemotherapy.21947595Adkins FC, Gonzalez-Angulo AM, Lei X, Hernandez-Aya LF, Mittendorf EA, Litton JK, Wagner J, Hunt KK, Woodward WA, Meric-Bernstam FAnnals of surgical oncologyTriple-negative breast cancer is not a contraindication for breast conservation. Ann Surg Oncol. 2011 Oct; 18(11):3164-73.Ann Surg Oncol2011-09-27T00:00:002011Triple-negative breast cancer is not a contraindication for breast conservation.22451578Smith TB, Gilcrease MZ, Santiago L, Hunt KK, Yang WTAJR. American journal of roentgenologyImaging features of primary breast sarcoma. AJR Am J Roentgenol. 2012 Apr; 198(4):W386-93.AJR Am J Roentgenol2012-04-01T00:00:002012Imaging features of primary breast sarcoma.22460701Yi M, Liu P, Li X, Mittendorf EA, He J, Ren Y, Nayeemuddin K, Hunt KKCancerComparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States. Cancer. 2012 Sep 01; 118(17):4117-25.Cancer2012-01-03T00:00:002012Comparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States.22648744Kong AL, Tereffe W, Hunt KK, Yi M, Kang T, Weatherspoon K, Mittendorf EA, Bedrosian I, Hwang RF, Babiera GV, Buchholz TA, Meric-Bernstam FCancerImpact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer. Cancer. 2012 Dec 15; 118(24):6287-96.Cancer2012-05-30T00:00:002012Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer.23306905Lang JE, Tereffe W, Mitchell MP, Rao R, Feng L, Meric-Bernstam F, Bedrosian I, Kuerer HM, Hunt KK, Hortobagyi GN, Babiera GVAnnals of surgical oncologyPrimary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival. Ann Surg Oncol. 2013 Jun; 20(6):1893-9.Ann Surg Oncol2013-01-11T00:00:002013Primary tumor extirpation in breast cancer patients who present with stage IV disease is associated with improved survival.23907433Liu P, Li X, Mittendorf EA, Li J, Du XL, He J, Ren Y, Yang J, Hunt KK, Yi MBritish journal of cancerComparison of clinicopathologic features and survival in young American women aged 18-39 years in different ethnic groups with breast cancer. Br J Cancer. 2013 Sep 03; 109(5):1302-9.Br J Cancer2013-08-01T00:00:002013Comparison of clinicopathologic features and survival in young American women aged 18-39 years in different ethnic groups with breast cancer.Authorship 2789809Authorship 27926110Authorship 27930711Authorship 27933213526195710Kim ES, Bernstein D, Hilsenbeck SG, Chung CH, Dicker AP, Ersek JL, Stein S, Khuri FR, Burgess E, Hunt K, Ivy P, Bruinooge SS, Meropol N, Schilsky RLJournal of clinical oncology : official journal of the American Society of Clinical OncologyModernizing Eligibility Criteria for Molecularly Driven Trials. J Clin Oncol. 2015 Sep 01; 33(25):2815-20.J Clin Oncol2015-07-20T00:00:002015Modernizing Eligibility Criteria for Molecularly Driven Trials.9754762Gershenwald JE, Hunt KK, Kroll SS, Ross MI, Baldwin BJ, Feig BW, Ames FC, Schusterman MA, Singletary SEAnnals of surgical oncologySynchronous elective contralateral mastectomy and immediate bilateral breast reconstruction in women with early-stage breast cancer. Ann Surg Oncol. 1998 Sep; 5(6):529-38.Ann Surg Oncol1998-09-01T00:00:001998Synchronous elective contralateral mastectomy and immediate bilateral breast reconstruction in women with early-stage breast cancer.9354430Hunt KK, Deng J, Liu TJ, Wilson-Heiner M, Swisher SG, Clayman G, Hung MCCancer researchAdenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res. 1997 Nov 01; 57(21):4722-6.Cancer Res1997-11-01T00:00:001997Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53.Authorship 2818021Authorship 2823404Authorship 2844803Authorship 2845193Authorship 2845383Authorship 2847863Authorship 2847882Authorship 2850851Authorship 2855401Authorship 2856111Authorship 2861972Authorship 2863274Authorship 2864714Authorship 2866071Authorship 2867651Authorship 2869615Authorship 2870122Authorship 28731110Authorship 2875375Authorship 2882331Authorship 2883122Authorship 28878012Authorship 2888456Authorship 2890366Authorship 2894402Authorship 28946010Authorship 2895079Authorship 2897662Authorship 2900403Authorship 2902317Authorship 2905786Authorship 2910214Authorship 2911162Authorship 2911304Authorship 29135410Authorship 2921551Authorship 2923219Authorship 2923784Authorship 2924573Authorship 29262811Authorship 2927157Authorship 2929573Authorship 2935529Authorship 2939087Authorship 2939673Authorship 29401610Authorship 29416310Authorship 29426412Authorship 2945852Authorship 29463714Authorship 2952346Authorship 2954771Authorship 29573611Authorship 2957827Authorship 29660328Authorship 29709310Authorship 2971662Authorship 2973744Authorship 29738212Authorship 2974133Authorship 2981977Authorship 2988966Authorship 2989666Authorship 2993961Authorship 2995622Authorship 3015522Authorship 3015714Authorship 3017463Authorship 3044379Authorship 3045614Authorship 3047168Authorship 3049226Authorship 3053793Authorship 3077941Authorship 3123792Authorship 3125104Authorship 3126731Authorship 3131071Authorship 3134547Authorship 3134701Authorship 3135593Authorship 3136574Authorship 3138051Authorship 3139603Authorship 3141173Authorship 3141756Authorship 3142084Authorship 3143401Authorship 3146033Authorship 3146671Authorship 3146723Authorship 3151103Authorship 3151252Authorship 3151842Authorship 31529744406728Hunt KK, Young MBJAMALetter: Fire-eater's asbestosis. JAMA. 1974 Jul 01; 229(1):23.JAMA1974-07-01T00:00:001974Letter: Fire-eater's asbestosis.12079434Nelson TL, Hunt KJ, Rosamond WD, Ammerman AS, Keyserling TC, Mokdad AH, Will JCPreventive medicineObesity and associated coronary heart disease risk factors in a population of low-income African-American and white women: the North Carolina WISEWOMAN project. Prev Med. 2002 Jul; 35(1):1-6.Prev Med2002-07-01T00:00:002002Obesity and associated coronary heart disease risk factors in a population of low-income African-American and white women: the North Carolina WISEWOMAN project.12226141Han TS, Williams K, Sattar N, Hunt KJ, Lean ME, Haffner SMObesity researchAnalysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study. Obes Res. 2002 Sep; 10(9):923-31.Obes Res2002-09-01T00:00:002002Analysis of obesity and hyperinsulinemia in the development of metabolic syndrome: San Antonio Heart Study.12468769Hunt KJ, Duggirala R, G?ring HH, Williams JT, Almasy L, Blangero J, O'Leary DH, Stern MPStrokeGenetic basis of variation in carotid artery plaque in the San Antonio Family Heart Study. Stroke. 2002 Dec; 33(12):2775-80.Stroke2002-12-01T00:00:002002Genetic basis of variation in carotid artery plaque in the San Antonio Family Heart Study.12958039Hunt KJ, Williams K, Rivera D, O'Leary DH, Haffner SM, Stern MP, Gonz?lez Villalpando CArteriosclerosis, thrombosis, and vascular biologyElevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes. Arterioscler Thromb Vasc Biol. 2003 Oct 01; 23(10):1845-50.Arterioscler Thromb Vasc Biol2003-09-04T00:00:002003Elevated carotid artery intima-media thickness levels in individuals who subsequently develop type 2 diabetes.14630600Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP, Hazuda HPAmerican journal of epidemiologyAll-cause and cardiovascular mortality among Mexican-American and non-Hispanic White older participants in the San Antonio Heart Study- evidence against the "Hispanic paradox". Am J Epidemiol. 2003 Dec 01; 158(11):1048-57.Am J Epidemiol2003-12-01T00:00:002003All-cause and cardiovascular mortality among Mexican-American and non-Hispanic White older participants in the San Antonio Heart Study- evidence against the "Hispanic paradox".14975120Arya R, Lehman D, Hunt KJ, Schneider J, Almasy L, Blangero J, Stern MP, Duggirala R, Framingham Heart StudyBMC geneticsEvidence for bivariate linkage of obesity and HDL-C levels in the Framingham Heart Study. BMC Genet. 2003 Dec 31; 4 Suppl 1:S52.BMC Genet2003-12-31T00:00:002003Evidence for bivariate linkage of obesity and HDL-C levels in the Framingham Heart Study.14979879Carson AP, Carson AL, Rose KM, Sanford CP, Ephross SA, Stang PE, Hunt KJ, Brown CA, Szklo MHeadacheLifetime prevalence of migraine and other headaches lasting 4 or more hours: the Atherosclerosis Risk in Communities (ARIC) study. Headache. 2004 Jan; 44(1):20-8.Headache2004-01-01T00:00:002004Lifetime prevalence of migraine and other headaches lasting 4 or more hours: the Atherosclerosis Risk in Communities (ARIC) study.15161798Meigs JB, Williams K, Sullivan LM, Hunt KJ, Haffner SM, Stern MP, Gonz?lez Villalpando C, Perhanidis JS, Nathan DM, D'Agostino RB, D'Agostino RB, Wilson PWDiabetes careUsing metabolic syndrome traits for efficient detection of impaired glucose tolerance. Diabetes Care. 2004 Jun; 27(6):1417-26.Diabetes Care2004-06-01T00:00:002004Using metabolic syndrome traits for efficient detection of impaired glucose tolerance.15326061Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP, San Antonio Heart StudyCirculationNational Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation. 2004 Sep 07; 110(10):1251-7.Circulation2004-08-23T00:00:002004National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study.15505004Stern MP, Williams K, Gonz?lez-Villalpando C, Hunt KJ, Haffner SMDiabetes careDoes the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care. 2004 Nov; 27(11):2676-81.Diabetes Care2004-11-01T00:00:002004Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?15793264Lehman DM, Fu DJ, Freeman AB, Hunt KJ, Leach RJ, Johnson-Pais T, Hamlington J, Dyer TD, Arya R, Abboud H, G?ring HH, Duggirala R, Blangero J, Konrad RJ, Stern MPDiabetesA single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans. Diabetes. 2005 Apr; 54(4):1214-21.Diabetes2005-04-01T00:00:002005A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-D glucosaminidase is associated with type 2 diabetes in Mexican Americans.15823490Stern MP, Williams K, Hunt KJAtherosclerosis. SupplementsImpact of diabetes/metabolic syndrome in patients with established cardiovascular disease. Atheroscler Suppl. 2005 May; 6(2):3-6.Atheroscler Suppl2005-05-01T00:00:002005Impact of diabetes/metabolic syndrome in patients with established cardiovascular disease.15954917Qunibi WY, Abouzahr F, Mizani MR, Nolan CR, Arya R, Hunt KJKidney internationalCardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes. Kidney Int. 2005 Jul; 68(1):271-7.Kidney Int2005-07-01T00:00:002005Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes.16123354Hunt KJ, Lehman DM, Arya R, Fowler S, Leach RJ, G?ring HH, Almasy L, Blangero J, Dyer TD, Duggirala R, Stern MPDiabetesGenome-wide linkage analyses of type 2 diabetes in Mexican Americans: the San Antonio Family Diabetes/Gallbladder Study. Diabetes. 2005 Sep; 54(9):2655-62.Diabetes2005-09-01T00:00:002005Genome-wide linkage analyses of type 2 diabetes in Mexican Americans: the San Antonio Family Diabetes/Gallbladder Study.16431135Hunt KJ, Lukanova A, Rinaldi S, Lundin E, Norat T, Palmqvist R, Stattin P, Riboli E, Hallmans G, Kaaks RAnnals of epidemiologyA potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study. Ann Epidemiol. 2006 Jul; 16(7):563-71.Ann Epidemiol2006-01-23T00:00:002006A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study.16444766Lehman DM, Hamlington J, Hunt KJ, Leach RJ, Arya R, Abboud H, Duggirala R, Blangero J, G?ring HH, Stern MPDiabetes/metabolism research and reviewsA novel missense mutation in ADRB3 increases risk for type 2 diabetes in a Mexican American family. Diabetes Metab Res Rev. 2006 Jul-Aug; 22(4):331-6.Diabetes Metab Res Rev2006-07-01T00:00:002006A novel missense mutation in ADRB3 increases risk for type 2 diabetes in a Mexican American family.16505517Lorenzo C, Williams K, Hunt KJ, Haffner SMDiabetes careTrend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study. Diabetes Care. 2006 Mar; 29(3):625-30.Diabetes Care2006-03-01T00:00:002006Trend in the prevalence of the metabolic syndrome and its impact on cardiovascular disease incidence: the San Antonio Heart Study.17046841Blendon RJ, Hunt K, Benson JM, Fleischfresser C, Buhr THealth affairs (Project Hope)Understanding The American Public's Health Priorities: a 2006 perspective. Health Aff (Millwood). 2006 Nov-Dec; 25(6):w508-15.Health Aff (Millwood)2006-10-17T00:00:002006Understanding The American Public's Health Priorities: a 2006 perspective.17192325Lorenzo C, Williams K, Hunt KJ, Haffner SMDiabetes careThe National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care. 2007 Jan; 30(1):8-13.Diabetes Care2007-01-01T00:00:002007The National Cholesterol Education Program - Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes.17259383Lehman DM, Hunt KJ, Leach RJ, Hamlington J, Arya R, Abboud HE, Duggirala R, Blangero J, G?ring HH, Stern MPDiabetesHaplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans. Diabetes. 2007 Feb; 56(2):389-93.Diabetes2007-02-01T00:00:002007Haplotypes of transcription factor 7-like 2 (TCF7L2) gene and its upstream region are associated with type 2 diabetes and age of onset in Mexican Americans.17259399Lehman DM, Richardson DK, Jenkinson CP, Hunt KJ, Dyer TD, Leach RJ, Arya R, Abboud HE, Blangero J, Duggirala R, Stern MPDiabetesP2 promoter variants of the hepatocyte nuclear factor 4alpha gene are associated with type 2 diabetes in Mexican Americans. Diabetes. 2007 Feb; 56(2):513-7.Diabetes2007-02-01T00:00:002007P2 promoter variants of the hepatocyte nuclear factor 4alpha gene are associated with type 2 diabetes in Mexican Americans.17662617Hunt KJ, Williams K, Hazuda HP, Stern MP, Haffner SMAnnals of epidemiologyThe metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study. Ann Epidemiol. 2007 Nov; 17(11):870-7.Ann Epidemiol2007-07-27T00:00:002007The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study.18535548Fowler SP, Williams K, Resendez RG, Hunt KJ, Hazuda HP, Stern MPObesity (Silver Spring, Md.)Fueling the obesity epidemic? Artificially sweetened beverage use and long-term weight gain. Obesity (Silver Spring). 2008 Aug; 16(8):1894-900.Obesity (Silver Spring)2008-06-05T00:00:002008Fueling the obesity epidemic? Artificially sweetened beverage use and long-term weight gain.21156319Lopes-Virella MF, Baker NL, Hunt KJ, Lachin J, Nathan D, Virella G, DCCT/EDIC Research GroupAtherosclerosisOxidized LDL immune complexes and coronary artery calcification in type 1 diabetes. Atherosclerosis. 2011 Feb; 214(2):462-7.Atherosclerosis2010-11-17T00:00:002010Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes.21304026Egede LE, Gebregziabher M, Hunt KJ, Axon RN, Echols C, Gilbert GE, Mauldin PDThe Annals of pharmacotherapyRegional, Geographic, and Ethnic Differences in Medication Adherence Among Adults with Type 2 Diabetes. Ann Pharmacother. 2011 Feb; 45(2):169-78.Ann Pharmacother2011-02-01T00:00:002011Regional, Geographic, and Ethnic Differences in Medication Adherence Among Adults with Type 2 Diabetes.21335370Egede LE, Gebregziabher M, Hunt KJ, Axon RN, Echols C, Gilbert GE, Mauldin PDDiabetes careRegional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes. Diabetes Care. 2011 Apr; 34(4):938-43.Diabetes Care2011-02-18T00:00:002011Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes.21462724Hardman K, Hunt KJ, Carter RE, Jenkins C, Hill R, Lackland DTEthnicity & diseaseDiabetes management and vaccination rates in the Southeast United States, 2000 through 2007. Ethn Dis. 2011; 21(1):13-9.Ethn Dis2011-01-01T00:00:002011Diabetes management and vaccination rates in the Southeast United States, 2000 through 2007.21461824Fearmonti RM, Keyomarsi K, Hunt KKCancer treatment and researchBiomarkers in neoadjuvant trials. Cancer Treat Res. 2009; 147:1-36.Cancer Treat Res2009-01-01T00:00:002009Biomarkers in neoadjuvant trials.21840730Hunt KJ, Gonzalez ME, Lopez R, Haffner SM, Stern MP, Gonzalez-Villalpando CAnnals of epidemiologyDiabetes is more lethal in Mexicans and Mexican-Americans compared to Non-Hispanic whites. Ann Epidemiol. 2011 Dec; 21(12):899-906.Ann Epidemiol2011-08-15T00:00:002011Diabetes is more lethal in Mexicans and Mexican-Americans compared to Non-Hispanic whites.22322428Hunt KJ, Alanis MC, Johnson ER, Mayorga ME, Korte JEMaternal and child health journalMaternal pre-pregnancy weight and gestational weight gain and their association with birthweight with a focus on racial differences. Matern Child Health J. 2013 Jan; 17(1):85-94.Matern Child Health J2013-01-01T00:00:002013Maternal pre-pregnancy weight and gestational weight gain and their association with birthweight with a focus on racial differences.22415867Hunt KJ, Gebregziabher M, Egede LEJournal of general internal medicineRacial and ethnic differences in cardio-metabolic risk in individuals with undiagnosed diabetes: National Health and Nutrition Examination Survey 1999-2008. J Gen Intern Med. 2012 Aug; 27(8):893-900.J Gen Intern Med2012-03-14T00:00:002012Racial and ethnic differences in cardio-metabolic risk in individuals with undiagnosed diabetes: National Health and Nutrition Examination Survey 1999-2008.22948932Egede LE, Lynch CP, Gebregziabher M, Hunt KJ, Echols C, Gilbert GE, Mauldin PDJournal of general internal medicineDifferential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes. J Gen Intern Med. 2013 Feb; 28(2):208-15.J Gen Intern Med2012-09-05T00:00:002012Differential impact of longitudinal medication non-adherence on mortality by race/ethnicity among veterans with diabetes.22963984Lopes-Virella MF, Hunt KJ, Baker NL, Virella G, Moritz T, VADT InvestigatorsAtherosclerosisThe levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study. Atherosclerosis. 2012 Oct; 224(2):526-31.Atherosclerosis2012-08-21T00:00:002012The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study.23095325Gebregziabher M, Egede L, Gilbert GE, Hunt K, Nietert PJ, Mauldin PBMC medical research methodologyFitting parametric random effects models in very large data sets with application to VHA national data. BMC Med Res Methodol. 2012 Oct 24; 12:163.BMC Med Res Methodol2012-10-24T00:00:002012Fitting parametric random effects models in very large data sets with application to VHA national data.23238350Hunt KJ, Gebregziabher M, Lynch CP, Echols C, Mauldin PD, Egede LEAnnals of epidemiologyImpact of diabetes control on mortality by race in a national cohort of veterans. Ann Epidemiol. 2013 Feb; 23(2):74-9.Ann Epidemiol2012-12-11T00:00:002012Impact of diabetes control on mortality by race in a national cohort of veterans.23320734Hunt KK, Wingate H, Yokota T, Liu Y, Mills GB, Zhang F, Fang B, Su CH, Zhang M, Yi M, Keyomarsi KBreast cancer research : BCRElafin, an inhibitor of elastase, is a prognostic indicator in breast cancer. Breast Cancer Res. 2013 Jan 15; 15(1):R3.Breast Cancer Res2013-01-15T00:00:002013Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer.23536133Bhensdadia NM, Hunt KJ, Lopes-Virella MF, Michael Tucker J, Mataria MR, Alge JL, Neely BA, Janech MG, Arthur JM, Veterans Affairs Diabetes Trial (VADT) study groupKidney internationalUrine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes. Kidney Int. 2013 Jun; 83(6):1136-43.Kidney Int2013-03-27T00:00:002013Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes.23608249Alele JD, Luttrell LM, Hollis BW, Luttrell DK, Hunt KJ, VADT Study GroupAtherosclerosisRelationship between vitamin D status and incidence of vascular events in the Veterans Affairs Diabetes Trial. Atherosclerosis. 2013 Jun; 228(2):502-7.Atherosclerosis2013-04-04T00:00:002013Relationship between vitamin D status and incidence of vascular events in the Veterans Affairs Diabetes Trial.23736306Fowler SP, Puppala S, Arya R, Chittoor G, Farook VS, Schneider J, Resendez RG, Upadhayay RP, Vandeberg J, Hunt KJ, Bradshaw B, Cersosimo E, Vandeberg JL, Almasy L, Curran JE, Comuzzie AG, Lehman DM, Jenkinson CP, Lynch JL, Defronzo RA, Blangero J, Hale DE, Duggirala RHuman geneticsGenetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study. Hum Genet. 2013 Sep; 132(9):1059-71.Hum Genet2013-06-05T00:00:002013Genetic epidemiology of cardiometabolic risk factors and their clustering patterns in Mexican American children and adolescents: the SAFARI Study.24039941Mayorga ME, Reifsnider OS, Neyens DM, Gebregziabher MG, Hunt KJPloS oneSimulated estimates of pre-pregnancy and gestational diabetes mellitus in the US: 1980 to 2008. PLoS One. 2013; 8(9):e73437.PLoS One2013-09-05T00:00:002013Simulated estimates of pre-pregnancy and gestational diabetes mellitus in the US: 1980 to 2008.24267245Hunt KJ, Baker N, Cleary P, Backlund JY, Lyons T, Jenkins A, Virella G, Lopes-Virella MF, DCCT/EDIC Research GroupAtherosclerosisOxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes. Atherosclerosis. 2013 Dec; 231(2):315-22.Atherosclerosis2013-10-11T00:00:002013Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes.24325137Fornage BD, Hunt KKTechnology in cancer research & treatmentImage-guided Percutaneous Ablation of Small Breast Cancer: Which Technique is Leading the Pack? Technol Cancer Res Treat. 2015 Apr; 14(2):209-11.Technol Cancer Res Treat2014-11-26T00:00:002014Image-guided Percutaneous Ablation of Small Breast Cancer: Which Technique is Leading the Pack?24473943Luo S, Su X, DeSantis SM, Huang X, Yi M, Hunt KKStatistics in medicineJoint model for a diagnostic test without a gold standard in the presence of a dependent terminal event. Stat Med. 2014 Jul 10; 33(15):2554-66.Stat Med2014-01-29T00:00:002014Joint model for a diagnostic test without a gold standard in the presence of a dependent terminal event.24562447Yi M, Huo L, Koenig KB, Mittendorf EA, Meric-Bernstam F, Kuerer HM, Bedrosian I, Buzdar AU, Symmans WF, Crow JR, Bender M, Shah RR, Hortobagyi GN, Hunt KKAnnals of oncology : official journal of the European Society for Medical OncologyWhich threshold for ER positivity? a retrospective study based on 9639 patients. Ann Oncol. 2014 May; 25(5):1004-11.Ann Oncol2014-02-20T00:00:002014Which threshold for ER positivity? a retrospective study based on 9639 patients.24587029Wang J, Mittendorf EA, Sahin AA, Yi M, Caudle A, Hunt KK, Wu YPloS oneOutcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database. PLoS One. 2014; 9(2):e89778.PLoS One2014-02-25T00:00:002014Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database.24639192Bednarski BK, Araujo DM, Yi M, Torres KE, Lazar A, Trent JC, Cormier JN, Pisters PW, Lev DC, Pollock RE, Feig BW, Hunt KKAnnals of surgical oncologyAnalysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors. Ann Surg Oncol. 2014 Aug; 21(8):2499-505.Ann Surg Oncol2014-03-18T00:00:002014Analysis of prognostic factors impacting oncologic outcomes after neoadjuvant tyrosine kinase inhibitor therapy for gastrointestinal stromal tumors.24831919Li P, Hunt KJ, Taber DJ, Carter RE, Kettinger L, Luttrell D, Egidi MF, Finch NJ, Baliga P, Lin A, Biggins S, Hermayer KLTransplantationInflammatory biomarkers, glycemic variability, hypoglycemia, and renal transplant outcomes: results of a randomized controlled trial. Transplantation. 2014 Sep 27; 98(6):632-9.Transplantation2014-09-27T00:00:002014Inflammatory biomarkers, glycemic variability, hypoglycemia, and renal transplant outcomes: results of a randomized controlled trial.24841348Mittendorf EA, Caudle AS, Yang W, Krishnamurthy S, Shaitelman S, Chavez-MacGregor M, Woodward WA, Bedrosian I, Kuerer HM, Hunt KKAnnals of surgical oncologyImplementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy? Ann Surg Oncol. 2014 Aug; 21(8):2468-73.Ann Surg Oncol2014-05-20T00:00:002014Implementation of the american college of surgeons oncology group z1071 trial data in clinical practice: is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?24859939Caudle AS, Kuerer HM, Le-Petross HT, Yang W, Yi M, Bedrosian I, Krishnamurthy S, Fornage BD, Hunt KK, Mittendorf EAAnnals of surgical oncologyPredicting the extent of nodal disease in early-stage breast cancer. Ann Surg Oncol. 2014 Oct; 21(11):3440-7.Ann Surg Oncol2014-05-24T00:00:002014Predicting the extent of nodal disease in early-stage breast cancer.24882348Teshome M, Hunt KKSurgical oncology clinics of North AmericaNeoadjuvant therapy in the treatment of breast cancer. Surg Oncol Clin N Am. 2014 Jul; 23(3):505-23.Surg Oncol Clin N Am2014-04-24T00:00:002014Neoadjuvant therapy in the treatment of breast cancer.24890352MacDermed DM, Houtman KM, Thang SH, Allen PK, Caudle AS, Gainer SM, Hunt KK, Perkins GH, Shaitelman SF, Smith BD, Strom EA, Tereffe W, Woodward WA, Buchholz TA, Hoffman KEPractical radiation oncologyTherapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: implications for targeting the undissected axilla. Pract Radiat Oncol. 2014 Mar-Apr; 4(2):116-122.Pract Radiat Oncol2013-07-12T00:00:002013Therapeutic radiation dose delivered to the low axilla during whole breast radiation therapy in the prone position: implications for targeting the undissected axilla.24925040Pullen S, Gilman K, Hunt K, Lowery A, Rodriguez Vargas L, Rolle T, Tsoumas AJournal of allied healthPhysical therapy as an adjunct treatment for people living with HIV/AIDS: an allied health perspective. J Allied Health. 2014; 43(2):e11-7.J Allied Health2014-01-01T00:00:002014Physical therapy as an adjunct treatment for people living with HIV/AIDS: an allied health perspective.25083471Black DM, Hunt KK, Mittendorf EAGland surgeryLong term outcomes reporting the safety of breast conserving therapy compared to mastectomy: 20-year results of EORTC 10801. Gland Surg. 2013 Aug; 2(3):120-3.Gland Surg2013-08-01T00:00:002013Long term outcomes reporting the safety of breast conserving therapy compared to mastectomy: 20-year results of EORTC 10801.25083903Egede LE, Gebregziabher M, Zhao Y, Dismuke CE, Walker RJ, Hunt KJ, Axon RNPloS oneImpact of mental health visits on healthcare cost in patients with diabetes and comorbid mental health disorders. PLoS One. 2014; 9(8):e103804.PLoS One2014-08-01T00:00:002014Impact of mental health visits on healthcare cost in patients with diabetes and comorbid mental health disorders.25088746Klein RL, Hammad SM, Baker NL, Hunt KJ, Al Gadban MM, Cleary PA, Virella G, Lopes-Virella MF, DCCT/EDIC Research GroupMetabolism: clinical and experimentalDecreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes. Metabolism. 2014 Oct; 63(10):1287-95.Metabolism2014-07-09T00:00:002014Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetes.25195861Caruso JA, Akli S, Pageon L, Hunt KK, Keyomarsi KOncogeneThe serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase. Oncogene. 2015 Jul; 34(27):3556-67.Oncogene2014-09-08T00:00:002014The serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase.25249256Rueth NM, Black DM, Limmer AR, Gabriel E, Huo L, Fornage BD, Dogan BE, Chavez-MacGregor M, Yi M, Hunt KK, Strom EAAnnals of surgical oncologyBreast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer. Ann Surg Oncol. 2015 Jan; 22(1):90-5.Ann Surg Oncol2014-09-24T00:00:002014Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer.25279862Hunt KJ, Kistner-Griffin E, Spruill I, Teklehaimanot AA, Garvey WT, Sale M, Fernandes JSouthern medical journalCardiovascular risk in Gullah African Americans with high familial risk of type 2 diabetes mellitus: project SuGAR. South Med J. 2014 Oct; 107(10):607-14.South Med J2014-10-01T00:00:002014Cardiovascular risk in Gullah African Americans with high familial risk of type 2 diabetes mellitus: project SuGAR.25333877Ren Y, Black DM, Mittendorf EA, Liu P, Li X, Du XL, He J, Yang J, Hunt KK, Yi MPloS oneCrossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race. PLoS One. 2014; 9(10):e110281.PLoS One2014-10-21T00:00:002014Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race.25354575Ikoma N, Torres KE, Somaiah N, Hunt KK, Cormier JN, Tseng W, Lev D, Pollock R, Wang WL, Feig BAnnals of surgical oncologyAccuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes. Ann Surg Oncol. 2015 Apr; 22(4):1068-72.Ann Surg Oncol2014-10-30T00:00:002014Accuracy of preoperative percutaneous biopsy for the diagnosis of retroperitoneal liposarcoma subtypes.25425017Dixon JM, Rutgers E, Hunt KKBMJ (Clinical research ed.)Intraoperative assessment of axillary lymph nodes in patients with breast cancer. BMJ. 2014 Nov 25; 349:g6803.BMJ2014-11-25T00:00:002014Intraoperative assessment of axillary lymph nodes in patients with breast cancer.25441222Rajab HA, Baker NL, Hunt KJ, Klein R, Cleary PA, Lachin J, Virella G, Lopes-Virella MF, DCCT/EDIC Group of InvestigatorsJournal of diabetes and its complicationsThe predictive role of markers of Inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetes. J Diabetes Complications. 2015 Jan-Feb; 29(1):108-14.J Diabetes Complications2014-08-20T00:00:002014The predictive role of markers of Inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetes.25488970Mittendorf EA, Ballman KV, McCall LM, Yi M, Sahin AA, Bedrosian I, Hansen N, Gabram S, Hurd T, Giuliano AE, Hunt KKJournal of clinical oncology : official journal of the American Society of Clinical OncologyEvaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer. J Clin Oncol. 2015 Apr 01; 33(10):1119-27.J Clin Oncol2014-12-08T00:00:002014Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer.25517573Caudle AS, Yang WT, Mittendorf EA, Black DM, Hwang R, Hobbs B, Hunt KK, Krishnamurthy S, Kuerer HMJAMA surgerySelective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial. JAMA Surg. 2015 Feb; 150(2):137-43.JAMA Surg2015-02-01T00:00:002015Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial.25564996Huo L, Gong Y, Guo M, Gilcrease MZ, Wu Y, Zhang H, Zhang J, Resetkova E, Hunt KK, Deavers MTHistopathologyGATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry. Histopathology. 2015 Aug; 67(2):245-54.Histopathology2015-02-23T00:00:002015GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry.25584488Gonzalez-Angulo AM, Parinyanitikul N, Lei X, Mittendorf EA, Zhang H, Valero V, Hunt KK, Hortobagyi GN, Chavez-MacGregor MBritish journal of cancerEffect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy. Br J Cancer. 2015 Feb 17; 112(4):630-5.Br J Cancer2015-01-13T00:00:002015Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy.25626809Chang EI, Chang EI, Ito R, Zhang H, Nguyen AT, Skoracki RJ, Hanasono MM, Crosby MA, Ueno NT, Hunt KKPlastic and reconstructive surgeryChallenging a traditional paradigm: 12-year experience with autologous free flap breast reconstruction for inflammatory breast cancer. Plast Reconstr Surg. 2015 Feb; 135(2):262e-269e.Plast Reconstr Surg2015-02-01T00:00:002015Challenging a traditional paradigm: 12-year experience with autologous free flap breast reconstruction for inflammatory breast cancer.25646192Boughey JC, Ballman KV, Hunt KK, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Le-Petross HTJournal of clinical oncology : official journal of the American Society of Clinical OncologyAxillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance). J Clin Oncol. 2015 Oct 20; 33(30):3386-93.J Clin Oncol2015-02-02T00:00:002015Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).25664534Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Flippo-Morton TS, Kuerer HM, Bowling M, Hunt KK, Alliance for Clinical Trials in OncologyAnnals of surgeryFactors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance). Ann Surg. 2015 Mar; 261(3):547-52.Ann Surg2015-03-01T00:00:002015Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance).25678814Nietert PJ, Shaftman SR, Silver RM, Wolf BJ, Egan BM, Hunt KJ, Smith EAClinical epidemiologyRaynaud phenomenon and mortality: 20+ years of follow-up of the Charleston Heart Study cohort. Clin Epidemiol. 2015; 7:161-8.Clin Epidemiol2015-02-03T00:00:002015Raynaud phenomenon and mortality: 20+ years of follow-up of the Charleston Heart Study cohort.25727559Boughey JC, Hunt KKAnnals of surgical oncologySpotlight on neoadjuvant therapy for breast cancer. Ann Surg Oncol. 2015 May; 22(5):1406-7.Ann Surg Oncol2015-03-02T00:00:002015Spotlight on neoadjuvant therapy for breast cancer.25743327Dineen SP, Roland CL, Feig R, May C, Zhou S, Demicco E, Sannaa GA, Ingram D, Wang WL, Ravi V, Guadagnolo A, Lev D, Pollock RE, Hunt K, Cormier J, Lazar A, Feig B, Torres KEAnnals of surgical oncologyRadiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions. Ann Surg Oncol. 2015 Nov; 22(12):3913-20.Ann Surg Oncol2015-03-06T00:00:002015Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions.25852210Hunt KJ, Baker NL, Cleary PA, Klein R, Virella G, Lopes-Virella MF, DCCT/EDIC Group of InvestigatorsDiabetes careLongitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC Cohort. Diabetes Care. 2015 Jul; 38(7):1281-9.Diabetes Care2015-04-07T00:00:002015Longitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC Cohort.25905585Francis AM, Haugen CE, Grimes LM, Crow JR, Yi M, Mittendorf EA, Bedrosian I, Caudle AS, Babiera GV, Krishnamurthy S, Kuerer HM, Hunt KKAnnals of surgical oncologyIs Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ? Ann Surg Oncol. 2015 Dec; 22(13):4270-9.Ann Surg Oncol2015-04-24T00:00:002015Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?26001368Brudvik KW, Patel SH, Roland CL, Conrad C, Torres KE, Hunt KK, Cormier JN, Feig BW, Aloia TA, Vauthey JNJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractSurvival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients. J Gastrointest Surg. 2015 Aug; 19(8):1476-83.J Gastrointest Surg2015-05-22T00:00:002015Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients.26063878Buchholz TA, Mittendorf EA, Hunt KKJournal of the National Cancer Institute. MonographsSurgical Considerations After Neoadjuvant Chemotherapy: Breast Conservation Therapy. J Natl Cancer Inst Monogr. 2015 May; 2015(51):11-4.J Natl Cancer Inst Monogr2015-05-01T00:00:002015Surgical Considerations After Neoadjuvant Chemotherapy: Breast Conservation Therapy.26108797Caruso JA, Karakas C, Zhang J, Yi M, Albarracin C, Sahin A, Bondy M, Liu J, Hunt KK, Keyomarsi KBreast cancer research : BCRErratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence. Breast Cancer Res. 2015 Jun 25; 17:87.Breast Cancer Res2015-06-25T00:00:002015Erratum to: Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence.26130233Bishop AJ, Zagars GK, Torres KE, Hunt KK, Cormier JN, Feig BW, Guadagnolo BAInternational journal of radiation oncology, biology, physicsCombined Modality Management of Retroperitoneal Sarcomas: A Single-Institution Series of 121 Patients. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):158-65.Int J Radiat Oncol Biol Phys2015-05-02T00:00:002015Combined Modality Management of Retroperitoneal Sarcomas: A Single-Institution Series of 121 Patients.26156655Bedrosian I, Xing Y, Abdel Rahman S, Allen L, Le-Petross H, Whitman GJ, Meric-Bernstam F, Hunt KK, Babiera GV, Cormier JNAnnals of surgical oncologyA Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular Cancer. Ann Surg Oncol. 2016 Jan; 23(1):23-9.Ann Surg Oncol2015-07-09T00:00:002015A Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular Cancer.26177983Tseng WW, Zhou S, To CA, Thall PF, Lazar AJ, Pollock RE, Lin PP, Cormier JN, Lewis VO, Feig BW, Hunt KK, Ballo MT, Patel S, Pisters PWCancerPhase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma. Cancer. 2015 Oct 15; 121(20):3659-67.Cancer2015-07-15T00:00:002015Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma.26182523Martin LW, Veeramachaneni NK, Katz MH, You YN, Boughey JC, Nelson H, Hunt KKBulletin of the American College of SurgeonsNew manual for cancer surgery issued: Operative Standards for Cancer Surgery. Bull Am Coll Surg. 2015 Jun; 100(6):43-4.Bull Am Coll Surg2015-06-01T00:00:002015New manual for cancer surgery issued: Operative Standards for Cancer Surgery.26202554DeSnyder SM, Hunt KK, Smith BD, Moran MS, Klimberg S, Lucci AAnnals of surgical oncologyAssessment of Practice Patterns Following Publication of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer. Ann Surg Oncol. 2015 Oct; 22(10):3250-6.Ann Surg Oncol2015-07-23T00:00:002015Assessment of Practice Patterns Following Publication of the SSO-ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer.26247543Shaitelman SF, Schlembach PJ, Arzu I, Ballo M, Bloom ES, Buchholz D, Chronowski GM, Dvorak T, Grade E, Hoffman KE, Kelly P, Ludwig M, Perkins GH, Reed V, Shah S, Stauder MC, Strom EA, Tereffe W, Woodward WA, Ensor J, Baumann D, Thompson AM, Amaya D, Davis T, Guerra W, Hamblin L, Hortobagyi G, Hunt KK, Buchholz TA, Smith BDJAMA oncologyAcute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial. JAMA Oncol. 2015 Oct; 1(7):931-41.JAMA Oncol2015-10-01T00:00:002015Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.26279027Smith GL, Huo J, Giordano SH, Hunt KK, Buchholz TA, Smith BDInternational journal of radiation oncology, biology, physicsUtilization and Outcomes of Breast Brachytherapy in Younger Women. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):91-101.Int J Radiat Oncol Biol Phys2015-05-14T00:00:002015Utilization and Outcomes of Breast Brachytherapy in Younger Women.26279028Shaitelman SF, Tereffe W, Dogan BE, Hess KR, Caudle AS, Valero V, Stauder MC, Krishnamurthy S, Candelaria RP, Strom EA, Woodward WA, Hunt KK, Buchholz TA, Whitman GJInternational journal of radiation oncology, biology, physicsRole of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):102-10.Int J Radiat Oncol Biol Phys2015-05-16T00:00:002015Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment.26282647Mittendorf EA, Bedrosian I, Hunt KKJournal of clinical oncology : official journal of the American Society of Clinical OncologyReply to L. Antolini et al. J Clin Oncol. 2015 Nov 20; 33(33):3978-9.J Clin Oncol2015-08-17T00:00:002015Reply to L. Antolini et al.26286912Hatzis C, Symmans WF, Zhang Y, Gould RE, Moulder SL, Hunt KK, Abu-Khalaf M, Hofstatter EW, Lannin D, Chagpar AB, Pusztai LClinical cancer research : an official journal of the American Association for Cancer ResearchRelationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer. Clin Cancer Res. 2016 Jan 01; 22(1):26-33.Clin Cancer Res2015-08-18T00:00:002015Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer.26295353Egede LE, Gebregziabher M, Zhao Y, Dismuke CE, Walker RJ, Hunt KJ, Axon RNThe American journal of managed careDifferential impact of mental health multimorbidity on healthcare costs in diabetes. Am J Manag Care. 2015 Aug; 21(8):535-44.Am J Manag Care2015-08-01T00:00:002015Differential impact of mental health multimorbidity on healthcare costs in diabetes.26397343Dogan BE, Dryden MJ, Wei W, Fornage BD, Buchholz TA, Smith B, Hunt K, Krishnamurthy S, Yang WTAJR. American journal of roentgenologySonography and Sonographically Guided Needle Biopsy of Internal Mammary Nodes in Staging of Patients With Breast Cancer. AJR Am J Roentgenol. 2015 Oct; 205(4):905-11.AJR Am J Roentgenol2015-10-01T00:00:002015Sonography and Sonographically Guided Needle Biopsy of Internal Mammary Nodes in Staging of Patients With Breast Cancer.26470897Hunt KKOncology (Williston Park, N.Y.)Axillary Surgery After Chemotherapy: Challenges and Opportunities. Oncology (Williston Park). 2015 Oct; 29(10):741-2.Oncology (Williston Park)2015-10-01T00:00:002015Axillary Surgery After Chemotherapy: Challenges and Opportunities.26501538Yi M, Hunt KKJAMAOptimizing Mammography Screening Intervals. JAMA. 2015 Oct 20; 314(15):1635-6.JAMA2015-10-20T00:00:002015Optimizing Mammography Screening Intervals.26624901Hobeika L, Hunt KJ, Neely BA, Arthur JMThe American journal of the medical sciencesComparison of the Rate of Renal Function Decline in NonProteinuric Patients With and Without Diabetes. Am J Med Sci. 2015 Dec; 350(6):447-52.Am J Med Sci2015-12-01T00:00:002015Comparison of the Rate of Renal Function Decline in NonProteinuric Patients With and Without Diabetes.26628470Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S, Weisenburger DD, Liu J, Morgan EA, Kanagal-Shamanna R, Parkash V, Ning J, Sohani AR, Ferry JA, Mehta-Shah N, Dogan A, Liu H, Thormann N, Di Napoli A, DiNapoli A, Lade S, Piccolini J, Reyes R, Williams T, McCarthy CM, Hanson SE, Nastoupil LJ, Gaur R, Oki Y, Young KH, Miranda RNJournal of clinical oncology : official journal of the American Society of Clinical OncologyComplete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma. J Clin Oncol. 2016 Jan 10; 34(2):160-8.J Clin Oncol2015-11-30T00:00:002015Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma.26677537Leitch AM, Boughey JC, Hunt KKBulletin of the American College of SurgeonsResponse to preoperative endocrine therapy in breast cancer patients can alter surgical and chemotherapy options. Bull Am Coll Surg. 2015 Nov; 100(11):43-5.Bull Am Coll Surg2015-11-01T00:00:002015Response to preoperative endocrine therapy in breast cancer patients can alter surgical and chemotherapy options.10560853Newman LA, Kuerer HM, Hunt KK, Ames FC, Ross MI, Theriault R, Fry N, Kroll SS, Robb GL, Singletary SEAnnals of surgical oncologyFeasibility of immediate breast reconstruction for locally advanced breast cancer. Ann Surg Oncol. 1999 Oct-Nov; 6(7):671-5.Ann Surg Oncol1999-10-01T00:00:001999Feasibility of immediate breast reconstruction for locally advanced breast cancer.11994589Kronowitz SJ, Chang DW, Robb GL, Hunt KK, Ames FC, Ross MI, Singletary SE, Symmans WF, Kroll SS, Kuerer HMPlastic and reconstructive surgeryImplications of axillary sentinel lymph node biopsy in immediate autologous breast reconstruction. Plast Reconstr Surg. 2002 May; 109(6):1888-96.Plast Reconstr Surg2002-05-01T00:00:002002Implications of axillary sentinel lymph node biopsy in immediate autologous breast reconstruction.11376574Newman LA, Kuerer HM, McNeese MD, Hunt KK, Gurtner GC, Vlastos GS, Robb G, Singletary SEAmerican journal of surgeryReduction mammoplasty improves breast conservation therapy in patients with macromastia. Am J Surg. 2001 Mar; 181(3):215-20.Am J Surg2001-03-01T00:00:002001Reduction mammoplasty improves breast conservation therapy in patients with macromastia.11839343Feig BW, Curley S, Lucci A, Hunt KK, Vauthey JN, Mansfield PF, Cleary K, Hamilton S, Ellis V, Brame M, Berger DHAmerican journal of surgeryA caution regarding lymphatic mapping in patients with colon cancer. Am J Surg. 2001 Dec; 182(6):707-12.Am J Surg2001-12-01T00:00:002001A caution regarding lymphatic mapping in patients with colon cancer.15114121Kronowitz SJ, Hunt KK, Kuerer HM, Babiera G, McNeese MD, Buchholz TA, Strom EA, Robb GLPlastic and reconstructive surgeryDelayed-immediate breast reconstruction. Plast Reconstr Surg. 2004 May; 113(6):1617-28.Plast Reconstr Surg2004-05-01T00:00:002004Delayed-immediate breast reconstruction.15139051Patten LC, Berger DH, Rodriguez-Bigas M, Mansfield P, Delpassand E, Cleary KR, Fagan SP, Curley SA, Hunt KK, Feig BWCancerA prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping. Cancer. 2004 May 15; 100(10):2104-9.Cancer2004-05-15T00:00:002004A prospective evaluation of radiocolloid and immunohistochemical staining in colon carcinoma lymphatic mapping.74Professor14Associate ProfessorBreast Surgical Oncology12567059Butler CE, Hunt KK, Singletary SEAnnals of plastic surgeryManagement of breast carcinoma identified intraoperatively during reduction mammaplasty. Ann Plast Surg. 2003 Feb; 50(2):193-7.Ann Plast Surg2003-02-01T00:00:002003Management of breast carcinoma identified intraoperatively during reduction mammaplasty.12679309Hwang RF, Krishnamurthy S, Hunt KK, Mirza N, Ames FC, Feig B, Kuerer HM, Singletary SE, Babiera G, Meric F, Akins JS, Neely J, Ross MIAnnals of surgical oncologyClinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol. 2003 Apr; 10(3):248-54.Ann Surg Oncol2003-04-01T00:00:002003Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer.26811528Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE, Shaitelman SF, Chavez-MacGregor M, Smith BD, Candelaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Kuerer HMJournal of clinical oncology : official journal of the American Society of Clinical OncologyImproved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection. J Clin Oncol. 2016 Apr 01; 34(10):1072-8.J Clin Oncol2016-01-25T00:00:002016Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.27007608Dryden MJ, Dogan BE, Fox P, Wang C, Black DM, Hunt K, Yang WTAJR. American journal of roentgenologyImaging Factors That Influence Surgical Margins After Preoperative 125I Radioactive Seed Localization of Breast Lesions: Comparison With Wire Localization. AJR Am J Roentgenol. 2016 May; 206(5):1112-8.AJR Am J Roentgenol2016-03-23T00:00:002016Imaging Factors That Influence Surgical Margins After Preoperative 125I Radioactive Seed Localization of Breast Lesions: Comparison With Wire Localization.16714331Lu J, Wei Q, Bondy ML, Li D, Brewster A, Shete S, Yu TK, Sahin A, Meric-Bernstam F, Hunt KK, Singletary SE, Ross MI, Wang LECarcinogenesisPolymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or=55 years. Carcinogenesis. 2006 Nov; 27(11):2209-16.Carcinogenesis2006-05-19T00:00:002006Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or=55 years.27406093Carter SA, Lyons GR, Kuerer HM, Bassett RL, Oates S, Thompson A, Caudle AS, Mittendorf EA, Bedrosian I, Lucci A, DeSnyder SM, Babiera G, Yi M, Baumann DP, Clemens MW, Garvey PB, Hunt KK, Hwang RFAnnals of surgical oncologyOperative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction. Ann Surg Oncol. 2016 10; 23(10):3190-8.Ann Surg Oncol2016-07-12T00:00:002016Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction.27502118Miller CA, Gindin Y, Lu C, Griffith OL, Griffith M, Shen D, Hoog J, Li T, Larson DE, Watson M, Davies SR, Hunt K, Suman VJ, Snider J, Walsh T, Colditz GA, DeSchryver K, Wilson RK, Mardis ER, Ellis MJNature communicationsAromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers. Nat Commun. 2016 08 09; 7:12498.Nat Commun2016-08-09T00:00:002016Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers.12602900Albo D, Ames FC, Hunt KK, Ross MI, Singletary SE, Kuerer HMBreast cancer research and treatmentEvaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Breast Cancer Res Treat. 2003 Jan; 77(1):9-14.Breast Cancer Res Treat2003-01-01T00:00:002003Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy.17851762Lu J, Wei Q, Bondy ML, Brewster AM, Bevers TB, Yu TK, Buchholz TA, Meric-Bernstam F, Hunt KK, Singletary SE, Wang LEBreast cancer research and treatmentGenetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged <or=55 years. Breast Cancer Res Treat. 2008 Jul; 110(2):357-66.Breast Cancer Res Treat2007-09-13T00:00:002007Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged <or=55 years.15378473Tseng JF, Kronowitz SJ, Sun CC, Perry AC, Hunt KK, Babiera GV, Newman LA, Singletary SE, Mirza NQ, Ames FC, Meric-Bernstam F, Ross MI, Feig BW, Robb GL, Kuerer HMCancerThe effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer. 2004 Oct 01; 101(7):1514-23.Cancer2004-10-01T00:00:002004The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer.18716089Bedi DG, Krishnamurthy R, Krishnamurthy S, Edeiken BS, Le-Petross H, Fornage BD, Bassett RL, Hunt KKAJR. American journal of roentgenologyCortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study. AJR Am J Roentgenol. 2008 Sep; 191(3):646-52.AJR Am J Roentgenol2008-09-01T00:00:002008Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study.15604959Babiera GV, Delpassand ES, Breslin TM, Ross MI, Ames FC, Singletary SE, Kuerer HM, Feig BW, Meric-Bernstam F, Hunt KKClinical nuclear medicineLymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy. Clin Nucl Med. 2005 Jan; 30(1):11-5.Clin Nucl Med2005-01-01T00:00:002005Lymphatic drainage patterns on early versus delayed breast lymphoscintigraphy performed after injection of filtered Tc-99m sulfur colloid in breast cancer patients undergoing sentinel lymph node biopsy.14752082Raut CP, Daley MD, Hunt KK, Akins J, Ross MI, Singletary SE, Marshall GD, Meric-Bernstam F, Babiera G, Feig BW, Ames FC, Kuerer HMJournal of clinical oncology : official journal of the American Society of Clinical OncologyAnaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. J Clin Oncol. 2004 Feb 01; 22(3):567-8.J Clin Oncol2004-02-01T00:00:002004Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis.15981283Raut CP, Hunt KK, Akins JS, Daley MD, Ross MI, Singletary SE, Marshall GD, Meric-Bernstam F, Babiera G, Feig BW, Ames FC, Kuerer HMCancerIncidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer. 2005 Aug 15; 104(4):692-9.Cancer2005-08-15T00:00:002005Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol.20443145Sharma R, Bedrosian I, Lucci A, Hwang RF, Rourke LL, Qiao W, Buchholz TA, Kronowitz SJ, Krishnamurthy S, Babiera GV, Gonzalez-Angulo AM, Meric-Bernstam F, Mittendorf EA, Hunt KK, Kuerer HMAnnals of surgical oncologyPresent-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy. Ann Surg Oncol. 2010 Nov; 17(11):2899-908.Ann Surg Oncol2010-05-05T00:00:002010Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapy.16173826Ku G, Fornage BD, Jin X, Xu M, Hunt KK, Wang LVTechnology in cancer research & treatmentThermoacoustic and photoacoustic tomography of thick biological tissues toward breast imaging. Technol Cancer Res Treat. 2005 Oct; 4(5):559-66.Technol Cancer Res Treat2005-10-01T00:00:002005Thermoacoustic and photoacoustic tomography of thick biological tissues toward breast imaging.20665494Shinde SS, Forman MR, Kuerer HM, Yan K, Peintinger F, Hunt KK, Hortobagyi GN, Pusztai L, Symmans WFCancerHigher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer. Cancer. 2010 Nov 01; 116(21):4933-43.Cancer2010-11-01T00:00:002010Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer.16199989Schechter NR, Strom EA, Perkins GH, Arzu I, McNeese MD, Langstein HN, Kronowitz SJ, Meric-Bernstam F, Babiera G, Hunt KK, Hortobagyi GN, Buchholz TAAmerican journal of clinical oncologyImmediate breast reconstruction can impact postmastectomy irradiation. Am J Clin Oncol. 2005 Oct; 28(5):485-94.Am J Clin Oncol2005-10-01T00:00:002005Immediate breast reconstruction can impact postmastectomy irradiation.20945319Yi M, Kronowitz SJ, Meric-Bernstam F, Feig BW, Symmans WF, Lucci A, Ross MI, Babiera GV, Kuerer HM, Hunt KKCancerLocal, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy. Cancer. 2011 Mar 01; 117(5):916-24.Cancer2010-10-13T00:00:002010Local, regional, and systemic recurrence rates in patients undergoing skin-sparing mastectomy compared with conventional mastectomy.21311392Kronowitz SJ, Lam C, Terefe W, Hunt KK, Kuerer HM, Valero V, Lance S, Robb GL, Feng L, Buchholz TAPlastic and reconstructive surgeryA multidisciplinary protocol for planned skin-preserving delayed breast reconstruction for patients with locally advanced breast cancer requiring postmastectomy radiation therapy: 3-year follow-up. Plast Reconstr Surg. 2011 Jun; 127(6):2154-2166.Plast Reconstr Surg2011-06-01T00:00:002011A multidisciplinary protocol for planned skin-preserving delayed breast reconstruction for patients with locally advanced breast cancer requiring postmastectomy radiation therapy: 3-year follow-up.16404237Kronowitz SJ, Feledy JA, Hunt KK, Kuerer HM, Youssef A, Koutz CA, Robb GLPlastic and reconstructive surgeryDetermining the optimal approach to breast reconstruction after partial mastectomy. Plast Reconstr Surg. 2006 Jan; 117(1):1-11; discussion 12-4.Plast Reconstr Surg2006-01-01T00:00:002006Determining the optimal approach to breast reconstruction after partial mastectomy.Authorship 3745991417016172Kronowitz SJ, Kuerer HM, Hunt KK, Ross MI, Massey PR, Ensor JE, Robb GLPlastic and reconstructive surgeryImpact of sentinel lymph node biopsy on the evolution of breast reconstruction. Plast Reconstr Surg. 2006 Oct; 118(5):1089-1099.Plast Reconstr Surg2006-10-01T00:00:002006Impact of sentinel lymph node biopsy on the evolution of breast reconstruction.22772869Alvarado R, Yi M, Le-Petross H, Gilcrease M, Mittendorf EA, Bedrosian I, Hwang RF, Caudle AS, Babiera GV, Akins JS, Kuerer HM, Hunt KKAnnals of surgical oncologyThe role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer. Ann Surg Oncol. 2012 Oct; 19(10):3177-84.Ann Surg Oncol2012-07-07T00:00:002012The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer.18090737Kronowitz SJ, Hunt KK, Kuerer HM, Strom EA, Buchholz TA, Ensor JE, Koutz CA, Robb GLPlastic and reconstructive surgeryPractical guidelines for repair of partial mastectomy defects using the breast reduction technique in patients undergoing breast conservation therapy. Plast Reconstr Surg. 2007 Dec; 120(7):1755-1768.Plast Reconstr Surg2007-12-01T00:00:002007Practical guidelines for repair of partial mastectomy defects using the breast reduction technique in patients undergoing breast conservation therapy.18234447Buchholz TA, Woodward WA, Duan Z, Fang S, Oh JL, Tereffe W, Strom EA, Perkins GH, Yu TK, Hunt KK, Meric-Bernstam F, Hortobagyi GN, Giordano SHInternational journal of radiation oncology, biology, physicsRadiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):1022-7.Int J Radiat Oncol Biol Phys2008-01-30T00:00:002008Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes.17764565Feng W, Shen L, Wen S, Rosen DG, Jelinek J, Hu X, Huan S, Huang M, Liu J, Sahin AA, Hunt KK, Bast RC, Shen Y, Issa JP, Yu YBreast cancer research : BCRCorrelation between CpG methylation profiles and hormone receptor status in breast cancers. Breast Cancer Res. 2007; 9(4):R57.Breast Cancer Res2007-01-01T00:00:002007Correlation between CpG methylation profiles and hormone receptor status in breast cancers.18457326Yi M, Meric-Bernstam F, Ross MI, Akins JS, Hwang RF, Lucci A, Kuerer HM, Babiera GV, Gilcrease MZ, Hunt KKCancerHow many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer? Cancer. 2008 Jul 01; 113(1):30-7.Cancer2008-07-01T00:00:002008How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?19050516Kronowitz SJ, Kuerer HM, Buchholz TA, Valero V, Hunt KKPlastic and reconstructive surgeryA management algorithm and practical oncoplastic surgical techniques for repairing partial mastectomy defects. Plast Reconstr Surg. 2008 Dec; 122(6):1631-1647.Plast Reconstr Surg2008-12-01T00:00:002008A management algorithm and practical oncoplastic surgical techniques for repairing partial mastectomy defects.19571599Cox JD, Giralt SA, Veazie ML, Ajani JA, Bruner JM, Chan KW, Hittelman WN, Hunt KK, Iyer RB, Karp DD, Kuban DA, Lippman SM, Raad II, Rodriguez-Bigas MA, Zwelling LA, Markman MOncologyEvaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience. Oncology. 2009; 77(2):75-81.Oncology2009-07-01T00:00:002009Evaluating quality in clinical cancer research: the M.D. Anderson Cancer Center experience.19622598Anaya DA, Lahat G, Wang X, Xiao L, Pisters PW, Cormier JN, Hunt KK, Feig BW, Lev DC, Pollock REAnnals of oncology : official journal of the European Society for Medical OncologyPostoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent. Ann Oncol. 2010 Feb; 21(2):397-402.Ann Oncol2009-07-21T00:00:002009Postoperative nomogram for survival of patients with retroperitoneal sarcoma treated with curative intent.27881578Hunt KK, Karakas C, Ha MJ, Biernacka A, Yi M, Sahin AA, Adjapong O, Hortobagyi GN, Bondy M, Thompson P, Cheung KL, Ellis IO, Bacus S, Symmans WF, Do KA, Keyomarsi KClinical cancer research : an official journal of the American Association for Cancer ResearchCytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer. Clin Cancer Res. 2017 Jun 15; 23(12):2991-3002.Clin Cancer Res2016-11-23T00:00:002016Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.28045625Ellis MJ, Suman VJ, Hoog J, Goncalves R, Sanati S, Creighton CJ, DeSchryver K, Crouch E, Brink A, Watson M, Luo J, Tao Y, Barnes M, Dowsett M, Budd GT, Winer E, Silverman P, Esserman L, Carey L, Ma CX, Unzeitig G, Pluard T, Whitworth P, Babiera G, Guenther JM, Dayao Z, Ota D, Leitch M, Olson JA, Allred DC, Hunt KJournal of clinical oncology : official journal of the American Society of Clinical OncologyKi67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance). J Clin Oncol. 2017 Apr 01; 35(10):1061-1069.J Clin Oncol2017-01-03T00:00:002017Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance).20133259Silberfein EJ, Hunt KK, Broglio K, Shen J, Sahin A, Le-Petross H, Oh J, Litton J, Hwang RF, Mittendorf EAClinical breast cancerClinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinoma. Clin Breast Cancer. 2010 Feb; 10(1):52-8.Clin Breast Cancer2010-02-01T00:00:002010Clinicopathologic factors associated with involved margins after breast-conserving surgery for invasive lobular carcinoma.28107181Alexander A, Karakas C, Chen X, Carey JP, Yi M, Bondy M, Thompson P, Cheung KL, Ellis IO, Gong Y, Krishnamurthy S, Alvarez RH, Ueno NT, Hunt KK, Keyomarsi KOncotargetCyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer. Oncotarget. 2017 Feb 28; 8(9):14897-14911.Oncotarget2017-02-28T00:00:002017Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer.20485141Lahat G, Dhuka AR, Hallevi H, Xiao L, Zou C, Smith KD, Phung TL, Pollock RE, Benjamin R, Hunt KK, Lazar AJ, Lev DAnnals of surgeryAngiosarcoma: clinical and molecular insights. Ann Surg. 2010 Jun; 251(6):1098-106.Ann Surg2010-06-01T00:00:002010Angiosarcoma: clinical and molecular insights.28135148Symmans WF, Wei C, Gould R, Yu X, Zhang Y, Liu M, Walls A, Bousamra A, Ramineni M, Sinn B, Hunt K, Buchholz TA, Valero V, Buzdar AU, Yang W, Brewster AM, Moulder S, Pusztai L, Hatzis C, Hortobagyi GNJournal of clinical oncology : official journal of the American Society of Clinical OncologyLong-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype. J Clin Oncol. 2017 Apr 01; 35(10):1049-1060.J Clin Oncol2017-01-30T00:00:002017Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.21532405Sharma R, Rourke LL, Kronowitz SJ, Oh JL, Lucci A, Litton JK, Robb GL, Babiera GV, Mittendorf EA, Hunt KK, Kuerer HMPlastic and reconstructive surgeryManagement of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapy. Plast Reconstr Surg. 2011 May; 127(5):1763-1772.Plast Reconstr Surg2011-05-01T00:00:002011Management of local-regional recurrence following immediate breast reconstruction in patients with early breast cancer treated without postmastectomy radiotherapy.Authorship 841544Authorship 841692Authorship 842357Authorship 842427Authorship 842475Authorship 842580Authorship 842591Authorship 843538Authorship 843620Authorship 844211Authorship 844545Authorship 845045Authorship 845304Authorship 845318Authorship 845407Authorship 845600Authorship 846062Authorship 847031Authorship 847079Authorship 847574Authorship 847991Authorship 848520Authorship 848591Authorship 849295Authorship 849859Authorship 849870Authorship 850246Authorship 850323Authorship 850327Authorship 851172Authorship 851660Authorship 851811Authorship 851969Authorship 852253Authorship 852324Authorship 853169Authorship 853568Authorship 853629Authorship 854021Authorship 854026Authorship 854056Authorship 854149Authorship 854277Authorship 854622Authorship 855154Authorship 855294Authorship 855580Authorship 856372Authorship 856468Authorship 856498Authorship 857432Authorship 857511Authorship 857796Authorship 857903Authorship 858039Authorship 858157Authorship 858472Authorship 858490Authorship 859010Authorship 859314Authorship 859439Authorship 860025Authorship 860911Authorship 861381Authorship 861412Authorship 861764Authorship 862272Authorship 862830Authorship 863572Authorship 863864Authorship 863965Authorship 864119Authorship 864677Authorship 864709Authorship 865202Authorship 865452Authorship 865545Authorship 865662Authorship 865795Authorship 866221Authorship 866268Authorship 866357Authorship 866431Authorship 866842Authorship 866873Authorship 867006Authorship 867115Authorship 867307Authorship 867486Authorship 868183American Journal of RoentgenologyImaging factors that influence surgical margins after preoperative <sup>125</sup>I radioactive seed localization of breast lesions. American Journal of Roentgenology. 206:1112-1118.Imaging factors that influence surgical margins after preoperative <sup>125</sup>I radioactive seed localization of breast lesionsBreast DiseasesCyclin e amplification/overexpression is a mechanism of trastuzumab resistance in HER2<sup>+</sup> breast cancer patients. Breast Diseases. 22:266-267.Cyclin e amplification/overexpression is a mechanism of trastuzumab resistance in HER2<sup>+</sup> breast cancer patientsAnnals of Surgical OncologyValue-Based Breast Cancer Care. Annals of Surgical Oncology. 1-6.Value-Based Breast Cancer CareJournal of Clinical OncologyAxillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery. Journal of Clinical Oncology. 33:3386-3393.Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgeryLocal-regional therapy following systemic treatment. Local-regional therapy following systemic treatmentBreast JournalConsiderations for the Treatment of Young Patients with Breast Cancer. Breast Journal. 22:667-672.Considerations for the Treatment of Young Patients with Breast CancerBreast DiseasesChest wall recurrence after mastectomy does not always portend a dismal outcome. Breast Diseases. 15:164-165.Chest wall recurrence after mastectomy does not always portend a dismal outcomeBreast Cancer ResearchErratum to. Breast Cancer Research. 17.Erratum toJournal of Clinical OncologyImproved axillary evaluation following neoadjuvant therapy for patientswith node-positive breast cancer using selective evaluation of clipped nodes. Journal of Clinical Oncology. 34:1072-1078.Improved axillary evaluation following neoadjuvant therapy for patientswith node-positive breast cancer using selective evaluation of clipped nodesAnnals of Surgical OncologySociety of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy. Annals of Surgical Oncology. 24:375-397.Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) MastectomyBreast DiseasesNodal-stage classification in invasive lobular breast carcinoma. Breast Diseases. 22:366-367.Nodal-stage classification in invasive lobular breast carcinomaBritish Journal of SurgeryAuthor's reply. British Journal of Surgery. 93:1026.Author's replyBreast Cancer ResearchElafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence. Breast Cancer Research. 16.Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrenceJournal of Clinical OncologyIn reply [15]. Journal of Clinical Oncology. 23:3648-3649.In reply [15]Cancer JournalOutcome of breast cancer patients with chest wall recurrence. Cancer Journal. 9:507.Outcome of breast cancer patients with chest wall recurrenceJournal of Gastrointestinal SurgerySurvival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 Patients. Journal of Gastrointestinal Surgery. 19:1476-1483.Survival After Resection of Gastrointestinal Stromal Tumor and Sarcoma Liver Metastases in 146 PatientsChinese Clinical OncologyManagement of invasive and non-invasive breast cancer in the United States and China. Chinese Clinical Oncology. 5.Management of invasive and non-invasive breast cancer in the United States and ChinaAnnals of Surgical OncologyOperative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer. Annals of Surgical Oncology. 1-9.Operative and Oncologic Outcomes in 9861 Patients with Operable Breast CancerWomen's Oncology ReviewBreast conservation after neoadjuvant chemotherapy. Women's Oncology Review. 4:311-312.Breast conservation after neoadjuvant chemotherapyBreast DiseasesClinical practice implementation of findings from the American College of Surgeons Oncology Group Z0010 and Z0011 trials. Breast Diseases. 22:115-118.Clinical practice implementation of findings from the American College of Surgeons Oncology Group Z0010 and Z0011 trialsChinese Clinical OncologyOrganizing a breast cancer database. Chinese Clinical Oncology. 5.Organizing a breast cancer databaseOperative standards for cancer surgery. Operative standards for cancer surgeryAnnals of Surgical OncologyA Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular Cancer. Annals of Surgical Oncology. A Cost Analysis of Preoperative Breast MRI Use for Patients with Invasive Lobular CancerAnnals of Surgical OncologyPostmastectomy Radiation Treatment Rates as a Quality Measure. Annals of Surgical Oncology. 1-3.Postmastectomy Radiation Treatment Rates as a Quality MeasureAnnals of Surgical OncologyTrends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast Cancer. Annals of Surgical Oncology. 1-7.Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast CancerAnnals of SurgeryCombining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer. Annals of Surgery. Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast CancerCancer Biology and TherapyHerceptin plus chemotherapy combination in preoperative regimen may offer clinical benefit in early stage breast cancer. Cancer Biology and Therapy. 4.Herceptin plus chemotherapy combination in preoperative regimen may offer clinical benefit in early stage breast cancerMolecular Cancer ResearchAXL inhibition suppresses the DNA damage response and sensitizes cells to PARP inhibition in multiple cancers. Molecular Cancer Research. 15:45-58.AXL inhibition suppresses the DNA damage response and sensitizes cells to PARP inhibition in multiple cancersJournal of Clinical OncologyComplete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. Journal of Clinical Oncology. 34:160-168.Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphomaCurrent Breast Cancer ReportsAxillary dissection in women with invasive breast cancer and sentinel node metastasis. Current Breast Cancer Reports. 3:75-78.Axillary dissection in women with invasive breast cancer and sentinel node metastasisAnnals of Surgical OncologyPaget's disease of the breast. Annals of Surgical Oncology. 12:1-7.Paget's disease of the breastJournal of Clinical OncologyIn reply [14]. Journal of Clinical Oncology. 23:8131-8132.In reply [14]Technology in Cancer Research and TreatmentImage-guided Percutaneous Ablation of Small Breast Cancer. Technology in Cancer Research and Treatment. 14:209-211.Image-guided Percutaneous Ablation of Small Breast CancerClinical Cancer ResearchRelationship between complete pathologic response to neoadjuvant chemotherapy and survival in triple-negative breast cancer. Clinical Cancer Research. 22:26-33.Relationship between complete pathologic response to neoadjuvant chemotherapy and survival in triple-negative breast cancerMolecular Cancer TherapeuticsSequential combination therapy of CDK inhibition and doxorubicin is synthetically lethal in p53-mutant Triple-negative breast cancer. Molecular Cancer Therapeutics. 15:593-607.Sequential combination therapy of CDK inhibition and doxorubicin is synthetically lethal in p53-mutant Triple-negative breast cancerBiomarkers in neoadjuvant trials. 125-160.Biomarkers in neoadjuvant trialsFinding common aberrations in array CGH data. 1199-1204.Finding common aberrations in array CGH dataWomen's Oncology ReviewBreast conservation after neoadjuvant chemotherapy. Women's Oncology Review. 4:225-227.Breast conservation after neoadjuvant chemotherapyJournal of Clinical OncologyIn reply. Journal of Clinical Oncology. 27:641-642.In replyAnnals of Surgical OncologyUse of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients. Annals of Surgical Oncology. 23:1508-1514.Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer PatientsOncologyHave we made progress in inflammatory breast cancer? Not so fast. Oncology. 25.Have we made progress in inflammatory breast cancer? Not so fastAnnals of Surgical OncologySpotlight on Neoadjuvant Therapy for Breast Cancer. Annals of Surgical Oncology. 22:1406-1407.Spotlight on Neoadjuvant Therapy for Breast CancerSeminars in Breast DiseaseThe rationale for integration of lymphatic mapping and sentinel node biopsy in the management of breast cancer after neoadjuvant chemotherapy. Seminars in Breast Disease. 5:80-87.The rationale for integration of lymphatic mapping and sentinel node biopsy in the management of breast cancer after neoadjuvant chemotherapyAnnals of SurgeryAnnals of Surgery. Annals of SurgeryBreast DiseasesEffect of active resistive exercise on breast cancer-related lymphedema. Breast Diseases. 22:255-256.Effect of active resistive exercise on breast cancer-related lymphedemaAnnals of Surgical OncologyLimiting Axillary Surgery for Patients with Initial Biopsy-Proven Axillary Metastases After Preoperative Chemotherapy. Annals of Surgical Oncology. 1-3.Limiting Axillary Surgery for Patients with Initial Biopsy-Proven Axillary Metastases After Preoperative ChemotherapyJournal of Breast CancerA novel therapeutic approach to breast cancer using a selective cyclooxygenase 2 inhibitor and adenovirus-mediated delivery of the melanoma differentiation-associated gene-7 (Ad-mda7). Journal of Breast Cancer. 11:49-55.A novel therapeutic approach to breast cancer using a selective cyclooxygenase 2 inhibitor and adenovirus-mediated delivery of the melanoma differentiation-associated gene-7 (Ad-mda7)Annals of Surgical OncologyNomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer. Annals of Surgical Oncology. 1-9.Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast CancerJournal of Clinical OncologyIn reply [12]. Journal of Clinical Oncology. 23:6804-6805.In reply [12]Annals of Surgical OncologyAnalysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma. Annals of Surgical Oncology. 1-9.Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma22722193Ellis MJ, Ding L, Shen D, Luo J, Suman VJ, Wallis JW, Van Tine BA, Hoog J, Goiffon RJ, Goldstein TC, Ng S, Lin L, Crowder R, Snider J, Ballman K, Weber J, Chen K, Koboldt DC, Kandoth C, Schierding WS, McMichael JF, Miller CA, Lu C, Harris CC, McLellan MD, Wendl MC, DeSchryver K, Allred DC, Esserman L, Unzeitig G, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Leitch M, Hunt K, Olson J, Tao Y, Maher CA, Fulton LL, Fulton RS, Harrison M, Oberkfell B, Du F, Demeter R, Vickery TL, Elhammali A, Piwnica-Worms H, McDonald S, Watson M, Dooling DJ, Ota D, Chang LW, Bose R, Ley TJ, Piwnica-Worms D, Stuart JM, Wilson RK, Mardis ERNatureWhole-genome analysis informs breast cancer response to aromatase inhibition. Nature. 2012 Jun 10; 486(7403):353-60.Nature2012-06-10T00:00:002012Whole-genome analysis informs breast cancer response to aromatase inhibition.OncogeneThe serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastase. Oncogene. 34:3556-3567.The serine protease inhibitor elafin maintains normal growth control by opposing the mitogenic effects of neutrophil elastaseInternational Journal of Radiation Oncology Biology PhysicsPatterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer. International Journal of Radiation Oncology Biology Physics. 94:493-502.Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast CancerONCOLOGY (United States)Following the data. ONCOLOGY (United States). 28.Following the dataBreast cancer. 19-34.Breast cancerAnnals of Surgical OncologyA Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma. Annals of Surgical Oncology. 1-8.A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast CarcinomaJournal of Applied StatisticsSimultaneous inference of a misclassified outcome and competing risks failure time data. Journal of Applied Statistics. 42:1080-1090.Simultaneous inference of a misclassified outcome and competing risks failure time dataOncogenePKCiota promotes ovarian tumor progression through deregulation of cyclin E. Oncogene. PKCiota promotes ovarian tumor progression through deregulation of cyclin ENature CommunicationsAromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers. Nature Communications. 7.Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancersONCOLOGY (United States)Axillary surgery after chemotherapy. ONCOLOGY (United States). 29:741-742.Axillary surgery after chemotherapyArchives of SurgeryHospital-associated costs due to surgical site infection after breast surgery - Invited critique. Archives of Surgery. 143:61.Hospital-associated costs due to surgical site infection after breast surgery - Invited critiqueAmerican Journal of Hematology/ OncologyStaging of breast cancer patients undergoing neoadjuvant chemotherapy. American Journal of Hematology/ Oncology. 7.Staging of breast cancer patients undergoing neoadjuvant chemotherapyAnnals of Surgical OncologyResponse to letter to the editor. Annals of Surgical Oncology. 16:2661.Response to letter to the editorCancer ResearchCyclin e associates with the lipogenic enzyme ATP-citrate lyase to enable malignant growth of breast cancer cells. Cancer Research. 76:2406-2418.Cyclin e associates with the lipogenic enzyme ATP-citrate lyase to enable malignant growth of breast cancer cellsFrontiers in OncologyVariation in practice of the diagnostic workup of asymptomatic patients diagnosed with invasive breast cancer. Frontiers in Oncology. 6.Variation in practice of the diagnostic workup of asymptomatic patients diagnosed with invasive breast cancerOncoImmunologyChimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras. OncoImmunology. 4.Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of RasBreast DiseasesDifferences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. Breast Diseases. 26:125-126.Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United StatesJournal of Clinical OncologyReply to K.J. Van Zee et al. Journal of Clinical Oncology. 30:3144-3145.Reply to K.J. Van Zee et alJournal of Clinical OncologyIn reply [18]. Journal of Clinical Oncology. 23:7760-7761.In reply [18]Plastic and Reconstructive SurgeryReply [15]. Plastic and Reconstructive Surgery. 118:814-815.Reply [15]HistopathologyGATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry. Histopathology. GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistryObstetrical and Gynecological SurveyBiliary disease during pregnancy. Obstetrical and Gynecological Survey. 50:497-498.Biliary disease during pregnancyJAMA SurgeryClinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma. JAMA Surgery. 151:347-354.Clinical Observations and Molecular Variables of Primary Vascular LeiomyosarcomaAnnals of Surgical OncologyOutcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. Annals of Surgical Oncology. 1-8.Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary TherapyThe multidisciplinary approach to breast cancer management. 393-409.The multidisciplinary approach to breast cancer managementBreast Cancer Research and TreatmentLymphatic mapping for male breast cancer. Breast Cancer Research and Treatment. 69:308.Lymphatic mapping for male breast cancerBreast DiseasesThe clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancer. Breast Diseases. 22:67-68.The clinical impact and outcomes of immunohistochemistry-only metastasis in breast cancerBreast JournalResponse to induction chemotherapy in black and white patients with locally advanced breast cancer. Breast Journal. 6:242-246.Response to induction chemotherapy in black and white patients with locally advanced breast cancerAnnals of Surgical OncologyRadiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic Lesions. Annals of Surgical Oncology. Radiation-Associated Undifferentiated Pleomorphic Sarcoma is Associated with Worse Clinical Outcomes than Sporadic LesionsAnnals of SurgeryLocoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases. Annals of Surgery. 264:413-419.Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastasesAnnals of Surgical OncologyPredicting the Extent of Nodal Disease in Early-Stage Breast Cancer. Annals of Surgical Oncology. Predicting the Extent of Nodal Disease in Early-Stage Breast CancerOncologyThe Cox et al Article Reviewed. Oncology. 12:1294-1298.The Cox et al Article ReviewedAnnals of Surgical OncologyAnnals of Surgical Oncology. 22:3250-3256.Annals of Surgical OncologyBiomedical Optics ExpressHigh-resolution fiber optic microscopy with fluorescent contrast enhancement for the identification of axillary lymph node metastases in breast cancer. Biomedical Optics Express. 1:911-922.High-resolution fiber optic microscopy with fluorescent contrast enhancement for the identification of axillary lymph node metastases in breast cancerInternational Journal of Radiation Oncology Biology PhysicsOutcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy. International Journal of Radiation Oncology Biology Physics. 96:637-644.Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node BiopsyBreast DiseasesHistologic localization of sentinel lymph node metastases in breast cancer. Breast Diseases. 15:310.Histologic localization of sentinel lymph node metastases in breast cancerCell CycleEstrogen receptor alpha is cell cycle-regulated and regulates the cell cycle in a ligand-dependent fashion. Cell Cycle. 1-12.Estrogen receptor alpha is cell cycle-regulated and regulates the cell cycle in a ligand-dependent fashionBreast Cancer Research and TreatmentPredictors of systemic recurrence and impact of local failure among early stage breast cancer patients treated with breast conserving therapy. Breast Cancer Research and Treatment. 69:227.Predictors of systemic recurrence and impact of local failure among early stage breast cancer patients treated with breast conserving therapyBreast cancer imaging by microwave-induced thermoacoustic tomography. 45-48.Breast cancer imaging by microwave-induced thermoacoustic tomographyAcademic RadiologyIncremental Cancer Detection of Locoregional Restaging with Diagnostic Mammography Combined with Whole-Breast and Regional Nodal Ultrasound in Women with Newly Diagnosed Breast Cancer. Academic Radiology. 24:191-199.Incremental Cancer Detection of Locoregional Restaging with Diagnostic Mammography Combined with Whole-Breast and Regional Nodal Ultrasound in Women with Newly Diagnosed Breast Cancer22821997Brewer Savannah KJ, Demicco EG, Lusby K, Ghadimi MP, Belousov R, Young E, Zhang Y, Huang KL, Lazar AJ, Hunt KK, Pollock RE, Creighton CJ, Anderson ML, Lev DClinical cancer research : an official journal of the American Association for Cancer ResearchDual targeting of mTOR and aurora-A kinase for the treatment of uterine Leiomyosarcoma. Clin Cancer Res. 2012 Sep 01; 18(17):4633-45.Clin Cancer Res2012-07-20T00:00:002012Dual targeting of mTOR and aurora-A kinase for the treatment of uterine Leiomyosarcoma.Cancer BulletinAmbulatory surgery for breast cancer. Cancer Bulletin. 47:292-297.Ambulatory surgery for breast cancer11032588Breslin TM, Cohen L, Sahin A, Fleming JB, Kuerer HM, Newman LA, Delpassand ES, House R, Ames FC, Feig BW, Ross MI, Singletary SE, Buzdar AU, Hortobagyi GN, Hunt KKJournal of clinical oncology : official journal of the American Society of Clinical OncologySentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol. 2000 Oct 15; 18(20):3480-6.J Clin Oncol2000-10-15T00:00:002000Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer.11776497Solorzano CC, Ross MI, Delpassand E, Mirza N, Akins JS, Kuerer HM, Meric F, Ames FC, Newman L, Feig B, Singletary SE, Hunt KKAnnals of surgical oncologyUtility of breast sentinel lymph node biopsy using day-before-surgery injection of high-dose 99mTc-labeled sulfur colloid. Ann Surg Oncol. 2001 Dec; 8(10):821-7.Ann Surg Oncol2001-12-01T00:00:002001Utility of breast sentinel lymph node biopsy using day-before-surgery injection of high-dose 99mTc-labeled sulfur colloid.28801307Haricharan S, Punturi N, Singh P, Holloway KR, Anurag M, Schmelz J, Schmidt C, Lei JT, Suman V, Hunt K, Olson JA, Hoog J, Li S, Huang S, Edwards DP, Kavuri SM, Bainbridge MN, Ma CX, Ellis MJCancer discoveryLoss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer. Cancer Discov. 2017 10; 7(10):1168-1183.Cancer Discov2017-08-11T00:00:002017Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer.14597440Bedrosian I, Bedi D, Kuerer HM, Fornage BD, Harker L, Ross MI, Ames FC, Krishnamurthy S, Edeiken-Monroe BS, Meric F, Feig BW, Akins J, Singletary SE, Mirza NQ, Hunt KKAnnals of surgical oncologyImpact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol. 2003 Nov; 10(9):1025-30.Ann Surg Oncol2003-11-01T00:00:002003Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer.14769300Chagpar A, Langstein HN, Kronowitz SJ, Singletary SE, Ross MI, Buchholz TA, Hunt KK, Kuerer HMAmerican journal of surgeryTreatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction. Am J Surg. 2004 Feb; 187(2):164-9.Am J Surg2004-02-01T00:00:002004Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction.15726547Shahar KH, Buchholz TA, Delpassand E, Sahin AA, Ross MI, Ames FC, Kuerer HM, Feig BW, Meric-Bernstam F, Babiera GV, Singletary SE, Akins JS, Mirza NQ, Hunt KKCancerLower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma. Cancer. 2005 Apr 01; 103(7):1323-9.Cancer2005-04-01T00:00:002005Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma.16798488Kawase K, Gayed IW, Hunt KK, Kuerer HM, Akins J, Yi M, Grimes L, Babiera GV, Ross MI, Feig BW, Ames FC, Singletary SE, Buchholz TA, Symmans WF, Meric-Bernstam FJournal of the American College of SurgeonsUse of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer. J Am Coll Surg. 2006 Jul; 203(1):64-72.J Am Coll Surg2006-05-26T00:00:002006Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer.17000390Boughey JC, Bedrosian I, Meric-Bernstam F, Ross MI, Kuerer HM, Akins JS, Giordano SH, Babiera GV, Ames FC, Hunt KKJournal of the American College of SurgeonsComparative analysis of sentinel lymph node operation in male and female breast cancer patients. J Am Coll Surg. 2006 Oct; 203(4):475-80.J Am Coll Surg2006-08-23T00:00:002006Comparative analysis of sentinel lymph node operation in male and female breast cancer patients.17418973McGuire SE, Gonzalez-Angulo AM, Huang EH, Tucker SL, Kau SW, Yu TK, Strom EA, Oh JL, Woodward WA, Tereffe W, Hunt KK, Kuerer HM, Sahin AA, Hortobagyi GN, Buchholz TAInternational journal of radiation oncology, biology, physicsPostmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1004-9.Int J Radiat Oncol Biol Phys2007-04-06T00:00:002007Postmastectomy radiation improves the outcome of patients with locally advanced breast cancer who achieve a pathologic complete response to neoadjuvant chemotherapy.17826073Vo T, Xing Y, Meric-Bernstam F, Mirza N, Vlastos G, Symmans WF, Perkins GH, Buchholz TA, Babiera GV, Kuerer HM, Bedrosian I, Akins JS, Hunt KKAmerican journal of surgeryLong-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy. Am J Surg. 2007 Oct; 194(4):527-31.Am J Surg2007-10-01T00:00:002007Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy.28947566Doostan I, Karakas C, Kohansal M, Low KH, Ellis MJ, Olson JA, Suman VJ, Hunt KK, Moulder SL, Keyomarsi KClinical cancer research : an official journal of the American Association for Cancer ResearchCytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer. Clin Cancer Res. 2017 Dec 01; 23(23):7288-7300.Clin Cancer Res2017-09-25T00:00:002017Cytoplasmic Cyclin E Mediates Resistance to Aromatase Inhibitors in Breast Cancer.29194092Ferrufino-Schmidt MC, Medeiros LJ, Liu H, Clemens MW, Hunt KK, Laurent C, Lofts J, Amin MB, Ming Chai S, Morine A, Di Napoli A, Dogan A, Parkash V, Bhagat G, Tritz D, Quesada AE, Pina-Oviedo S, Hu Q, Garcia-Gomez FJ, Jose Borrero J, Horna P, Thakral B, Narbaitz M, Hughes RC, Yang LJ, Fromm JR, Wu D, Zhang D, Sohani AR, Hunt J, Vadlamani IU, Morgan EA, Ferry JA, Szigeti R, C Tardio J, Granados R, Dertinger S, Offner FA, Pircher A, Hosry J, Young KH, Miranda RNThe American journal of surgical pathologyClinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma. Am J Surg Pathol. 2018 03; 42(3):293-305.Am J Surg Pathol2018-03-01T00:00:002018Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma.23334251Lusby K, Savannah KB, Demicco EG, Zhang Y, Ghadimi MP, Young ED, Colombo C, Lam R, Dogan TE, Hornick JL, Lazar AJ, Hunt KK, Anderson ML, Creighton CJ, Lev D, Pollock REAnnals of surgical oncologyUterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience. Ann Surg Oncol. 2013 Jul; 20(7):2364-72.Ann Surg Oncol2013-01-20T00:00:002013Uterine leiomyosarcoma management, outcome, and associated molecular biomarkers: a single institution's experience.23583978Monda KL, Chen GK, Taylor KC, Palmer C, Edwards TL, Lange LA, Ng MC, Adeyemo AA, Allison MA, Bielak LF, Chen G, Graff M, Irvin MR, Rhie SK, Li G, Liu Y, Liu Y, Lu Y, Nalls MA, Sun YV, Wojczynski MK, Yanek LR, Aldrich MC, Ademola A, Amos CI, Bandera EV, Bock CH, Britton A, Broeckel U, Cai Q, Caporaso NE, Carlson CS, Carpten J, Casey G, Chen WM, Chen F, Chen YD, Chiang CW, Coetzee GA, Demerath E, Deming-Halverson SL, Driver RW, Dubbert P, Feitosa MF, Feng Y, Freedman BI, Gillanders EM, Gottesman O, Guo X, Haritunians T, Harris T, Harris CC, Hennis AJ, Hernandez DG, McNeill LH, Howard TD, Howard BV, Howard VJ, Johnson KC, Kang SJ, Keating BJ, Kolb S, Kuller LH, Kutlar A, Langefeld CD, Lettre G, Lohman K, Lotay V, Lyon H, Manson JE, Maixner W, Meng YA, Monroe KR, Morhason-Bello I, Murphy AB, Mychaleckyj JC, Nadukuru R, Nathanson KL, Nayak U, N'diaye A, Nemesure B, Wu SY, Leske MC, Neslund-Dudas C, Neuhouser M, Nyante S, Ochs-Balcom H, Ogunniyi A, Ogundiran TO, Ojengbede O, Olopade OI, Palmer JR, Ruiz-Narvaez EA, Palmer ND, Press MF, Rampersaud E, Rasmussen-Torvik LJ, Rodriguez-Gil JL, Salako B, Schadt EE, Schwartz AG, Shriner DA, Siscovick D, Smith SB, Wassertheil-Smoller S, Speliotes EK, Spitz MR, Sucheston L, Taylor H, Tayo BO, Tucker MA, Van Den Berg DJ, Edwards DR, Wang Z, Wiencke JK, Winkler TW, Witte JS, Wrensch M, Wu X, Yang JJ, Levin AM, Young TR, Zakai NA, Cushman M, Zanetti KA, Zhao JH, Zhao W, Zheng Y, Zhou J, Ziegler RG, Zmuda JM, Fernandes JK, Gilkeson GS, Kamen DL, Hunt KJ, Spruill IJ, Ambrosone CB, Ambs S, Arnett DK, Atwood L, Becker DM, Berndt SI, Bernstein L, Blot WJ, Borecki IB, Bottinger EP, Bowden DW, Burke G, Chanock SJ, Cooper RS, Ding J, Duggan D, Evans MK, Fox C, Garvey WT, Bradfield JP, Hakonarson H, Grant SF, Hsing A, Chu L, Hu JJ, Huo D, Ingles SA, John EM, Jordan JM, Kabagambe EK, Kardia SL, Kittles RA, Goodman PJ, Klein EA, Kolonel LN, Le Marchand L, Liu S, McKnight B, Millikan RC, Mosley TH, Padhukasahasram B, Williams LK, Patel SR, Peters U, Pettaway CA, Peyser PA, Psaty BM, Redline S, Rotimi CN, Rybicki BA, Sale MM, Schreiner PJ, Signorello LB, Singleton AB, Stanford JL, Strom SS, Thun MJ, Vitolins M, Zheng W, Moore JH, Williams SM, Ketkar S, Zhu X, Zonderman AB, NABEC Consortium, UKBEC Consortium, BioBank Japan Project, AGEN Consortium, Kooperberg C, Papanicolaou GJ, Henderson BE, Reiner AP, Hirschhorn JN, Loos RJ, North KE, Haiman CANature geneticsA meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat Genet. 2013 Jun; 45(6):690-6.Nat Genet2013-04-14T00:00:002013A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry.Authorship 8875246Authorship 88754714Authorship 88755611Authorship 8877451Authorship 88836831Authorship 8884728Authorship 88892810Authorship 88929917Authorship 88944419Authorship 88973012Authorship 8902145D015412Procedures16610250.646965Mastectomy, SegmentalD020360Procedures66449650.385167Neoadjuvant TherapyD021701Procedures22114080.580974Sentinel Lymph Node BiopsyD001943Disorders1432156510.17611Breast NeoplasmsAuthorship 8919741Authorship 8929421Authorship 8931772Authorship 8960643Authorship 8997118Authorship 9000106Authorship 9023053Authorship 9036114Authorship 9038184Authorship 9040379Authorship 9042793Authorship 9046212Authorship 9046297Authorship 9049392Authorship 9053969Authorship 9054503Authorship 9057371Authorship 9059943Authorship 90603110Authorship 90639015Authorship 9064875Authorship 9066293Authorship 9071824Authorship 9074632Authorship 90762313Authorship 9076962Authorship 9078566Authorship 9087567Authorship 9092198Authorship 90924712Authorship 90929613Authorship 9094698Authorship 9096435Authorship 9099395Authorship 9105577Authorship 9107949Authorship 9109754Authorship 9110075Authorship 9111012Authorship 91130612Authorship 9114024Authorship 9114619Authorship 9118853Authorship 91191410Authorship 9121129Authorship 9123612Authorship 91247321Authorship 9131125Authorship 91351021Authorship 9136057Authorship 91383710Authorship 91430411Authorship 9143782Authorship 9144496Authorship 9144818Authorship 9146211Authorship 91475413Authorship 9148268Authorship 9149752Authorship 9150515Authorship 9153288Authorship 9154726Authorship 9158167Authorship 9158983Authorship 9167357Authorship 9167733Authorship 9170515Authorship 9175763Authorship 9178793Authorship 9178961Authorship 9180198Authorship 9186267Authorship 91893011Authorship 9214907Authorship 92248015Authorship 9225083Authorship 92263317Authorship 9230755Authorship 9236389Authorship 92382110Authorship 92622917Authorship 9264698Authorship 9267805Authorship 92746715Authorship 9278741Authorship 92821412Authorship 9287989Authorship 9288554Authorship 92904811Authorship 9291878Authorship 9302903Authorship 9302941Authorship 9303824Authorship 93051830Authorship 93090417Authorship 9328119Authorship 9328442Authorship 9329722Authorship 93393411Authorship 9340105Authorship 9351874Authorship 9364159Authorship 9367747Authorship 9372755Authorship 9376012Authorship 9376159Authorship 9386395Authorship 9391782Authorship 939208196359Tellis CJ, Hunt KKMilitary medicineEosinophilic granuloma with pulmonary involvement: a review. Mil Med. 1978 Apr; 143(4):256-62.Mil Med1978-04-01T00:00:001978Eosinophilic granuloma with pulmonary involvement: a review.5076465Hunt KKThe New England journal of medicinePost-cyclophosphamide pneumonitis. N Engl J Med. 1972 Sep 28; 287(13):668-9.N Engl J Med1972-09-28T00:00:001972Post-cyclophosphamide pneumonitis.5576446Hunt KKThe New England journal of medicineThe second-strength PPD test. N Engl J Med. 1971 Jun 10; 284(23):1326.N Engl J Med1971-06-10T00:00:001971The second-strength PPD test.11348372Newman LA, Kuerer HM, Hunt KK, Ames FC, Ross MI, Feig BW, Hortobagyi GN, Buzdar AU, Singletary SEThe breast journalResponse to Induction Chemotherapy in Black and White Patients with Locally Advanced Breast Cancer. Breast J. 2000 Jul; 6(4):242-246.Breast J2000-07-01T00:00:002000Response to Induction Chemotherapy in Black and White Patients with Locally Advanced Breast Cancer.21258518Rosbach KJ, Shin D, Muldoon TJ, Quraishi MA, Middleton LP, Hunt KK, Meric-Bernstam F, Yu TK, Richards-Kortum RR, Yang WBiomedical optics expressHigh-resolution fiber optic microscopy with fluorescent contrast enhancement for the identification of axillary lymph node metastases in breast cancer: a pilot study. Biomed Opt Express. 2010 Sep 16; 1(3):911-922.Biomed Opt Express2010-09-16T00:00:002010High-resolution fiber optic microscopy with fluorescent contrast enhancement for the identification of axillary lymph node metastases in breast cancer: a pilot study.20881142Shiroma EJ, Pickelsimer EE, Ferguson PL, Gebregziabher M, Lattimore PK, Nicholas JS, Dukes T, Hunt KJJournal of correctional health care : the official journal of the National Commission on Correctional Health CareAssociation of medically attended traumatic brain injury and in-prison behavioral infractions: a statewide longitudinal study. J Correct Health Care. 2010 Oct; 16(4):273-86.J Correct Health Care2010-10-01T00:00:002010Association of medically attended traumatic brain injury and in-prison behavioral infractions: a statewide longitudinal study.25138206Lynch CP, Gebregziabher M, Zhao Y, Hunt KJ, Egede LEBMC endocrine disordersImpact of medical and psychiatric multi-morbidity on mortality in diabetes: emerging evidence. BMC Endocr Disord. 2014 Aug 20; 14:68.BMC Endocr Disord2014-08-20T00:00:002014Impact of medical and psychiatric multi-morbidity on mortality in diabetes: emerging evidence.25821331Luo S, Su X, Yi M, Hunt KKJournal of applied statisticsSimultaneous inference of a misclassified outcome and competing risks failure time data. J Appl Stat. 2015; 42(5):1080-1090.J Appl Stat2015-01-01T00:00:002015Simultaneous inference of a misclassified outcome and competing risks failure time data.25672779Dixon JM, Rutgers E, Hunt KKBMJ (Clinical research ed.)Authors' reply to Rayter. BMJ. 2015 Feb 11; 350:h714.BMJ2015-02-11T00:00:002015Authors' reply to Rayter.26279297Nanos-Webb A, Bui T, Karakas C, Zhang D, Carey JP, Mills GB, Hunt KK, Keyomarsi KOncogenePKCiota promotes ovarian tumor progression through deregulation of cyclin E. Oncogene. 2016 05 12; 35(19):2428-40.Oncogene2015-08-17T00:00:002015PKCiota promotes ovarian tumor progression through deregulation of cyclin E.26629783Roland CL, Boland GM, Demicco EG, Lusby K, Ingram D, May CD, Kivlin CM, Watson K, Al Sannaa GA, Wang WL, Ravi V, Pollock RE, Lev D, Cormier JN, Hunt KK, Feig BW, Lazar AJ, Torres KEJAMA surgeryClinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma. JAMA Surg. 2016 Apr; 151(4):347-54.JAMA Surg2016-04-01T00:00:002016Clinical Observations and Molecular Variables of Primary Vascular Leiomyosarcoma.26847678Roland CL, May CD, Watson KL, Al Sannaa GA, Dineen SP, Feig R, Landers S, Ingram DR, Wang WL, Guadagnolo BA, Feig B, Hunt KK, Cormier JN, Lazar AJ, Torres KEAnnals of surgical oncologyAnalysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma. Ann Surg Oncol. 2016 07; 23(7):2220-8.Ann Surg Oncol2016-02-03T00:00:002016Analysis of Clinical and Molecular Factors Impacting Oncologic Outcomes in Undifferentiated Pleomorphic Sarcoma.26826118Jabbour-Leung NA, Chen X, Bui T, Jiang Y, Yang D, Vijayaraghavan S, McArthur MJ, Hunt KK, Keyomarsi KMolecular cancer therapeuticsSequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer. Mol Cancer Ther. 2016 04; 15(4):593-607.Mol Cancer Ther2016-01-29T00:00:002016Sequential Combination Therapy of CDK Inhibition and Doxorubicin Is Synthetically Lethal in p53-Mutant Triple-Negative Breast Cancer.26893221Teshome M, Wei C, Hunt KK, Thompson A, Rodriguez K, Mittendorf EAAnnals of surgical oncologyUse of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis. Ann Surg Oncol. 2016 May; 23(5):1508-14.Ann Surg Oncol2016-02-18T00:00:002016Use of a Magnetic Tracer for Sentinel Lymph Node Detection in Early-Stage Breast Cancer Patients: A Meta-analysis.27014631Chagpar AB, Babiera GV, Aguirre J, Hunt KK, Hughes TFrontiers in oncologyVariation in Practice of the Diagnostic Workup of Asymptomatic Patients Diagnosed with Invasive Breast Cancer. Front Oncol. 2016; 6:56.Front Oncol2016-03-11T00:00:002016Variation in Practice of the Diagnostic Workup of Asymptomatic Patients Diagnosed with Invasive Breast Cancer.26720612Mougalian SS, Hernandez M, Lei X, Lynch S, Kuerer HM, Symmans WF, Theriault RL, Fornage BD, Hsu L, Buchholz TA, Sahin AA, Hunt KK, Yang WT, Hortobagyi GN, Valero VJAMA oncologyTen-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy. JAMA Oncol. 2016 Apr; 2(4):508-16.JAMA Oncol2016-04-01T00:00:002016Ten-Year Outcomes of Patients With Breast Cancer With Cytologically Confirmed Axillary Lymph Node Metastases and Pathologic Complete Response After Primary Systemic Chemotherapy.26867878Haffty BG, McCall LM, Ballman KV, McLaughlin S, Jagsi R, Ollila DW, Hunt KK, Buchholz TA, Boughey JCInternational journal of radiation oncology, biology, physicsPatterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance). Int J Radiat Oncol Biol Phys. 2016 Mar 01; 94(3):493-502.Int J Radiat Oncol Biol Phys2015-11-10T00:00:002015Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance).26928812Lucenay KS, Doostan I, Karakas C, Bui T, Ding Z, Mills GB, Hunt KK, Keyomarsi KCancer researchCyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells. Cancer Res. 2016 04 15; 76(8):2406-18.Cancer Res2016-02-29T00:00:002016Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells.26995383Axon RN, Gebregziabher M, Everett CJ, Heidenreich P, Hunt KJAmerican heart journalDual health care system use is associated with higher rates of hospitalization and hospital readmission among veterans with heart failure. Am Heart J. 2016 Apr; 174:157-63.Am Heart J2015-12-18T00:00:002015Dual health care system use is associated with higher rates of hospitalization and hospital readmission among veterans with heart failure.26451325Zhou F, Krishnamurthy J, Wei Y, Li M, Hunt K, Johanning GL, Cooper LJ, Wang-Johanning FOncoimmunologyChimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras. Oncoimmunology. 2015 Nov; 4(11):e1047582.Oncoimmunology2015-05-26T00:00:002015Chimeric antigen receptor T cells targeting HERV-K inhibit breast cancer and its metastasis through downregulation of Ras.26649589Boughey JC, Ballman KV, Le-Petross HT, McCall LM, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Feliberti EC, Hunt KKAnnals of surgeryIdentification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance). Ann Surg. 2016 Apr; 263(4):802-7.Ann Surg2016-04-01T00:00:002016Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).26861948Lopes-Virella MF, Hunt KJ, Baker NL, Virella G, VADT Group of InvestigatorsJournal of diabetes and its complicationsHigh levels of AGE-LDL, and of IgG antibodies reacting with MDA-lysine epitopes expressed by oxLDL and MDA-LDL in circulating immune complexes predict macroalbuminuria in patients with type 2 diabetes. J Diabetes Complications. 2016 May-Jun; 30(4):693-9.J Diabetes Complications2016-01-14T00:00:002016High levels of AGE-LDL, and of IgG antibodies reacting with MDA-lysine epitopes expressed by oxLDL and MDA-LDL in circulating immune complexes predict macroalbuminuria in patients with type 2 diabetes.27035165Watson KL, Al Sannaa GA, Kivlin CM, Ingram DR, Landers SM, Roland CL, Cormier JN, Hunt KK, Feig BW, Ashleigh Guadagnolo B, Bishop AJ, Wang WL, Slopis JM, McCutcheon IE, Lazar AJ, Torres KEJournal of neurosurgeryPatterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. J Neurosurg. 2017 Jan; 126(1):319-329.J Neurosurg2016-04-01T00:00:002016Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.27160527Fayanju OM, Buchholz TA, Hunt KKAnnals of surgical oncologyPostmastectomy Radiation Treatment Rates as a Quality Measure: An Opportunity for Compliance Through Collaboration. Ann Surg Oncol. 2016 08; 23(8):2377-9.Ann Surg Oncol2016-05-09T00:00:002016Postmastectomy Radiation Treatment Rates as a Quality Measure: An Opportunity for Compliance Through Collaboration.27216742Vila J, Mittendorf EA, Farante G, Bassett RL, Veronesi P, Galimberti V, Peradze N, Stauder MC, Chavez-MacGregor M, Litton JF, Huo L, Kuerer HM, Hunt KK, Caudle ASAnnals of surgical oncologyNomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer. Ann Surg Oncol. 2016 10; 23(11):3501-3509.Ann Surg Oncol2016-05-23T00:00:002016Nomograms for Predicting Axillary Response to Neoadjuvant Chemotherapy in Clinically Node-Positive Patients with Breast Cancer.27221361Simmons RM, Ballman KV, Cox C, Carp N, Sabol J, Hwang RF, Attai D, Sabel M, Nathanson D, Kenler A, Gold L, Kaufman C, Han L, Bleznak A, Stanley Smith J, Holmes D, Fornage B, Le-Petross C, Hoda S, McCall L, Hunt KK, ACOSOG investigatorsAnnals of surgical oncologyA Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072. Ann Surg Oncol. 2016 08; 23(8):2438-45.Ann Surg Oncol2016-05-24T00:00:002016A Phase II Trial Exploring the Success of Cryoablation Therapy in the Treatment of Invasive Breast Carcinoma: Results from ACOSOG (Alliance) Z1072.27513155Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Morrow M, Hunt KKAnnals of surgeryLocoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial. Ann Surg. 2016 Sep; 264(3):413-20.Ann Surg2016-09-01T00:00:002016Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.27197511Yi M, Hunt KKChinese clinical oncologyOrganizing a breast cancer database: data management. Chin Clin Oncol. 2016 Jun; 5(3):45.Chin Clin Oncol2016-04-27T00:00:002016Organizing a breast cancer database: data management.27265301Liao N, Hunt KK, Balch CMChinese clinical oncologyManagement of invasive and non-invasive breast cancer in the United States and China. Chin Clin Oncol. 2016 Jun; 5(3):30.Chin Clin Oncol2016-06-01T00:00:002016Management of invasive and non-invasive breast cancer in the United States and China.27418346Axon RN, Gebregziabher M, Dismuke CE, Hunt KJ, Yeager D, Ana EJS, Egede LEJournal of general internal medicineDifferential Impact of Homelessness on Glycemic Control in Veterans with Type 2 Diabetes Mellitus. J Gen Intern Med. 2016 11; 31(11):1331-1337.J Gen Intern Med2016-07-14T00:00:002016Differential Impact of Homelessness on Glycemic Control in Veterans with Type 2 Diabetes Mellitus.27555121Taber DJ, Gebregziabher M, Hunt KJ, Srinivas T, Chavin KD, Baliga PK, Egede LEKidney internationalTwenty years of evolving trends in racial disparities for adult kidney transplant recipients. Kidney Int. 2016 10; 90(4):878-87.Kidney Int2016-08-20T00:00:002016Twenty years of evolving trends in racial disparities for adult kidney transplant recipients.26979306Fayanju OM, Mayo TL, Spinks TE, Lee S, Barcenas CH, Smith BD, Giordano SH, Hwang RF, Ehlers RA, Selber JC, Walters R, Tripathy D, Hunt KK, Buchholz TA, Feeley TW, Kuerer HMAnnals of surgical oncologyValue-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered Outcomes. Ann Surg Oncol. 2016 08; 23(8):2385-90.Ann Surg Oncol2016-03-15T00:00:002016Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered Outcomes.26986538Mittendorf EA, Vila J, Tucker SL, Chavez-MacGregor M, Smith BD, Symmans WF, Sahin AA, Hortobagyi GN, Hunt KKJAMA oncologyThe Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy: Incorporation of Prognostic Biologic Factors Into Staging After Treatment. JAMA Oncol. 2016 Jul 01; 2(7):929-36.JAMA Oncol2016-07-01T00:00:002016The Neo-Bioscore Update for Staging Breast Cancer Treated With Neoadjuvant Chemotherapy: Incorporation of Prognostic Biologic Factors Into Staging After Treatment.27049344JavanMoghadam S, Weihua Z, Hunt KK, Keyomarsi KCell cycle (Georgetown, Tex.)Estrogen receptor alpha is cell cycle-regulated and regulates the cell cycle in a ligand-dependent fashion. Cell Cycle. 2016 06 17; 15(12):1579-90.Cell Cycle2016-04-06T00:00:002016Estrogen receptor alpha is cell cycle-regulated and regulates the cell cycle in a ligand-dependent fashion.27182644Karakas C, Biernacka A, Bui T, Sahin AA, Yi M, Akli S, Schafer J, Alexander A, Adjapong O, Hunt KK, Keyomarsi KThe American journal of pathologyCytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer. Am J Pathol. 2016 07; 186(7):1900-1912.Am J Pathol2016-05-13T00:00:002016Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer.27336900Axon RN, Gebregziabher M, Hunt KJ, Lynch CP, Payne E, Walker RJ, Egede LEMedicineComorbid depression is differentially associated with longitudinal medication nonadherence by race/ethnicity in patients with type 2 diabetes. Medicine (Baltimore). 2016 Jun; 95(25):e3983.Medicine (Baltimore)2016-06-01T00:00:002016Comorbid depression is differentially associated with longitudinal medication nonadherence by race/ethnicity in patients with type 2 diabetes.27402921Taber DJ, Hunt KJ, Fominaya CE, Payne EH, Gebregziabher M, Srinivas TR, Baliga PK, Egede LEHypertension (Dallas, Tex. : 1979)Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients. Hypertension. 2016 09; 68(3):715-25.Hypertension2016-07-11T00:00:002016Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients.27469119Kuerer HM, Hunt KKAnnals of surgical oncologyLimiting Axillary Surgery for Patients with Initial Biopsy-Proven Axillary Metastases After Preoperative Chemotherapy: To Clip or Not to Clip? Ann Surg Oncol. 2016 10; 23(11):3432-3434.Ann Surg Oncol2016-07-28T00:00:002016Limiting Axillary Surgery for Patients with Initial Biopsy-Proven Axillary Metastases After Preoperative Chemotherapy: To Clip or Not to Clip?27657562Chagpar AB, Hughes T, Hunt K, Aguirre J, Babiera GThe American surgeonVariation in Follow-up of Asymptomatic Breast Cancer Patients: Can We Choose More Wisely? Am Surg. 2016 08; 82(8):e188-90.Am Surg2016-08-01T00:00:002016Variation in Follow-up of Asymptomatic Breast Cancer Patients: Can We Choose More Wisely?27663568Chiba A, Hoskin TL, Heins CN, Hunt KK, Habermann EB, Boughey JCAnnals of surgical oncologyTrends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast Cancer: A National Cancer Data Base Study. Ann Surg Oncol. 2017 Feb; 24(2):418-424.Ann Surg Oncol2016-09-23T00:00:002016Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor-Positive Breast Cancer: A National Cancer Data Base Study.27671334Balaji K, Vijayaraghavan S, Diao L, Tong P, Fan Y, Carey JP, Bui TN, Warner S, Heymach JV, Hunt KK, Wang J, Byers LA, Keyomarsi KMolecular cancer research : MCRAXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple Cancers. Mol Cancer Res. 2017 01; 15(1):45-58.Mol Cancer Res2016-09-26T00:00:002016AXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple Cancers.27822630FitzSullivan E, Bassett RL, Kuerer HM, Mittendorf EA, Yi M, Hunt KK, Babiera GV, Caudle AS, Black DM, Bedrosian I, Reyna C, Teshome M, Meric-Bernstam F, Hwang RAnnals of surgical oncologyOutcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy. Ann Surg Oncol. 2017 Mar; 24(3):652-659.Ann Surg Oncol2016-10-03T00:00:002016Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy.27979979Taber DJ, Hunt KJ, Gebregziabher M, Srinivas T, Chavin KD, Baliga PK, Egede LEClinical journal of the American Society of Nephrology : CJASNA Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients. Clin J Am Soc Nephrol. 2017 01 06; 12(1):131-139.Clin J Am Soc Nephrol2016-12-15T00:00:002016A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients.28081944Maa AY, Wojciechowski B, Hunt KJ, Dismuke C, Shyu J, Janjua R, Lu X, Medert CM, Lynch MGOphthalmologyEarly Experience with Technology-Based Eye Care Services (TECS): A Novel Ophthalmologic Telemedicine Initiative. Ophthalmology. 2017 04; 124(4):539-546.Ophthalmology2017-01-09T00:00:002017Early Experience with Technology-Based Eye Care Services (TECS): A Novel Ophthalmologic Telemedicine Initiative.27735826Vila J, Teshome M, Tucker SL, Woodward WA, Chavez-MacGregor M, Hunt KK, Mittendorf EAAnnals of surgeryCombining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg. 2017 03; 265(3):574-580.Ann Surg2017-03-01T00:00:002017Combining Clinical and Pathologic Staging Variables Has Prognostic Value in Predicting Local-regional Recurrence Following Neoadjuvant Chemotherapy for Breast Cancer.27868058Wei W, Ramos PS, Hunt KJ, Wolf BJ, Hardiman G, Chung DInternational journal of genomicsGPA-MDS: A Visualization Approach to Investigate Genetic Architecture among Phenotypes Using GWAS Results. Int J Genomics. 2016; 2016:6589843.Int J Genomics2016-10-27T00:00:002016GPA-MDS: A Visualization Approach to Investigate Genetic Architecture among Phenotypes Using GWAS Results.27955877Candelaria RP, Huang ML, Adrada BE, Bassett R, Hunt KK, Kuerer HM, Smith BD, Chavez-MacGregor M, Yang WTAcademic radiologyIncremental Cancer Detection of Locoregional Restaging with Diagnostic Mammography Combined with Whole-Breast and Regional Nodal Ultrasound in Women with Newly Diagnosed Breast Cancer. Acad Radiol. 2017 02; 24(2):191-199.Acad Radiol2016-12-07T00:00:002016Incremental Cancer Detection of Locoregional Restaging with Diagnostic Mammography Combined with Whole-Breast and Regional Nodal Ultrasound in Women with Newly Diagnosed Breast Cancer.27933411Hunt KK, Euhus DM, Boughey JC, Chagpar AB, Feldman SM, Hansen NM, Kulkarni SA, McCready DR, Mamounas EP, Wilke LG, Van Zee KJ, Morrow MAnnals of surgical oncologySociety of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy. Ann Surg Oncol. 2017 Feb; 24(2):375-397.Ann Surg Oncol2016-12-08T00:00:002016Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.27542172Menen RS, Hunt KKThe breast journalConsiderations for the Treatment of Young Patients with Breast Cancer. Breast J. 2016 Nov; 22(6):667-672.Breast J2016-08-19T00:00:002016Considerations for the Treatment of Young Patients with Breast Cancer.27678203Smith BD, Jiang J, Shih YC, Giordano SH, Huo J, Jagsi R, Momoh AO, Caudle AS, Hunt KK, Shaitelman SF, Buchholz TA, Shirvani SMJournal of the National Cancer InstituteCost and Complications of Local Therapies for Early-Stage Breast Cancer. J Natl Cancer Inst. 2017 01; 109(1).J Natl Cancer Inst2016-09-27T00:00:002016Cost and Complications of Local Therapies for Early-Stage Breast Cancer.27681760Stauder MC, Caudle AS, Allen PK, Shaitelman SF, Smith BD, Hoffman KE, Buchholz TA, Chavez-Macgregor M, Hunt KK, Meric-Bernstam F, Woodward WAInternational journal of radiation oncology, biology, physicsOutcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy. Int J Radiat Oncol Biol Phys. 2016 11 01; 96(3):637-44.Int J Radiat Oncol Biol Phys2016-07-13T00:00:002016Outcomes of Post Mastectomy Radiation Therapy in Patients Receiving Axillary Lymph Node Dissection After Positive Sentinel Lymph Node Biopsy.27907919Taber DJ, Fleming JN, Fominaya CE, Gebregziabher M, Hunt KJ, Srinivas TR, Baliga PK, McGillicuddy JW, Egede LEAmerican journal of nephrologyThe Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation. Am J Nephrol. 2017; 45(1):91-98.Am J Nephrol2016-12-02T00:00:002016The Impact of Health Care Appointment Non-Adherence on Graft Outcomes in Kidney Transplantation.28549010Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, Arribas E, Moseley T, Teshome M, Miggins MV, Valero V, Hunt KK, Yang WTAnnals of surgeryA Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg. 2018 05; 267(5):946-951.Ann Surg2018-05-01T00:00:002018A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.28557016Ikoma N, Torres KE, Lin HY, Ravi V, Roland CL, Mann GN, Hunt KK, Cormier JN, Feig BWJournal of surgical oncologyRecurrence patterns of retroperitoneal leiomyosarcoma and impact of salvage surgery. J Surg Oncol. 2017 Sep; 116(3):313-319.J Surg Oncol2017-05-29T00:00:002017Recurrence patterns of retroperitoneal leiomyosarcoma and impact of salvage surgery.28608612Akay CL, Albarracin C, Torstenson T, Bassett R, Mittendorf EA, Yi M, Kuerer HM, Babiera GV, Bedrosian I, Hunt KK, Hwang RFThe breast journalFactors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer. Breast J. 2018 01; 24(1):28-34.Breast J2017-06-13T00:00:002017Factors impacting the accuracy of intra-operative evaluation of sentinel lymph nodes in breast cancer.28619757Francis AM, Alexander A, Liu Y, Vijayaraghavan S, Low KH, Yang D, Bui T, Somaiah N, Ravi V, Keyomarsi K, Hunt KKMolecular cancer therapeuticsCDK4/6 Inhibitors Sensitize Rb-positive Sarcoma Cells to Wee1 Kinase Inhibition through Reversible Cell-Cycle Arrest. Mol Cancer Ther. 2017 09; 16(9):1751-1764.Mol Cancer Ther2017-06-15T00:00:002017CDK4/6 Inhibitors Sensitize Rb-positive Sarcoma Cells to Wee1 Kinase Inhibition through Reversible Cell-Cycle Arrest.28358936Moran MS, Zhao Y, Ma S, Kirova Y, Fourquet A, Chen P, Hoffman K, Hunt K, Wong J, Halasz LM, Freedman G, Prosnitz R, Yassa M, Nguyen DHA, Hijal T, Haffty BG, Wai ES, Truong PTJAMA oncologyAssociation of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy. JAMA Oncol. 2017 Aug 01; 3(8):1060-1068.JAMA Oncol2017-08-01T00:00:002017Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy.28423171Tadros AB, Yang WT, Krishnamurthy S, Rauch GM, Smith BD, Valero V, Black DM, Lucci A, Caudle AS, DeSnyder SM, Teshome M, Barcenas CH, Miggins M, Adrada BE, Moseley T, Hwang RF, Hunt KK, Kuerer HMJAMA surgeryIdentification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery. JAMA Surg. 2017 07 01; 152(7):665-670.JAMA Surg2017-07-01T00:00:002017Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery.28592619Chavez-MacGregor M, Mittendorf EA, Clarke CA, Lichtensztajn DY, Hunt KK, Giordano SHThe oncologistIncorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System. Oncologist. 2017 11; 22(11):1292-1300.Oncologist2017-06-07T00:00:002017Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System.28657941Boughey JC, Ballman KV, McCall LM, Mittendorf EA, Symmans WF, Julian TB, Byrd D, Hunt KKAnnals of surgeryTumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance). Ann Surg. 2017 10; 266(4):667-676.Ann Surg2017-10-01T00:00:002017Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: Long-term Follow-up From ACOSOG Z1071 (Alliance).28726077Mittendorf EA, Chavez-MacGregor M, Vila J, Yi M, Lichtensztajn DY, Clarke CA, Giordano SH, Hunt KKAnnals of surgical oncologyBioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology. Ann Surg Oncol. 2017 Nov; 24(12):3502-3509.Ann Surg Oncol2017-07-19T00:00:002017Bioscore: A Staging System for Breast Cancer Patients that Reflects the Prognostic Significance of Underlying Tumor Biology.28333010Reddy JP, Lei X, Huang SC, Nicklaus KM, Fingeret MC, Shaitelman SF, Hunt KK, Buchholz TA, Merchant F, Markey MK, Smith BDInternational journal of radiation oncology, biology, physicsQuantitative Assessment of Breast Cosmetic Outcome After Whole-Breast Irradiation. Int J Radiat Oncol Biol Phys. 2017 04 01; 97(5):894-902.Int J Radiat Oncol Biol Phys2016-12-21T00:00:002016Quantitative Assessment of Breast Cosmetic Outcome After Whole-Breast Irradiation.28653662Vijayaraghavan S, Karakas C, Doostan I, Chen X, Bui T, Yi M, Raghavendra AS, Zhao Y, Bashour SI, Ibrahim NK, Karuturi M, Wang J, Winkler JD, Amaravadi RK, Hunt KK, Tripathy D, Keyomarsi KNature communicationsCDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers. Nat Commun. 2017 06 27; 8:15916.Nat Commun2017-06-27T00:00:002017CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers.28164214Fisher JM, Garside MJ, Brock P, Gibson V, Hunt K, Briggs S, Gordon ALAge and ageingWhy geriatric medicine? A survey of UK specialist trainees in geriatric medicine. Age Ageing. 2017 07 01; 46(4):672-677.Age Ageing2017-07-01T00:00:002017Why geriatric medicine? A survey of UK specialist trainees in geriatric medicine.28742682Tadros AB, Smith BD, Shen Y, Lin H, Krishnamurthy S, Lucci A, Barcenas CH, Hwang RF, Rauch G, Santiago L, Strom EA, DeSnyder SM, Yang WT, Black DM, Albarracin CT, Chavez-MacGregor M, Hunt KK, Kuerer HMAnnals of surgeryDuctal Carcinoma In Situ and Margins <2?mm: Contemporary Outcomes With Breast Conservation. Ann Surg. 2019 01; 269(1):150-157.Ann Surg2019-01-01T00:00:002019Ductal Carcinoma In Situ and Margins <2?mm: Contemporary Outcomes With Breast Conservation.29132570Hunt KKSurgical oncology clinics of North AmericaIntegrating New Knowledge and Surgical Innovation into the Diagnosis and Management of Breast Cancer. Surg Oncol Clin N Am. 2018 01; 27(1):xv-xvi.Surg Oncol Clin N Am2018-01-01T00:00:002018Integrating New Knowledge and Surgical Innovation into the Diagnosis and Management of Breast Cancer.28928852Kuerer HM, Smith BD, Chavez-MacGregor M, Albarracin C, Barcenas CH, Santiago L, Edgerton ME, Rauch GM, Giordano SH, Sahin A, Krishnamurthy S, Woodward W, Tripathy D, Yang WT, Hunt KKJournal of CancerDCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes. J Cancer. 2017; 8(14):2653-2662.J Cancer2017-08-22T00:00:002017DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes.29118060Baker NL, Hunt KJ, Stevens DR, Jarai G, Rosen GD, Klein RL, Virella G, Lopes-Virella MF, DCCT/EDIC Research GroupDiabetes careAssociation Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes. Diabetes Care. 2018 01; 41(1):128-135.Diabetes Care2017-11-08T00:00:002017Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 Diabetes.29180466Carey JPW, Karakas C, Bui T, Chen X, Vijayaraghavan S, Zhao Y, Wang J, Mikule K, Litton JK, Hunt KK, Keyomarsi KCancer researchSynthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer. Cancer Res. 2018 02 01; 78(3):742-757.Cancer Res2017-11-27T00:00:002017Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer.28766207Caudle AS, Bedrosian I, Milton DR, DeSnyder SM, Kuerer HM, Hunt KK, Mittendorf EAAnnals of surgical oncologyUse of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members. Ann Surg Oncol. 2017 Oct; 24(10):2925-2934.Ann Surg Oncol2017-08-01T00:00:002017Use of Sentinel Lymph Node Dissection After Neoadjuvant Chemotherapy in Patients with Node-Positive Breast Cancer at Diagnosis: Practice Patterns of American Society of Breast Surgeons Members.28898379Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow MJAMAEffect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial. JAMA. 2017 09 12; 318(10):918-926.JAMA2017-09-12T00:00:002017Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.29100726Weiss A, Mittendorf EA, DeSnyder SM, Hwang RF, Bea V, Bedrosian I, Hoffman K, Adrade B, Sahin AA, Kuerer HM, Hunt KK, Caudle ASClinical breast cancerExpanding Implementation of ACOSOG Z0011 in Surgeon Practice. Clin Breast Cancer. 2018 08; 18(4):276-281.Clin Breast Cancer2017-10-13T00:00:002017Expanding Implementation of ACOSOG Z0011 in Surgeon Practice.29468609Fisher SB, Chiang YJ, Feig BW, Cormier JN, Hunt KK, Torres KE, Roland CLAnnals of surgical oncologyComparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems for Soft Tissue Sarcoma of the Trunk and Extremities. Ann Surg Oncol. 2018 May; 25(5):1126-1132.Ann Surg Oncol2018-02-21T00:00:002018Comparative Performance of the 7th and 8th Editions of the American Joint Committee on Cancer Staging Systems for Soft Tissue Sarcoma of the Trunk and Extremities.29308306Keung EZ, Tsai JW, Ali AM, Cormier JN, Bishop AJ, Guadagnolo BA, Torres KE, Somaiah N, Hunt KK, Wargo JA, Lazar AJ, Wang WL, Roland CLOncoimmunologyAnalysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy. Oncoimmunology. 2018; 7(2):e1385689.Oncoimmunology2017-10-31T00:00:002017Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: Rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy.29309429Kortemeier E, Ramos PS, Hunt KJ, Kim HJ, Hardiman G, Chung DPloS oneShinyGPA: An interactive visualization toolkit for investigating pleiotropic architecture using GWAS datasets. PLoS One. 2018; 13(1):e0190949.PLoS One2018-01-08T00:00:002018ShinyGPA: An interactive visualization toolkit for investigating pleiotropic architecture using GWAS datasets.29381381Le-Petross HT, McCall LM, Hunt KK, Mittendorf EA, Ahrendt GM, Wilke LG, Ballman KV, Boughey JCAJR. American journal of roentgenologyAxillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance). AJR Am J Roentgenol. 2018 Mar; 210(3):669-676.AJR Am J Roentgenol2018-01-30T00:00:002018Axillary Ultrasound Identifies Residual Nodal Disease After Chemotherapy: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).29382658Hunt KJ, Jaffa MA, Garrett SM, Luttrell DK, Lipson KE, Lopes-Virella MF, Luttrell LM, Jaffa AA, VADT InvestigatorsDiabetes carePlasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) Cohort. Diabetes Care. 2018 04; 41(4):840-846.Diabetes Care2018-01-30T00:00:002018Plasma Connective Tissue Growth Factor (CTGF/CCN2) Levels Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) Cohort.29448300Roland CL, Bednarski BK, Watson K, Torres KE, Cormier JN, Wang WL, Lazar AJ, Somaiah N, Hunt KK, Feig BWJournal of surgical oncologyIdentification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy. J Surg Oncol. 2018 Apr; 117(5):879-885.J Surg Oncol2018-02-15T00:00:002018Identification of preoperative factors associated with outcomes following surgical management of intra-abdominal recurrent or metastatic GIST following neoadjuvant tyrosine kinase inhibitor therapy.29520652Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, Mann GN, Hunt KK, Cormier JN, Feig BWAnnals of surgical oncologySalvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation may not Provide Benefit. Ann Surg Oncol. 2018 Aug; 25(8):2193-2200.Ann Surg Oncol2018-03-08T00:00:002018Salvage Surgery for Recurrent Retroperitoneal Well-Differentiated Liposarcoma: Early Reoperation may not Provide Benefit.29742355Hunt KJ, Gebregziahber M, Everett CJ, Heidenreich PA, Axon RNRural and remote healthThe interaction between rural/urban status and dual use status among veterans with heart failure. Rural Remote Health. 2018 05; 18(2):4495.Rural Remote Health2018-05-10T00:00:002018The interaction between rural/urban status and dual use status among veterans with heart failure.29222540Weiss A, Chavez-MacGregor M, Lichtensztajn DY, Yi M, Tadros A, Hortobagyi GN, Giordano SH, Hunt KK, Mittendorf EAJAMA oncologyValidation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer. JAMA Oncol. 2018 Feb 01; 4(2):203-209.JAMA Oncol2018-02-01T00:00:002018Validation Study of the American Joint Committee on Cancer Eighth Edition Prognostic Stage Compared With the Anatomic Stage in Breast Cancer.29227383Olvera L, Hunt K, Johnson K, Li SYJournal of Christian nursing : a quarterly publication of Nurses Christian FellowshipThe APRN as Servant Leader. J Christ Nurs. 2018 Jan/Mar; 35(1):13.J Christ Nurs2018-01-01T00:00:002018The APRN as Servant Leader.29228466Ikoma N, Roland CL, Torres KE, Chiang YJ, Wang WL, Somaiah N, Mann GN, Hunt KK, Cormier JN, Feig BWJournal of surgical oncologyConcomitant organ resection does not improve outcomes in primary retroperitoneal well-differentiated liposarcoma: A retrospective cohort study at a major sarcoma center. J Surg Oncol. 2018 May; 117(6):1188-1194.J Surg Oncol2017-12-11T00:00:002017Concomitant organ resection does not improve outcomes in primary retroperitoneal well-differentiated liposarcoma: A retrospective cohort study at a major sarcoma center.29723396Valachis A, Mamounas EP, Mittendorf EA, Hayashi N, Ishitobi M, Natoli C, Fitzal F, Rubio IT, Tiezzi DG, Shin HC, Anderson SJ, Hunt KK, Matsuda N, Ohsumi S, Totomi A, Nilsson CCancerRisk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis. Cancer. 2018 07 15; 124(14):2923-2930.Cancer2018-05-03T00:00:002018Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysis.29145767Davis ML, Neelon B, Nietert PJ, Hunt KJ, Burgette LF, Lawson AB, Egede LEStatistical methods in medical researchAddressing geographic confounding through spatial propensity scores: a study of racial disparities in diabetes. Stat Methods Med Res. 2019 03; 28(3):734-748.Stat Methods Med Res2017-11-16T00:00:002017Addressing geographic confounding through spatial propensity scores: a study of racial disparities in diabetes.29208319Keung EZ, Chiang YJ, Voss RK, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CLEuropean journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical OncologyDefining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma. Eur J Surg Oncol. 2018 01; 44(1):170-177.Eur J Surg Oncol2017-11-27T00:00:002017Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma.29485067Swanick CW, Lei X, Xu Y, Shen Y, Goodwin NA, Smith GL, Giordano SH, Hunt KK, Jagsi R, Shaitelman SF, Peterson SK, Smith BDInternational journal of radiation oncology, biology, physicsLong-term Patient-Reported Outcomes in Older Breast Cancer Survivors: A Population-Based Survey Study. Int J Radiat Oncol Biol Phys. 2018 03 15; 100(4):882-890.Int J Radiat Oncol Biol Phys2017-12-09T00:00:002017Long-term Patient-Reported Outcomes in Older Breast Cancer Survivors: A Population-Based Survey Study.29635424Loghavi S, Medeiros LJ, Javadi S, Lin P, Khoury JD, Nastoupil L, Hunt KK, Clemens MW, Miranda RNAesthetic surgery journalBreast Implant-Associated Anaplastic Large Cell Lymphoma With Bone Marrow Involvement. Aesthet Surg J. 2018 Jun 13; 38(7).Aesthet Surg J2018-06-13T00:00:002018Breast Implant-Associated Anaplastic Large Cell Lymphoma With Bone Marrow Involvement.30005768Weiss A, King TA, Hunt KK, Mittendorf EAThe Surgical clinics of North AmericaIncorporating Biologic Factors into the American Joint Committee on Cancer Breast Cancer Staging System: Review of the Supporting Evidence. Surg Clin North Am. 2018 Aug; 98(4):687-702.Surg Clin North Am2018-05-21T00:00:002018Incorporating Biologic Factors into the American Joint Committee on Cancer Breast Cancer Staging System: Review of the Supporting Evidence.30283913Malek AM, Hunt KJ, DellaValle DM, Greenberg D, St Peter JV, Marriott BPCurrent developments in nutritionReported Consumption of Low-Calorie Sweetener in Foods, Beverages, and Food and Beverage Additions by US Adults: NHANES 2007-2012. Curr Dev Nutr. 2018 Sep; 2(9):nzy054.Curr Dev Nutr2018-06-28T00:00:002018Reported Consumption of Low-Calorie Sweetener in Foods, Beverages, and Food and Beverage Additions by US Adults: NHANES 2007-2012.29980907Armer JM, Ballman KV, McCall L, Armer NC, Sun Y, Udmuangpia T, Hunt KK, Mittendorf EA, Byrd DR, Julian TB, Boughey JCSupportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerLymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy. Support Care Cancer. 2019 Feb; 27(2):495-503.Support Care Cancer2018-07-06T00:00:002018Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy.29987598DeSnyder SM, Hunt KK, Dong W, Smith BD, Moran MS, Chavez-MacGregor M, Shen Y, Kuerer HM, Lucci AAnnals of surgical oncologyAmerican Society of Breast Surgeons' Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation. Ann Surg Oncol. 2018 Oct; 25(10):2965-2974.Ann Surg Oncol2018-07-09T00:00:002018American Society of Breast Surgeons' Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation.29987605Rosenkranz KM, Ballman K, McCall L, Kubicky C, Cuttino L, Le-Petross H, Hunt KK, Giuliano A, Van Zee KJ, Haffty B, Boughey JCAnnals of surgical oncologyThe Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial. Ann Surg Oncol. 2018 Oct; 25(10):2858-2866.Ann Surg Oncol2018-07-09T00:00:002018The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.29992496Hunt KK, Wingate HFAnnals of surgical oncologySatisfaction and Sustainability in a Surgical Career. Ann Surg Oncol. 2018 Oct; 25(10):2785-2789.Ann Surg Oncol2018-07-10T00:00:002018Satisfaction and Sustainability in a Surgical Career.30194068Caruso JA, Duong MT, Carey JPW, Hunt KK, Keyomarsi KCancer researchLow-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies. Cancer Res. 2018 10 01; 78(19):5481-5491.Cancer Res2018-09-07T00:00:002018Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.30193295Buzdar AU, Suman VJ, Meric-Bernstam F, Leitch AM, Ellis MJ, Boughey JC, Unzeitig GW, Royce ME, Hunt KKJAMA oncologyDisease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial. JAMA Oncol. 2019 01 01; 5(1):45-50.JAMA Oncol2019-01-01T00:00:002019Disease-Free and Overall Survival Among Patients With Operable HER2-Positive Breast Cancer Treated With Sequential vs Concurrent Chemotherapy: The ACOSOG Z1041 (Alliance) Randomized Clinical Trial.30394881Fisher SB, Chiang YJ, Feig BW, Cormier JN, Hunt KK, Torres KE, Roland CLAmerican journal of clinical oncologyAn Evaluation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) Staging System for Retroperitoneal Sarcomas Using the National Cancer Data Base (NCDB): Does Size Matter? Am J Clin Oncol. 2019 02; 42(2):160-165.Am J Clin Oncol2019-02-01T00:00:002019An Evaluation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) Staging System for Retroperitoneal Sarcomas Using the National Cancer Data Base (NCDB): Does Size Matter?30181387Chen X, Low KH, Alexander A, Jiang Y, Karakas C, Hess KR, Carey JPW, Bui TN, Vijayaraghavan S, Evans KW, Yi M, Ellis DC, Cheung KL, Ellis IO, Fu S, Meric-Bernstam F, Hunt KK, Keyomarsi KClinical cancer research : an official journal of the American Association for Cancer ResearchCyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition. Clin Cancer Res. 2018 12 15; 24(24):6594-6610.Clin Cancer Res2018-09-04T00:00:002018Cyclin E Overexpression Sensitizes Triple-Negative Breast Cancer to Wee1 Kinase Inhibition.30238244Partain NS, Hunt KKAnnals of surgical oncologyImaging Surveillance After Definitive Treatment for Breast Cancer. Ann Surg Oncol. 2018 12; 25(13):3790-3792.Ann Surg Oncol2018-09-20T00:00:002018Imaging Surveillance After Definitive Treatment for Breast Cancer.30249211Keung EZ, Lazar AJ, Torres KE, Wang WL, Cormier JN, Ashleigh Guadagnolo B, Bishop AJ, Lin H, Hunt KK, Bird J, Lewis VO, Patel SR, Wargo JA, Somaiah N, Roland CLBMC cancerPhase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer. 2018 Sep 24; 18(1):913.BMC Cancer2018-09-24T00:00:002018Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma.29712608Ikoma N, Roland CL, Cormier JN, Chiang YJ, Torres KE, Hunt KK, You YN, Feig BWThe American surgeonNongastrointestinal Stromal Tumor Spindle Cell Sarcomas of the Colon or Rectum. Am Surg. 2018 Apr 01; 84(4):570-575.Am Surg2018-04-01T00:00:002018Nongastrointestinal Stromal Tumor Spindle Cell Sarcomas of the Colon or Rectum.29947001Tevis SE, Neuman HB, Mittendorf EA, Kuerer HM, Bedrosian I, DeSnyder SM, Thompson AM, Black DM, Scoggins ME, Sahin AA, Hunt KK, Caudle ASAnnals of surgical oncologyMultidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins. Ann Surg Oncol. 2018 Oct; 25(10):2932-2938.Ann Surg Oncol2018-06-26T00:00:002018Multidisciplinary Intraoperative Assessment of Breast Specimens Reduces Number of Positive Margins.30017226Stevens DR, Malek AM, Laggis C, Hunt KJAnnals of epidemiologyIn utero exposure to tobacco smoke, subsequent cardiometabolic risks, and metabolic syndrome among U.S. adolescents. Ann Epidemiol. 2018 09; 28(9):619-624.e1.Ann Epidemiol2018-07-03T00:00:002018In utero exposure to tobacco smoke, subsequent cardiometabolic risks, and metabolic syndrome among U.S. adolescents.30089255Lei JT, Shao J, Zhang J, Iglesia M, Chan DW, Cao J, Anurag M, Singh P, He X, Kosaka Y, Matsunuma R, Crowder R, Hoog J, Phommaly C, Goncalves R, Ramalho S, Peres RMR, Punturi N, Schmidt C, Bartram A, Jou E, Devarakonda V, Holloway KR, Lai WV, Hampton O, Rogers A, Tobias E, Parikh PA, Davies SR, Li S, Ma CX, Suman VJ, Hunt KK, Watson MA, Hoadley KA, Thompson EA, Chen X, Kavuri SM, Creighton CJ, Maher CA, Perou CM, Haricharan S, Ellis MJCell reportsFunctional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer. Cell Rep. 2018 08 07; 24(6):1434-1444.e7.Cell Rep2018-08-07T00:00:002018Functional Annotation of ESR1 Gene Fusions in Estrogen Receptor-Positive Breast Cancer.30359480Caudle AS, Kuerer HM, Krishnamurthy S, Shin K, Hobbs BP, Ma J, Mittendorf EA, Washington AC, DeSnyder SM, Black DM, Hunt KK, Yang WTCancerFeasibility of fine-needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study. Cancer. 2019 02 01; 125(3):365-373.Cancer2018-10-25T00:00:002018Feasibility of fine-needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study.30715139Tevis SE, Hunt KK, Miranda RN, Lange C, Butler CE, Clemens MWAesthetic surgery journalDifferences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population. Aesthet Surg J. 2019 09 13; 39(10):1065-1070.Aesthet Surg J2019-09-13T00:00:002019Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population.30716524Advani PG, Lei X, Swanick CW, Xu Y, Shen Y, Goodwin NA, Smith GL, Giordano SH, Hunt KK, Jagsi R, Smith BDInternational journal of radiation oncology, biology, physicsLocal Therapy Decisional Regret in Older Women With Breast Cancer: A Population-Based Study. Int J Radiat Oncol Biol Phys. 2019 06 01; 104(2):383-391.Int J Radiat Oncol Biol Phys2019-02-01T00:00:002019Local Therapy Decisional Regret in Older Women With Breast Cancer: A Population-Based Study.30371248Axon RN, Gebregziabher M, Everett CJ, Heidenreich P, Hunt KJJournal of the American Heart AssociationDual Healthcare System Use During Episodes of Acute Care Heart Failure Associated With Higher Healthcare Utilization and Mortality Risk. J Am Heart Assoc. 2018 08 07; 7(15):e009054.J Am Heart Assoc2018-08-07T00:00:002018Dual Healthcare System Use During Episodes of Acute Care Heart Failure Associated With Higher Healthcare Utilization and Mortality Risk.30537987Bhardwaj A, Singh H, Trinidad CM, Albarracin CT, Hunt KK, Bedrosian IBreast cancer research : BCRThe isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer. Breast Cancer Res. 2018 12 11; 20(1):150.Breast Cancer Res2018-12-11T00:00:002018The isomiR-140-3p-regulated mevalonic acid pathway as a potential target for prevention of triple negative breast cancer.30542836Rosenkranz KM, Ballman K, McCall L, Kubicky CD, Cuttino L, Le-Petross H, Hunt K, Giuliano A, Van Zee K, Haffty B, Boughey JAnnals of surgical oncologyReply to "Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report". Ann Surg Oncol. 2019 Feb; 26(2):702.Ann Surg Oncol2018-12-12T00:00:002018Reply to "Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report".D018270Disorders28812150.592846Carcinoma, Ductal, BreastAuthorship 94133720Authorship 9419135Authorship 9421557Authorship 942722230843891Nurudeen S, Hunt KKClinical advances in hematology & oncology : H&OContemporary management of the axilla in breast cancer. Clin Adv Hematol Oncol. 2018 Dec; 16(12):823-831.Clin Adv Hematol Oncol2018-12-01T00:00:002018Contemporary management of the axilla in breast cancer.30867218Kettner NM, Vijayaraghavan S, Durak MG, Bui T, Kohansal M, Ha MJ, Liu B, Rao X, Wang J, Yi M, Carey JPW, Chen X, Eckols TK, Raghavendra AS, Ibrahim NK, Karuturi MS, Watowich SS, Sahin A, Tweardy DJ, Hunt KK, Tripathy D, Keyomarsi KClinical cancer research : an official journal of the American Association for Cancer ResearchCombined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer. Clin Cancer Res. 2019 07 01; 25(13):3996-4013.Clin Cancer Res2019-03-13T00:00:002019Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer.30817556Lamaris GA, Butler CE, Deva AK, Miranda RN, Hunt KK, Connell T, Lipa JE, Clemens MWPlastic and reconstructive surgeryBreast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg. 2019 03; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S.Plast Reconstr Surg2019-03-01T00:00:002019Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma.Authorship 94359010Authorship 9438926Authorship 94418522Authorship 944202530317543Keung EZ, Chiang YJ, Cormier JN, Torres KE, Hunt KK, Feig BW, Roland CLCancerTreatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma. Cancer. 2018 12 01; 124(23):4495-4503.Cancer2018-10-14T00:00:002018Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.30044695Parker PA, Peterson SK, Shen Y, Bedrosian I, Black DM, Thompson AM, Nelson JC, DeSnyder SM, Cook RL, Hunt KK, Volk RJ, Cantor SB, Dong W, Brewster AMJournal of clinical oncology : official journal of the American Society of Clinical OncologyProspective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer. J Clin Oncol. 2018 09 01; 36(25):2630-2638.J Clin Oncol2018-07-25T00:00:002018Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer.30379626Shaitelman SF, Lei X, Thompson A, Schlembach P, Bloom ES, Arzu IY, Buchholz D, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Amaya DN, Shen Y, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BDJournal of clinical oncology : official journal of the American Society of Clinical OncologyThree-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial. J Clin Oncol. 2018 Oct 31; JCO1800317.J Clin Oncol2018-10-31T00:00:002018Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial.30737785Park KU, Kyrish K, Terrell J, Yi M, Caudle AS, Hunt KK, Kuerer HM, Bedrosian I, Thompson A, DeSnyder SM, other members of Department of Breast Surgical Oncology Study GroupJournal of surgical oncologySurgeon perception versus reality: Opioid use after breast cancer surgery. J Surg Oncol. 2019 Jun; 119(7):909-915.J Surg Oncol2019-02-08T00:00:002019Surgeon perception versus reality: Opioid use after breast cancer surgery.Authorship 9457761031025270Weiss A, Lin H, Babiera GV, Bedrosian I, Shaitelman SF, Shen Y, Kuerer HM, Mittendorf EA, Caudle AS, Hunt KK, Hwang RFBreast cancer research and treatmentEvolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes. Breast Cancer Res Treat. 2019 Jul; 176(2):435-444.Breast Cancer Res Treat2019-04-25T00:00:002019Evolution in practice patterns of axillary management following mastectomy in patients with 1-2 positive sentinel nodes.Authorship 9462853Authorship 946330331043336Lopes-Virella MF, Baker NL, Hunt KJ, Hammad SM, Arthur J, Virella G, Klein RL, DCCT/EDIC Research GroupJournal of clinical lipidologyGlycosylated sphingolipids and progression to kidney dysfunction in type 1 diabetes. J Clin Lipidol. 2019 May - Jun; 13(3):481-491.e1.J Clin Lipidol2019-04-03T00:00:002019Glycosylated sphingolipids and progression to kidney dysfunction in type 1 diabetes.31052522Malek AM, Newman JC, Hunt KJ, Marriott BPNutrientsRace/Ethnicity, Enrichment/Fortification, and Dietary Supplementation in the U.S. Population, NHANES 2009?2012. Nutrients. 2019 May 02; 11(5).Nutrients2019-05-02T00:00:002019Race/Ethnicity, Enrichment/Fortification, and Dietary Supplementation in the U.S. Population, NHANES 2009?2012.Authorship 946844531061222Blackwell CK, Elliott AJ, Ganiban J, Herbstman J, Hunt K, Forrest CB, Camargo CA, program collaborators for Environmental influences on Child Health OutcomesPediatricsGeneral Health and Life Satisfaction in Children With Chronic Illness. Pediatrics. 2019 06; 143(6).Pediatrics2019-05-06T00:00:002019General Health and Life Satisfaction in Children With Chronic Illness.20572042Wei B, Ding T, Xing Y, Wei W, Tian Z, Tang F, Abraham S, Nayeemuddin K, Hunt K, Wu YCancerInvasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma. Cancer. 2010 Oct 01; 116(19):4463-73.Cancer2010-10-01T00:00:002010Invasive neuroendocrine carcinoma of the breast: a distinctive subtype of aggressive mammary carcinoma.21334720Tian Z, Wei B, Tang F, Wei W, Gilcrease MZ, Huo L, Albarracin CT, Resetkova E, Middleton L, Sahin A, Xing Y, Hunt KK, Chen J, Bu H, Rashid A, Abraham SC, Wu YHuman pathologyPrognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation. Hum Pathol. 2011 Aug; 42(8):1169-77.Hum Pathol2011-02-21T00:00:002011Prognostic significance of tumor grading and staging in mammary carcinomas with neuroendocrine differentiation.22009292Wu Y, Mittendorf EA, Kelten C, Tucker SL, Wei W, Middleton LP, Broglio K, Buchholz TA, Hunt KK, Sahin AACancerOccult axillary lymph node metastases do not have prognostic significance in early stage breast cancer. Cancer. 2012 Mar 15; 118(6):1507-14.Cancer2011-08-25T00:00:002011Occult axillary lymph node metastases do not have prognostic significance in early stage breast cancer.23985644Gould DJ, Hunt KK, Liu J, Kuerer HM, Crosby MA, Babiera G, Kronowitz SJPlastic and reconstructive surgeryImpact of surgical techniques, biomaterials, and patient variables on rate of nipple necrosis after nipple-sparing mastectomy. Plast Reconstr Surg. 2013 Sep; 132(3):330e-338e.Plast Reconstr Surg2013-09-01T00:00:002013Impact of surgical techniques, biomaterials, and patient variables on rate of nipple necrosis after nipple-sparing mastectomy.Authorship 9470343Authorship 9471715Authorship 948378331099662Savard MF, Khan O, Hunt KK, Verma SAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual MeetingRedrawing the Lines: The Next Generation of Treatment in Metastatic Breast Cancer. Am Soc Clin Oncol Educ Book. 2019 Jan; 39:e8-e21.Am Soc Clin Oncol Educ Book2019-05-17T00:00:002019Redrawing the Lines: The Next Generation of Treatment in Metastatic Breast Cancer.31085287Haffty BG, McCall LM, Ballman KV, Buchholz TA, Hunt KK, Boughey JCInternational journal of radiation oncology, biology, physicsImpact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial. Int J Radiat Oncol Biol Phys. 2019 09 01; 105(1):174-182.Int J Radiat Oncol Biol Phys2019-05-11T00:00:002019Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial.31172534Zhao B, Tsai C, Hunt KK, Blair SLJournal of surgical oncologyAdherence to surgical and oncologic standards improves survival in breast cancer patients. J Surg Oncol. 2019 Aug; 120(2):148-159.J Surg Oncol2019-06-06T00:00:002019Adherence to surgical and oncologic standards improves survival in breast cancer patients.Authorship 950956731260503Couch D, Yu Z, Nam JH, Allen C, Ramos PS, da Silveira WA, Hunt KJ, Hazard ES, Hardiman G, Lawson A, Chung DPloS oneGAIL: An interactive webserver for inference and dynamic visualization of gene-gene associations based on gene ontology guided mining of biomedical literature. PLoS One. 2019; 14(7):e0219195.PLoS One2019-07-01T00:00:002019GAIL: An interactive webserver for inference and dynamic visualization of gene-gene associations based on gene ontology guided mining of biomedical literature.Authorship 9517411131297674Alvarado MD, Mittendorf EA, Teshome M, Thompson AM, Bold RJ, Gittleman MA, Beitsch PD, Blair SL, Kivilaid K, Harmer QJ, Hunt KKAnnals of surgical oncologySentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol. 2019 Oct; 26(11):3510-3516.Ann Surg Oncol2019-07-11T00:00:002019SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.Authorship 952140731314062Armer JM, Ballman KV, McCall L, Ostby PL, Zagar E, Kuerer HM, Hunt KK, Boughey JCJAMA surgeryFactors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection. JAMA Surg. 2019 09 01; 154(9):800-809.JAMA Surg2019-09-01T00:00:002019Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.Authorship 953025731364862Stevens DR, Taylor SN, Roberts JR, Neelon B, Newman RB, Vena JE, Hunt KJBreastfeeding medicine : the official journal of the Academy of Breastfeeding MedicineBreastfeeding Initiation as Related to the Interaction of Race/Ethnicity and Maternal Diabetes. Breastfeed Med. 2019 11; 14(9):630-639.Breastfeed Med2019-07-31T00:00:002019Breastfeeding Initiation as Related to the Interaction of Race/Ethnicity and Maternal Diabetes.Authorship 9533326Authorship 953594531383966Lyapichev KA, Pi?a-Oviedo S, Medeiros LJ, Evans MG, Liu H, Miranda AR, Hunt KK, Clemens MW, Stewart JM, Amin MB, Quesada AE, Chai SM, Di Napoli A, Yoga A, Dave SK, Wistuba II, Wu Y, Bueso-Ramos CE, Schlette EJ, Ferrufino-Schmidt MC, Loghavi S, Khoury JD, Young KH, Miranda RNModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncA proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma. Mod Pathol. 2020 03; 33(3):367-379.Mod Pathol2019-08-05T00:00:002019A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma.31399819Park KU, Weiss A, Rosso K, Yi M, Hunt K, Kuerer H, Hanson SE, Candelaria R, Tevis S, Thompson AAnnals of surgical oncologyUse of Mammographic Measurements to Predict Complications After Nipple-Sparing Mastectomy in BRCA Mutation Carriers. Ann Surg Oncol. 2020 Feb; 27(2):367-372.Ann Surg Oncol2019-08-09T00:00:002019Use of Mammographic Measurements to Predict Complications After Nipple-Sparing Mastectomy in BRCA Mutation Carriers.Authorship 9542211Authorship 9542371331434620Hunt KJ, Jenkins AJ, Fu D, Stevens D, Ma JX, Klein RL, Azar M, Zhang SX, Lopes-Virella MF, Lyons TJ, VADT InvestigatorsJournal of diabetes and its complicationsSerum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort. J Diabetes Complications. 2019 10; 33(10):107410.J Diabetes Complications2019-07-26T00:00:002019Serum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort.31436549Karakas C, Francis AM, Ha MJ, Wingate HF, Meena RA, Yi M, Rasaputra KS, Barrera AMG, Arun B, Do KA, Sahin A, Keyomarsi K, Hunt KKAnnals of surgeryCytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer. Ann Surg. 2021 08 01; 274(2):e150-e159.Ann Surg2021-08-01T00:00:002021Cytoplasmic Cyclin E Expression Predicts for Response to Neoadjuvant Chemotherapy in Breast Cancer.Authorship 954492231450689Marriott BP, Hunt KJ, Malek AM, Newman JCNutrientsTrends in Intake of Energy and Total Sugar from Sugar-Sweetened Beverages in the United States among Children and Adults, NHANES 2003-2016. Nutrients. 2019 Aug 25; 11(9).Nutrients2019-08-25T00:00:002019Trends in Intake of Energy and Total Sugar from Sugar-Sweetened Beverages in the United States among Children and Adults, NHANES 2003-2016.Authorship 955570631522900Maa AY, Medert CM, Lu X, Janjua R, Howell AV, Hunt KJ, McCord S, Giangiacomo A, Lynch MGOphthalmologyDiagnostic Accuracy of Technology-based Eye Care Services: The Technology-based Eye Care Services Compare Trial Part I. Ophthalmology. 2020 01; 127(1):38-44.Ophthalmology2019-08-13T00:00:002019Diagnostic Accuracy of Technology-based Eye Care Services: The Technology-based Eye Care Services Compare Trial Part I.Authorship 957064631605327Al-Refaie WB, Decker PA, Ballman KV, Pisters PWT, Posner MC, Hunt KK, Meyers B, Weinberg AD, Nelson H, Newman L, Tan A, Le-Rademacher JG, Hurria A, Jatoi AAnnals of surgical oncologyComparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance). Ann Surg Oncol. 2019 Dec; 26(13):4213-4221.Ann Surg Oncol2019-10-11T00:00:002019Comparative Age-Based Prospective Multi-Institutional Observations of 12,367 Patients Enrolled to the American College of Surgeons Oncology Group (ACOSOG) Z901101 Trials (Alliance).Authorship 9574131131625045Weiss A, Lopez NE, Ward EP, Lee KC, Caudle AS, Dickson-Witmer D, Chang C, Kelly K, Martin LW, Jacobs LK, Hunt KK, Yao K, Blair SLAnnals of surgical oncologyChallenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC). Ann Surg Oncol. 2019 Dec; 26(13):4364-4371.Ann Surg Oncol2019-10-17T00:00:002019Challenges in Clinical Trial Implementation: Results from a Survey of the National Accreditation Program of Breast Centers (NAPBC).Authorship 958132531667721Yi M, Lin H, Bedrosian I, Shen Y, Hunt KK, Chavez-MacGregor M, King TA, Mittendorf EAAnnals of surgical oncologyStaging for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Utility of Incorporating Biologic Factors. Ann Surg Oncol. 2020 Feb; 27(2):359-366.Ann Surg Oncol2019-10-30T00:00:002019Staging for Breast Cancer Patients Receiving Neoadjuvant Chemotherapy: Utility of Incorporating Biologic Factors.Authorship 962015631791664Maa AY, McCord S, Lu X, Janjua R, Howell AV, Hunt KJ, Medert CM, Giangiacomo A, Lynch MGOphthalmologyThe Impact of OCT on Diagnostic Accuracy of the Technology-Based Eye Care Services Protocol: Part II of the Technology-Based Eye Care Services Compare Trial. Ophthalmology. 2020 04; 127(4):544-549.Ophthalmology2019-10-31T00:00:002019The Impact of OCT on Diagnostic Accuracy of the Technology-Based Eye Care Services Protocol: Part II of the Technology-Based Eye Care Services Compare Trial.Authorship 962352731820211Park KU, Kyrish K, Yi M, Bedrosian I, Caudle AS, Kuerer HM, Hunt KK, Miggins MV, DeSnyder SMAnnals of surgical oncologyOpioid Use after Breast-Conserving Surgery: Prospective Evaluation of Risk Factors for High Opioid Use. Ann Surg Oncol. 2020 Mar; 27(3):730-735.Ann Surg Oncol2019-12-09T00:00:002019Opioid Use after Breast-Conserving Surgery: Prospective Evaluation of Risk Factors for High Opioid Use.Authorship 9626917Authorship 9627359Authorship 962954331863417Fisher CS, Margenthaler JA, Hunt KK, Schwartz TAnnals of surgical oncologyThe Landmark Series: Axillary Management in Breast Cancer. Ann Surg Oncol. 2020 Mar; 27(3):724-729.Ann Surg Oncol2019-12-20T00:00:002019The Landmark Series: Axillary Management in Breast Cancer.31843190Keung EZ, Asare EA, Chiang YJ, Prakash LR, Rajkot N, Torres KE, Hunt KK, Feig BW, Cormier JN, Roland CL, Katz MHG, Lee JE, Tzeng CDAmerican journal of surgeryPostoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection. Am J Surg. 2020 07; 220(1):140-146.Am J Surg2019-11-30T00:00:002019Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection.31846095Asare EA, Davis CH, Chiang YJ, Sabir S, Rajkot NF, Phillips PR, Roland CL, Torres KE, Hunt KK, Feig BWJournal of surgical oncologyManagement and outcomes of ruptured, perforated or fistulized tumors of mesenchymal origin. J Surg Oncol. 2020 Mar; 121(3):474-479.J Surg Oncol2019-12-17T00:00:002019Management and outcomes of ruptured, perforated or fistulized tumors of mesenchymal origin.Authorship 9753735Authorship 975376931916091Kantor O, Niu J, Zhao H, Giordano SH, Hunt KK, King TA, Mittendorf EA, Chavez-MacGregor MAnnals of surgical oncologyComparative Analysis of Proposed Strategies for Incorporating Biologic Factors into Breast Cancer Staging. Ann Surg Oncol. 2020 Jul; 27(7):2229-2237.Ann Surg Oncol2020-01-08T00:00:002020Comparative Analysis of Proposed Strategies for Incorporating Biologic Factors into Breast Cancer Staging.31916092Smith BD, Lei X, Diao K, Xu Y, Shen Y, Smith GL, Giordano SH, DeSnyder SM, Hunt KK, Teshome M, Jagsi R, Shaitelman SF, Peterson SK, Swanick CWAnnals of surgical oncologyEffect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors. Ann Surg Oncol. 2020 Apr; 27(4):1013-1022.Ann Surg Oncol2020-01-08T00:00:002020Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors.Authorship 9758003Authorship 975855531941154Newman JC, McBurney MI, Hunt KJ, Malek AM, Marriott BPNutrientsModeling Possible Outcomes of Updated Daily Values on Nutrient Intakes of the United States Adult Population. Nutrients. 2020 Jan 13; 12(1).Nutrients2020-01-13T00:00:002020Modeling Possible Outcomes of Updated Daily Values on Nutrient Intakes of the United States Adult Population.31942030Mull BB, Livingston JA, Patel N, Bui T, Hunt KK, Keyomarsi KBritish journal of cancerSpecific, reversible G1 arrest by UCN-01 in vivo provides cytostatic protection of normal cells against cytotoxic chemotherapy in breast cancer. Br J Cancer. 2020 03; 122(6):812-822.Br J Cancer2020-01-16T00:00:002020Specific, reversible G1 arrest by UCN-01 in vivo provides cytostatic protection of normal cells against cytotoxic chemotherapy in breast cancer.Authorship 978125732077839Stevens DR, Neelon B, Roberts JR, Taylor SN, Newman RB, Vena JE, Hunt KJJournal of developmental origins of health and diseaseMediation of the association between maternal pre-pregnancy overweight/obesity and childhood overweight/obesity by birth anthropometry. J Dev Orig Health Dis. 2021 02; 12(1):71-78.J Dev Orig Health Dis2020-02-20T00:00:002020Mediation of the association between maternal pre-pregnancy overweight/obesity and childhood overweight/obesity by birth anthropometry.Authorship 9789235Authorship 979530732149390Roland CL, Grubbs EG, Katz MHG, Teshome M, Hunt KK, Tzeng CWJournal of surgical oncologyClinical trials-Designing, implementing, and collaborating. J Surg Oncol. 2020 Jul; 122(1):25-28.J Surg Oncol2020-03-09T00:00:002020Clinical trials-Designing, implementing, and collaborating.32197318Johnston SJ, Syed BM, Parks RM, Monteiro CJ, Caruso JA, Green AR, Ellis IO, Hunt KK, Karakas C, Keyomarsi K, Cheung KLCancersCytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age. Cancers (Basel). 2020 Mar 18; 12(3).Cancers (Basel)2020-03-18T00:00:002020Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age.Authorship 980169932199230Kuritzky A, Reyna C, McGuire KP, Sun W, DeSnyder SM, Aubry S, Nayyar A, Strassle P, Hunt KK, Zhou JM, Lee MCBreast (Edinburgh, Scotland)Evaluation of 2014 margin guidelines on re-excision and recurrence rates after breast conserving surgery: A multi-institution retrospective study. Breast. 2020 Jun; 51:29-33.Breast2020-03-06T00:00:002020Evaluation of 2014 margin guidelines on re-excision and recurrence rates after breast conserving surgery: A multi-institution retrospective study.Authorship 987826832318946Park KU, Mamounas EP, Katz MHG, Unzeitig G, Carpizo D, You YN, Francescatti A, Hunt KK, Boughey JCAnnals of surgical oncologyClinical Trials for the Surgical Oncologist: Opportunities and Hurdles. Ann Surg Oncol. 2020 Jul; 27(7):2269-2275.Ann Surg Oncol2020-04-21T00:00:002020Clinical Trials for the Surgical Oncologist: Opportunities and Hurdles.Authorship 9887634Authorship 988838532372313Boughey JC, Francescatti AB, Park KU, Hunt KKAnnals of surgical oncologyASO Author Reflections: Bridging the Gap between Clinical Trial Data and Real-World Cancer Care. Ann Surg Oncol. 2020 Jul; 27(7):2276-2277.Ann Surg Oncol2020-05-05T00:00:002020ASO Author Reflections: Bridging the Gap between Clinical Trial Data and Real-World Cancer Care.32378088Howe JR, Bartlett DL, Tyler DS, Wong SL, Hunt KK, DeMatteo RP, Society of Surgical OncologyAnnals of surgical oncologyCOVID-19 Guideline Modifications as CMS Announces "Opening Up America Again": Comments from the Society of Surgical Oncology. Ann Surg Oncol. 2020 Jul; 27(7):2111-2113.Ann Surg Oncol2020-05-06T00:00:002020COVID-19 Guideline Modifications as CMS Announces "Opening Up America Again": Comments from the Society of Surgical Oncology.Authorship 9893432Authorship 989488532398613Hwang RF, Hunt KKAnnals of surgeryThe Emergence of Robotic-assisted Breast Surgery: Proceed With Caution. Ann Surg. 2020 06; 271(6):1013-1015.Ann Surg2020-06-01T00:00:002020The Emergence of Robotic-assisted Breast Surgery: Proceed With Caution.32409969Keung EZ, Rajkot N, Torres KE, Somaiah N, Hunt KK, Feig BW, Scally CP, Ikoma N, Roland CLAnnals of surgical oncologyEvaluating the Impact of Surveillance Follow-Up Intervals in Patients Following Resection of Primary Well-Differentiated Liposarcoma of the Retroperitoneum. Ann Surg Oncol. 2021 Jan; 28(1):570-575.Ann Surg Oncol2020-05-14T00:00:002020Evaluating the Impact of Surveillance Follow-Up Intervals in Patients Following Resection of Primary Well-Differentiated Liposarcoma of the Retroperitoneum.Authorship 989986332442059Buchholz TA, Ali S, Hunt KKJournal of clinical oncology : official journal of the American Society of Clinical OncologyMultidisciplinary Management of Locoregional Recurrent Breast Cancer. J Clin Oncol. 2020 07 10; 38(20):2321-2328.J Clin Oncol2020-05-22T00:00:002020Multidisciplinary Management of Locoregional Recurrent Breast Cancer.Authorship 9914101132514803Alvarado MD, Mittendorf EA, Teshome M, Thompson AM, Bold RJ, Gittleman MA, Beitsch PD, Blair SL, Kivilaid K, Harmer QJ, Hunt KKAnnals of surgical oncologyCorrection to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer. Ann Surg Oncol. 2020 Dec; 27(Suppl 3):979.Ann Surg Oncol2020-12-01T00:00:002020Correction to: SentimagIC: A Non-inferiority Trial Comparing Superparamagnetic Iron Oxide Versus Technetium-99m and Blue Dye in the Detection of Axillary Sentinel Nodes in Patients with Early-Stage Breast Cancer.Authorship 992461232568749Tevis SE, Hunt KK, Miranda RN, Lange C, Pinnix CC, Iyer S, Butler CE, Clemens MWAnnals of surgeryBreast Implant-associated Anaplastic Large Cell Lymphoma: A Prospective Series of 52 Patients. Ann Surg. 2022 01 01; 275(1):e245-e249.Ann Surg2022-01-01T00:00:002022Breast Implant-associated Anaplastic Large Cell Lymphoma: A Prospective Series of 52 Patients.Authorship 995078732699926Rosenkranz KM, Ballman K, McCall L, McCarthy C, Kubicky CD, Cuttino L, Hunt KK, Giuliano A, Van Zee KJ, Haffty B, Boughey JCAnnals of surgical oncologyCosmetic Outcomes Following Breast-Conservation Surgery and Radiation for Multiple Ipsilateral Breast Cancer: Data from the Alliance Z11102 Study. Ann Surg Oncol. 2020 Nov; 27(12):4650-4661.Ann Surg Oncol2020-07-22T00:00:002020Cosmetic Outcomes Following Breast-Conservation Surgery and Radiation for Multiple Ipsilateral Breast Cancer: Data from the Alliance Z11102 Study.Authorship 996635132769125Hunt KJ, Davis M, Pearce J, Bian J, Guagliardo MF, Moy E, Axon RN, Neelon BDiabetes careGeographic and Racial/Ethnic Variation in Glycemic Control and Treatment in a National Sample of Veterans With Diabetes. Diabetes Care. 2020 10; 43(10):2460-2468.Diabetes Care2020-08-07T00:00:002020Geographic and Racial/Ethnic Variation in Glycemic Control and Treatment in a National Sample of Veterans With Diabetes.Authorship 998048132847041Hunt KJ, St Peter JV, Malek AM, Vrana-Diaz C, Marriott BP, Greenberg DNutrientsDaily Eating Frequency in US Adults: Associations with Low-Calorie Sweeteners, Body Mass Index, and Nutrient Intake (NHANES 2007-2016). Nutrients. 2020 Aug 24; 12(9).Nutrients2020-08-24T00:00:002020Daily Eating Frequency in US Adults: Associations with Low-Calorie Sweeteners, Body Mass Index, and Nutrient Intake (NHANES 2007-2016).Authorship 999158332897832Buchholz TA, Ali S, Hunt KKJournal of clinical oncology : official journal of the American Society of Clinical OncologyReply to A. Thomsen et al. J Clin Oncol. 2020 10 20; 38(30):3577.J Clin Oncol2020-09-08T00:00:002020Reply to A. Thomsen et al.Authorship 1003217933083644Chapman BV, Lei X, Patil P, Tripathi S, Nicklaus KM, Grossberg AJ, Shaitelman SF, Thompson AM, Hunt KK, Buchholz TA, Merchant F, Markey MK, Smith BD, Reddy JPAdvances in radiation oncologyQuantitative 3-Dimensional Photographic Assessment of Breast Cosmesis After Whole Breast Irradiation for Early Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial. Adv Radiat Oncol. 2020 Sep-Oct; 5(5):824-833.Adv Radiat Oncol2020-05-21T00:00:002020Quantitative 3-Dimensional Photographic Assessment of Breast Cosmesis After Whole Breast Irradiation for Early Stage Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.Authorship 10043036Authorship 1005448533132048Howell AV, Gebregziabher M, Thiers BH, Paulos CM, Wrangle JM, Hunt KJ, Wallace KJournal of geriatric oncologyImmune checkpoint inhibitors retain effectiveness in older patients with cutaneous metastatic melanoma. J Geriatr Oncol. 2021 04; 12(3):394-401.J Geriatr Oncol2020-10-29T00:00:002020Immune checkpoint inhibitors retain effectiveness in older patients with cutaneous metastatic melanoma.33220903DeCoster RC, Lynch EB, Bonaroti AR, Miranda RN, Hunt KK, Clemens MWClinics in plastic surgeryBreast Implant-Associated Anaplastic Large Cell Lymphoma: Defining Future Research Priorities. Clin Plast Surg. 2021 Jan; 48(1):33-43.Clin Plast Surg2021-01-01T00:00:002021Breast Implant-Associated Anaplastic Large Cell Lymphoma: Defining Future Research Priorities.Authorship 10084831333417121Simons JM, Scoggins ME, Kuerer HM, Krishnamurthy S, Yang WT, Sahin AA, Shen Y, Lin H, Bedrosian I, Mittendorf EA, Thompson A, Lane DL, Hunt KK, Caudle ASAnnals of surgical oncologyProspective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients. Ann Surg Oncol. 2021 Aug; 28(8):4277-4283.Ann Surg Oncol2021-01-08T00:00:002021Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients.Authorship 1008636933423122Kantor O, Chang C, Yao K, Boughey J, Roland C, Francescatti AB, Blair S, Dickson Witmer D, Hunt KK, Nelson H, Weiss A, Oseni TAnnals of surgical oncologyUptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers. Ann Surg Oncol. 2021 Sep; 28(9):4995-5004.Ann Surg Oncol2021-01-09T00:00:002021Uptake of Breast Cancer Clinical Trials at Minority Serving Cancer Centers.Authorship 10100341633507222Freedman RA, Minami CA, Winer EP, Morrow M, Smith AK, Walter LC, Sedrak MS, Gagnon H, Perilla-Glen A, Wildiers H, Wildes TM, Lichtman SM, Loh KP, Brain EGC, Ganschow PS, Hunt KK, Mayer DK, Ruddy KJ, Jagsi R, Lin NU, Canin B, LeStage BK, Revette AC, Schonberg MA, Keating NLJAMA oncologyIndividualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement. JAMA Oncol. 2021 Apr 01; 7(4):609-615.JAMA Oncol2021-04-01T00:00:002021Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast Cancer: Multidisciplinary Expert Panel and International Society of Geriatric Oncology Consensus Statement.Authorship 1010419233527629Sheu TG, Hunt KK, Middleton LPThe breast journalMYC and NOTCH1-positive postradiation cutaneous angiosarcoma of the breast. Breast J. 2021 03; 27(3):264-267.Breast J2021-02-01T00:00:002021MYC and NOTCH1-positive postradiation cutaneous angiosarcoma of the breast.Authorship 1012191633619981Malek AM, Wilson DA, Turan TN, Mateus J, Lackland DT, Hunt KJJournal of the American Heart AssociationMaternal Coronary Heart Disease, Stroke, and Mortality Within 1, 3, and 5 Years of Delivery Among Women With Hypertensive Disorders of Pregnancy and Pre-Pregnancy Hypertension. J Am Heart Assoc. 2021 02; 10(5):e018155.J Am Heart Assoc2021-02-23T00:00:002021Maternal Coronary Heart Disease, Stroke, and Mortality Within 1, 3, and 5 Years of Delivery Among Women With Hypertensive Disorders of Pregnancy and Pre-Pregnancy Hypertension.Authorship 10138197Authorship 1013998933720478Weiss A, Cooley V, Al-Hilli Z, Ballman K, Poorvu N, Haffty B, Hunt KK, Nelson H, Blair SL, Boughey JThe breast journalExtrapolation of ACOSOG Z0011 trial results-A survey of breast cancer providers. Breast J. 2021 06; 27(6):537-542.Breast J2021-03-15T00:00:002021Extrapolation of ACOSOG Z0011 trial results-A survey of breast cancer providers.33734413Landry JP, Schertz KL, Chiang YJ, Bhalla AD, Yi M, Keung EZ, Scally CP, Feig BW, Hunt KK, Roland CL, Guadagnolo A, Bishop AJ, Lazar AJ, Slopis JM, McCutcheon IE, Torres KEJAMA network openComparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020. JAMA Netw Open. 2021 03 01; 4(3):e210945.JAMA Netw Open2021-03-01T00:00:002021Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.Authorship 1014611133771294Hunt KKJournal of the American College of SurgeonsInvited Commentary. J Am Coll Surg. 2021 04; 232(4):378-379.J Am Coll Surg2021-04-01T00:00:002021Invited Commentary.Authorship 1015600233791601Tevis SE, Hunt KK, Clemens MWAesthetic surgery journal. Open forumStepwise En Bloc Resection of Breast Implant-Associated Anaplastic Large Cell Lymphoma with Oncologic Considerations. Aesthet Surg J Open Forum. 2019 Mar; 1(1):ojz005.Aesthet Surg J Open Forum2019-02-27T00:00:002019Stepwise En Bloc Resection of Breast Implant-Associated Anaplastic Large Cell Lymphoma with Oncologic Considerations.Authorship 10172831333916118Chen X, Yang D, Carey JPW, Karakas C, Albarracin C, Sahin AA, Arun BK, Guray Durak M, Li M, Kohansal M, Bui TN, Ha MJ, Hunt KK, Keyomarsi KCancersTargeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration. Cancers (Basel). 2021 Apr 01; 13(7).Cancers (Basel)2021-04-01T00:00:002021Targeting Replicative Stress and DNA Repair by Combining PARP and Wee1 Kinase Inhibitors Is Synergistic in Triple Negative Breast Cancers with Cyclin E or BRCA1 Alteration.Authorship 1017550833938495Smith-Graziani DJ, Parker PA, Peterson SK, Bedrosian I, Shen Y, Black DM, DeSnyder SM, Hunt KK, Dong W, Brewster AMAnnals of surgeryProspective Study of Pain Outcomes Associated With Breast Surgery in Women With Nonhereditary Breast Cancer. Ann Surg. 2023 03 01; 277(3):e617-e623.Ann Surg2021-04-30T00:00:002021Prospective Study of Pain Outcomes Associated With Breast Surgery in Women With Nonhereditary Breast Cancer.Authorship 10184411033990543Lulla AR, Akli S, Karakas C, Ha MJ, Fowlkes NW, Mitani Y, Bui T, Wang J, Rao X, Hunt KK, Meijer L, El-Naggar AK, Keyomarsi KOncogenesisLMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers. Oncogenesis. 2021 May 14; 10(5):40.Oncogenesis2021-05-14T00:00:002021LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancers.Authorship 101865219Authorship 10189183Authorship 10190361334010054Li GZ, Raut CP, Hunt KK, Feng M, Chugh RAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual MeetingBreast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Epidemiology, Diagnosis, Staging, and Histology-Specific Management Considerations. Am Soc Clin Oncol Educ Book. 2021 Mar; 41:390-404.Am Soc Clin Oncol Educ Book2021-03-01T00:00:002021Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Epidemiology, Diagnosis, Staging, and Histology-Specific Management Considerations.34017965Singh P, Scoggins ME, Sahin AA, Hwang RF, Kuerer HM, Caudle AS, Mittendorf EA, Thompson AM, Bedrosian I, Teshome M, DeSnyder SM, Meric-Bernstam F, Hunt KKAnnals of surgery open : perspectives of surgical history, education, and clinical approachesEffectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial. Ann Surg Open. 2020 Dec; 1(2).Ann Surg Open2020-12-01T00:00:002020Effectiveness and Safety of Magseed-localization for Excision of Breast Lesions: A Prospective, Phase IV Trial.33992718Weng JK, Lei X, Schlembach P, Bloom ES, Shaitelman SF, Arzu IY, Chronowski G, Dvorak T, Grade E, Hoffman K, Perkins G, Reed VK, Shah SJ, Stauder MC, Strom EA, Tereffe W, Woodward WA, Hortobagyi GN, Hunt KK, Buchholz TA, Smith BDInternational journal of radiation oncology, biology, physicsFive-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation. Int J Radiat Oncol Biol Phys. 2021 10 01; 111(2):360-370.Int J Radiat Oncol Biol Phys2021-05-13T00:00:002021Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation.Authorship 1020286834087191Pearce JL, Neelon B, Bloom MS, Buckley JP, Ananth CV, Perera F, Vena J, Hunt K, program collaborators for Environmental influences on Child Health OutcomesEnvironmental researchExploring associations between prenatal exposure to multiple endocrine disruptors and birth weight with exposure continuum mapping. Environ Res. 2021 09; 200:111386.Environ Res2021-06-02T00:00:002021Exploring associations between prenatal exposure to multiple endocrine disruptors and birth weight with exposure continuum mapping.Authorship 1021067734119494Nissen AP, Vreeland TJ, Teshome M, Archer MA, Francescatti AB, Katz MHG, Hunt KK, Zheng L, Mullett TWThe Annals of thoracic surgeryAmerican College of Surgeons Commission on Cancer Standard for Curative-intent Pulmonary Resection. Ann Thorac Surg. 2022 01; 113(1):5-8.Ann Thorac Surg2021-06-10T00:00:002021American College of Surgeons Commission on Cancer Standard for Curative-intent Pulmonary Resection.Authorship 10237318Authorship 1024520934155351Evans MG, Medeiros LJ, Marques-Piubelli ML, Wang HY, Ortiz-Hidalgo C, Pina-Oviedo S, Morine A, Clemens MW, Hunt KK, Iyer S, Hu Q, Recavarren C, Demichelis R, Romero M, Sohani AR, Misialek M, Amin MB, Bueso-Ramos CE, Carballo-Zarate AA, Lee HJ, Ok CY, Xu J, Miranda RNModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncBreast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease. Mod Pathol. 2021 12; 34(12):2148-2153.Mod Pathol2021-06-21T00:00:002021Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease.34226673Medeiros LJ, Marques-Piubelli ML, Sangiorgio VFI, Ruiz-Cordero R, Vega F, Feldman AL, Chapman JR, Clemens MW, Hunt KK, Evans MG, Khoo C, Lade S, Silberman M, Morkowski J, Pina EM, Mills DC, Bates CM, Magno WB, Sohani AR, Sieling BA, O'Donoghue JM, Bacon CM, Patani N, Televantou D, Turner SD, Johnson L, MacNeill F, Wotherspoon AC, Iyer SP, Malpica LE, Patel KP, Xu J, Miranda RNModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncEpstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship. Mod Pathol. 2021 12; 34(12):2154-2167.Mod Pathol2021-07-05T00:00:002021Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship.Authorship 1024830934247335Elmore LC, Kuerer HM, Barcenas CH, Smith BD, Miggins MV, Lucci A, Caudle AS, Meric-Bernstam F, Hunt KK, Teshome MAnnals of surgical oncologyClinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2021 Oct; 28(10):5477-5485.Ann Surg Oncol2021-07-10T00:00:002021Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy.Authorship 102566221Authorship 1025866834283254Kochat V, Raman AT, Landers SM, Tang M, Schulz J, Terranova C, Landry JP, Bhalla AD, Beird HC, Wu CC, Jiang Y, Mao X, Lazcano R, Gite S, Ingram DR, Yi M, Zhang J, Keung EZ, Scally CP, Roland CL, Hunt KK, Feig BW, Futreal PA, Hwu P, Wang WL, Lazar AJ, Slopis JM, Wilson-Robles H, Wiener DJ, McCutcheon IE, Wustefeld-Janssens B, Rai K, Torres KEActa neuropathologicaEnhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state. Acta Neuropathol. 2021 09; 142(3):565-590.Acta Neuropathol2021-07-20T00:00:002021Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state.34292426Adesoye T, Babayemi O, Postlewait LM, DeSnyder SM, Sun SX, Woodward WA, Ueno NT, Hunt KK, Lucci A, Teshome MAnnals of surgical oncologyInflammatory Breast Cancer at the Extremes of Age. Ann Surg Oncol. 2021 Oct; 28(10):5626-5634.Ann Surg Oncol2021-07-22T00:00:002021Inflammatory Breast Cancer at the Extremes of Age.Authorship 1026511534328640Kilgore LJ, Murphy BL, Postlewait LM, Liang DH, Bedrosian I, Lucci A, Kuerer HM, Hunt KK, Teshome MJournal of surgical oncologyImpact of the early COVID-19 pandemic on Breast Surgical Oncology fellow education. J Surg Oncol. 2021 Dec; 124(7):989-994.J Surg Oncol2021-07-30T00:00:002021Impact of the early COVID-19 pandemic on Breast Surgical Oncology fellow education.Authorship 10278311434394841Newman L, Fejerman L, Pal T, Mema E, McGinty G, Cheng A, Levy M, Momoh A, Troester M, Schneider B, McNeil L, Davis M, Babagbemi K, Hunt KCurrent breast cancer reportsBreast Cancer Disparities Through the Lens of the COVID-19 Pandemic. Curr Breast Cancer Rep. 2021; 13(3):110-112.Curr Breast Cancer Rep2021-08-06T00:00:002021Breast Cancer Disparities Through the Lens of the COVID-19 Pandemic.Authorship 1028332634431312Malek AM, Wilson DA, Turan TN, Mateus J, Lackland DT, Hunt KJJournal of the American Heart AssociationIncident Heart Failure Within the First and Fifth Year after Delivery Among Women With Hypertensive Disorders of Pregnancy and Prepregnancy Hypertension in a Diverse Population. J Am Heart Assoc. 2021 09 07; 10(17):e021616.J Am Heart Assoc2021-08-25T00:00:002021Incident Heart Failure Within the First and Fifth Year after Delivery Among Women With Hypertensive Disorders of Pregnancy and Prepregnancy Hypertension in a Diverse Population.Authorship 1031399634634438Cuttino LW, McCall L, Kubicky C, Ballman KV, Le-Petross H, Hunt KK, Haffty B, Rosenkranz KM, Boughey JCInternational journal of radiation oncology, biology, physicsThe Feasibility of Radiation Therapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial. Int J Radiat Oncol Biol Phys. 2022 03 01; 112(3):636-642.Int J Radiat Oncol Biol Phys2021-10-08T00:00:002021The Feasibility of Radiation Therapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.Authorship 10318061534669515Hildebrand JS, Ferguson PL, Sciscione AC, Grobman WA, Newman RB, Tita AT, Wapner RJ, Nageotte MP, Palomares K, Skupski DW, Cooper DM, Zhang C, Neelon B, Vena JE, Hunt KJChildhood obesity (Print)Breastfeeding Associations with Childhood Obesity and Body Composition: Findings from a Racially Diverse Maternal-Child Cohort. Child Obes. 2022 04; 18(3):178-187.Child Obes2021-10-20T00:00:002021Breastfeeding Associations with Childhood Obesity and Body Composition: Findings from a Racially Diverse Maternal-Child Cohort.Authorship 1034840734849578Khatiwada A, Wolf BJ, Yilmaz AS, Ramos PS, Pietrzak M, Lawson A, Hunt KJ, Kim HJ, Chung DBioinformatics (Oxford, England)GPA-Tree: statistical approach for functional-annotation-tree-guided prioritization of GWAS results. Bioinformatics. 2022 01 27; 38(4):1067-1074.Bioinformatics2022-01-27T00:00:002022GPA-Tree: statistical approach for functional-annotation-tree-guided prioritization of GWAS results.Authorship 1036674234989940Tamirisa N, Hunt KKAnnals of surgical oncologyNeoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline. Ann Surg Oncol. 2022 Mar; 29(3):1489-1492.Ann Surg Oncol2022-01-06T00:00:002022Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline.Authorship 10383222Authorship 10384799Authorship 103948713Authorship 103949318Authorship 10395667Authorship 10408243Authorship 104119310Authorship 10413029Authorship 1041346335128342Ferguson PL, Commodore S, Neelon B, Cobbs J, Sciscione AC, Grobman WA, Newman RB, Tita AT, Nageotte MP, Palomares K, Skupski DW, Vena JE, Hunt KJChild and adolescent obesity (Abingdon, England)Early Exposure to Animals and Childhood Body Mass Index Percentile and Percentage Fat Mass. Child Adolesc Obes. 2022; 5(1):3-15.Child Adolesc Obes2022-01-13T00:00:002022Early Exposure to Animals and Childhood Body Mass Index Percentile and Percentage Fat Mass.35128664Nassif EF, Cope B, Traweek R, Witt RG, Erstad DJ, Scally CP, Thirasastr P, Zarzour MA, Ludwig J, Benjamin R, Bishop AJ, Guadagnolo BA, Ingram D, Wani K, Wang WL, Lazar AJ, Torres KE, Hunt KK, Feig BW, Roland CL, Somaiah N, Keung EZInternational journal of cancerReal-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center. Int J Cancer. 2022 06 15; 150(12):2012-2024.Int J Cancer2022-02-18T00:00:002022Real-world use of palbociclib monotherapy in retroperitoneal liposarcomas at a large volume sarcoma center.35133007Ha MJ, Singareeka Raghavendra A, Kettner NM, Qiao W, Damodaran S, Layman RM, Hunt KK, Shen Y, Tripathy D, Keyomarsi KInternational journal of cancerPalbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional study. Int J Cancer. 2022 06 15; 150(12):2025-2037.Int J Cancer2022-03-03T00:00:002022Palbociclib plus endocrine therapy significantly enhances overall survival of HR+/HER2- metastatic breast cancer patients compared to endocrine therapy alone in the second-line setting: A large institutional study.35224688Voss RK, Callegaro D, Chiang YJ, Fiore M, Miceli R, Keung EZ, Feig BW, Torres KE, Scally CP, Hunt KK, Gronchi A, Roland CLAnnals of surgical oncologySarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients. Ann Surg Oncol. 2022 Feb 27.Ann Surg Oncol2022-02-27T00:00:002022Sarculator is a Good Model to Predict Survival in Resected Extremity and Trunk Sarcomas in US Patients.35233742Liang DH, Black D, Yi M, Luo CK, Singh P, Sahin A, Scoggins ME, Moseley TW, Hunt KKAnnals of surgical oncologyClinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of?Non-palpable Breast Lesions. Ann Surg Oncol. 2022 Jun; 29(6):3822-3828.Ann Surg Oncol2022-03-01T00:00:002022Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of?Non-palpable Breast Lesions.35298763Liang DH, Black D, Yi M, Luo CK, Singh P, Sahin A, Scoggins ME, Moseley TW, Hunt KKAnnals of surgical oncologyCorrection to: Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions. Ann Surg Oncol. 2022 Mar 17.Ann Surg Oncol2022-03-17T00:00:002022Correction to: Clinical Outcomes Using Magnetic Seeds as a Non-wire, Non-radioactive Alternative for Localization of Non-palpable Breast Lesions.35288816Francescatti AB, Hunt KK, Katz MHG, Cancer Surgery Standards Program of the American College of SurgeonsAnnals of surgical oncologyASO Author Reflections: Technical Standards for Cancer Surgery: From "How I Do It" to "How We Do It". Ann Surg Oncol. 2022 10; 29(11):6559-6560.Ann Surg Oncol2022-03-14T00:00:002022ASO Author Reflections: Technical Standards for Cancer Surgery: From "How I Do It" to "How We Do It".35187620Katz MHG, Francescatti AB, Hunt KK, Cancer Surgery Standards Program of the American College of SurgeonsAnnals of surgical oncologyTechnical Standards for Cancer Surgery: Commission on Cancer Standards 5.3-5.8. Ann Surg Oncol. 2022 Oct; 29(11):6549-6558.Ann Surg Oncol2022-02-20T00:00:002022Technical Standards for Cancer Surgery: Commission on Cancer Standards 5.3-5.8.35236635Yoon E, Ding Q, Hunt K, Sahin ASurgical pathology clinicsHigh-Grade Spindle Cell Lesions of the Breast: Key Pathologic and Clinical Updates. Surg Pathol Clin. 2022 Mar; 15(1):77-93.Surg Pathol Clin2022-01-31T00:00:002022High-Grade Spindle Cell Lesions of the Breast: Key Pathologic and Clinical Updates.Authorship 1044693535484601Allen CG, Judge DP, Levin E, Sterba K, Hunt K, Ramos PS, Melvin C, Wager K, Catchpole K, Clinton C, Ford M, McMahon LL, Lenert LImplementation science communicationsA pragmatic implementation research study for In Our DNA SC: a protocol to identify multi-level factors that support the implementation of a population-wide genomic screening initiative in diverse populations. Implement Sci Commun. 2022 Apr 28; 3(1):48.Implement Sci Commun2022-04-28T00:00:002022A pragmatic implementation research study for In Our DNA SC: a protocol to identify multi-level factors that support the implementation of a population-wide genomic screening initiative in diverse populations.17706484Hayes-Jordan A, Anderson P, Curley S, Herzog C, Lally KP, Green HL, Hunt K, Mansfield PJournal of pediatric surgeryContinuous hyperthermic peritoneal perfusion for desmoplastic small round cell tumor. J Pediatr Surg. 2007 Aug; 42(8):E29-32.J Pediatr Surg2007-08-01T00:00:002007Continuous hyperthermic peritoneal perfusion for desmoplastic small round cell tumor.14746836Bedrosian I, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, Vauthey JN, Delclos M, Crane C, Janjan N, Skibber JMJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractPredicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg. 2004 Jan; 8(1):56-62; discussion 62-3.J Gastrointest Surg2004-01-01T00:00:002004Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma.Authorship 1044988835501583Witt RG, Cope B, Erstad DJ, Chiang YJ, Nassif EF, Scally CP, Torres KE, Hunt KK, Feig BW, Roland CL, Keung EZAnnals of surgical oncologySentinel Lymph Node Biopsy and Formal Lymphadenectomy for Soft Tissue Sarcoma: A Single Center Experience of 86 Consecutive Cases. Ann Surg Oncol. 2022 Oct; 29(11):7092-7100.Ann Surg Oncol2022-04-30T00:00:002022Sentinel Lymph Node Biopsy and Formal Lymphadenectomy for Soft Tissue Sarcoma: A Single Center Experience of 86 Consecutive Cases.12439752Lin T, Huang X, Gu J, Zhang L, Roth JA, Xiong M, Curley SA, Yu Y, Hunt KK, Fang BOncogeneLong-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells. Oncogene. 2002 Nov 14; 21(52):8020-8.Oncogene2002-11-14T00:00:002002Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.23955388Duong MT, Akli S, Macalou S, Biernacka A, Debeb BG, Yi M, Hunt KK, Keyomarsi KCancer researchHbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells. Cancer Res. 2013 Sep 01; 73(17):5556-68.Cancer Res2013-08-16T00:00:002013Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells.19305161Wingate H, Puskas A, Duong M, Bui T, Richardson D, Liu Y, Tucker SL, Van Pelt C, Meijer L, Hunt K, Keyomarsi KCell cycle (Georgetown, Tex.)Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression. Cell Cycle. 2009 Apr 01; 8(7):1062-8.Cell Cycle2009-04-01T00:00:002009Low molecular weight cyclin E is specific in breast cancer and is associated with mechanisms of tumor progression.22285778Abbott DE, Brouquet A, Mittendorf EA, Andreou A, Meric-Bernstam F, Valero V, Green MC, Kuerer HM, Curley SA, Abdalla EK, Hunt KK, Vauthey JNSurgeryResection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome. Surgery. 2012 May; 151(5):710-6.Surgery2012-01-29T00:00:002012Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome.9409585Ricardo AE, Feig BW, Ellis LM, Hunt KK, Curley SA, MacFadyen BV, Mansfield PFAmerican journal of surgeryGallbladder cancer and trocar site recurrences. Am J Surg. 1997 Dec; 174(6):619-22; discussion 622-3.Am J Surg1997-12-01T00:00:001997Gallbladder cancer and trocar site recurrences.16392024Bedrosian I, Giacco G, Pederson L, Rodriguez-Bigas MA, Feig B, Hunt KK, Ellis L, Curley SA, Vauthey JN, Delclos M, Crane CH, Janjan N, Skibber JMDiseases of the colon and rectumOutcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum. 2006 Feb; 49(2):175-82.Dis Colon Rectum2006-02-01T00:00:002006Outcome after curative resection for locally recurrent rectal cancer.22479189Duong MT, Akli S, Wei C, Wingate HF, Liu W, Lu Y, Yi M, Mills GB, Hunt KK, Keyomarsi KPLoS geneticsLMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients. PLoS Genet. 2012; 8(3):e1002538.PLoS Genet2012-03-29T00:00:002012LMW-E/CDK2 deregulates acinar morphogenesis, induces tumorigenesis, and associates with the activated b-Raf-ERK1/2-mTOR pathway in breast cancer patients.Authorship 104578412Authorship 10458773Authorship 1046087635544130Hwang ES, Beitsch P, Blumencranz P, Carr D, Chagpar A, Clark L, Dekhne N, Dodge D, Dyess DL, Gold L, Grobmyer S, Hunt K, Karp S, Lesnikoski BA, Wapnir I, Smith BL, INSITE study teamJAMA surgeryClinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence-Guided System: A Nonrandomized Controlled Trial. JAMA Surg. 2022 07 01; 157(7):573-580.JAMA Surg2022-07-01T00:00:002022Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence-Guided System: A Nonrandomized Controlled Trial.35554520Baker NL, Hammad SM, Hunt KJ, Semler A, Klein RL, Lopes-Virella MFDiabetesPlasma apoM Levels and Progression to Kidney Dysfunction in Patients With Type 1 Diabetes. Diabetes. 2022 08 01; 71(8):1795-1799.Diabetes2022-08-01T00:00:002022Plasma apoM Levels and Progression to Kidney Dysfunction in Patients With Type 1 Diabetes.35578060Boughey JC, Blair SL, Subhedar PD, Edge SB, White JR, Hunt KKAnnals of surgical oncologyThe EA2108 Clinical Trial and Real-World Data: A Cautionary Tale in Stage IV Breast Cancer. Ann Surg Oncol. 2022 08; 29(8):4663-4666.Ann Surg Oncol2022-05-16T00:00:002022The EA2108 Clinical Trial and Real-World Data: A Cautionary Tale in Stage IV Breast Cancer.Authorship 10463845Authorship 1046509535597841Lillemoe HA, Miranda RN, Nastoupil LJ, Clemens MW, Hunt KKAnnals of surgical oncologyClinical Manifestations and Surgical Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Beyond the NCCN Guidelines. Ann Surg Oncol. 2022 Sep; 29(9):5722-5729.Ann Surg Oncol2022-05-21T00:00:002022Clinical Manifestations and Surgical Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Beyond the NCCN Guidelines.35609361Douglas SR, Lizarraga IM, Boughey JC, Weiss A, Hunt KK, Dickson-Witmer D, Subhedar PD, Park KU, Zhao B, Blair SLSurgical oncologyNational Cancer Database trends in surgical resection of the breast primary for stage IV breast cancer. Surg Oncol. 2022 Jun; 42:101778.Surg Oncol2022-05-11T00:00:002022National Cancer Database trends in surgical resection of the breast primary for stage IV breast cancer.Authorship 104690610Authorship 1047069735639805Santanelli di Pompeo F, Clemens MW, Atlan M, Botti G, Cordeiro PG, De Jong D, Di Napoli A, Hammond D, Haymaker CL, Horwitz SM, Hunt K, Lennox P, Mallucci P, Miranda RN, Munhoz AM, Swanson E, Turner SD, Firmani G, Sorotos MAesthetic surgery journal2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL. Aesthet Surg J. 2022 10 13; 42(11):1262-1278.Aesthet Surg J2022-10-13T00:00:0020222022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL.35653124Suman VJ, Du L, Hoskin T, Anurag M, Ma C, Bedrosian I, Hunt KK, Ellis MJ, Symmans WFClinical cancer research : an official journal of the American Association for Cancer ResearchEvaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031). Clin Cancer Res. 2022 08 02; 28(15):3287-3295.Clin Cancer Res2022-08-02T00:00:002022Evaluation of Sensitivity to Endocrine Therapy Index (SET2,3) for Response to Neoadjuvant Endocrine Therapy and Longer-Term Breast Cancer Patient Outcomes (Alliance Z1031).Authorship 1047510735660090Howell AV, Gebregziabher M, Thiers BH, Graboyes EM, Paulos CM, Wrangle JM, Hunt KJ, Wallace KJournal of geriatric oncologyAssociation of age with survival in older patients with cutaneous melanoma treated with immune checkpoint inhibitors. J Geriatr Oncol. 2022 09; 13(7):1003-1010.J Geriatr Oncol2022-06-01T00:00:002022Association of age with survival in older patients with cutaneous melanoma treated with immune checkpoint inhibitors.Authorship 10480186Authorship 1048107135703824Adams AM, Vreeland TJ, Teshome M, Francescatti AB, Zheng L, Hunt KK, Katz MHG, Messick CAJournal of the American College of SurgeonsAmerican College of Surgeons Commission on Cancer Standard 5.7 for Total Mesorectal Excision for Mid-to-Low Rectal Cancer. J Am Coll Surg. 2022 06 01; 234(6):1249-1253.J Am Coll Surg2022-03-16T00:00:002022American College of Surgeons Commission on Cancer Standard 5.7 for Total Mesorectal Excision for Mid-to-Low Rectal Cancer.35703454Hunt KKAnnals of surgeryEditorial on Toesca et al's "A Randomized Trial of Robotic Mastectomy Versus Open Surgery in Women With Breast Cancer or BRCA Mutation". Ann Surg. 2022 07 01; 276(1):20-21.Ann Surg2022-05-12T00:00:002022Editorial on Toesca et al's "A Randomized Trial of Robotic Mastectomy Versus Open Surgery in Women With Breast Cancer or BRCA Mutation".Authorship 106208413Authorship 10545871Authorship 10579875Authorship 10577712Authorship 10580213Authorship 10607299Authorship 105662020Authorship 10553718Authorship 10608655Authorship 105965817Authorship 10581776Authorship 10595679Authorship 10605313Authorship 1062098936094691Murphy BL, Yi M, Gutierrez Barrera AM, Tripathy D, Hunt KK, Arun BKAnnals of surgical oncologyOther Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing. Ann Surg Oncol. 2023 Mar; 30(3):1663-1668.Ann Surg Oncol2022-09-12T00:00:002022Other Primary Malignancies in Patients with Breast Cancer Who Undergo Germline Panel Testing.36670144Zhou Z, Adrada BE, Candelaria RP, Elshafeey NA, Boge M, Mohamed RM, Pashapoor S, Sun J, Xu Z, Panthi B, Son JB, Guirguis MS, Patel MM, Whitman GJ, Moseley TW, Scoggins ME, White JB, Litton JK, Valero V, Hunt KK, Tripathy D, Yang W, Wei P, Yam C, Pagel MD, Rauch GM, Ma JScientific reportsPrediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI. Sci Rep. 2023 01 20; 13(1):1171.Sci Rep2023-01-20T00:00:002023Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI.36394686Keung EZ, Hunt KK, Roland CLAnnals of surgical oncologyASO Author Reflections: A Call for Consensus, Collaboration and Data on the Role of Sentinel Lymph Node Biopsy for Soft Tissue Sarcoma. Ann Surg Oncol. 2022 Nov 17.Ann Surg Oncol2022-11-17T00:00:002022ASO Author Reflections: A Call for Consensus, Collaboration and Data on the Role of Sentinel Lymph Node Biopsy for Soft Tissue Sarcoma.36343656Guadagnolo BA, Bassett RL, Mitra D, Farooqi A, Hempel C, Dorber C, Willis T, Wang WL, Ratan R, Somaiah N, Benjamin RS, Torres KE, Hunt KK, Scally CP, Keung EZ, Satcher RL, Bird JE, Lin PP, Moon BS, Lewis VO, Roland CL, Bishop AJThe Lancet. OncologyHypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial. Lancet Oncol. 2022 12; 23(12):1547-1557.Lancet Oncol2022-11-04T00:00:002022Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial.36344674Li M, Tsavachidis S, Wang F, Bui T, Nguyen TDT, Luo L, Multani AS, Bondy ML, Hunt KK, Keyomarsi KOncogeneLow-molecular-weight cyclin E deregulates DNA replication and damage repair to promote genomic instability in breast cancer. Oncogene. 2022 Dec; 41(50):5331-5346.Oncogene2022-11-07T00:00:002022Low-molecular-weight cyclin E deregulates DNA replication and damage repair to promote genomic instability in breast cancer.36419172Santanelli di Pompeo F, Clemens MW, Atlan M, Botti G, Cordeiro PG, De Jong D, Di Napoli A, Hammond D, Haymaker CL, Horwitz SM, Hunt K, Lennox P, Mallucci P, Miranda RN, Munhoz AM, Panagiotakos D, Swanson EC, Turner SD, Firmani G, Sorotos MAesthetic surgery journalResponse to: What Is Missing From the 2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL? Aesthet Surg J. 2023 02 03; 43(2):NP138-NP140.Aesthet Surg J2023-02-03T00:00:002023Response to: What Is Missing From the 2022 Practice Recommendation Updates From the World Consensus Conference on BIA-ALCL?36008809Snider MJE, Maa AY, Guyton AC, Park H, Hunt KJ, Pope CBMC health services researchStakeholder perceptions affecting the implementation of teleophthalmology. BMC Health Serv Res. 2022 Aug 25; 22(1):1086.BMC Health Serv Res2022-08-25T00:00:002022Stakeholder perceptions affecting the implementation of teleophthalmology.36013178Allen CG, Lenert L, Hunt K, Jackson A, Levin E, Clinton C, Clark JT, Garrison K, Gallegos S, Wager K, He W, Sterba K, Ramos PS, Melvin C, Ford M, Catchpole K, McMahon L, Judge DPJournal of personalized medicineLessons Learned from the Pilot Phase of a Population-Wide Genomic Screening Program: Building the Base to Reach a Diverse Cohort of 100,000 Participants. J Pers Med. 2022 Jul 27; 12(8).J Pers Med2022-07-27T00:00:002022Lessons Learned from the Pilot Phase of a Population-Wide Genomic Screening Program: Building the Base to Reach a Diverse Cohort of 100,000 Participants.36315142Gleason JL, Sundaram R, Mitro SD, Hinkle SN, Gilman SE, Zhang C, Newman RB, Hunt KJ, Skupski DW, Grobman WA, Nageotte M, Robinson M, Kannan K, Grantz KLJAMA network openAssociation of Maternal Caffeine Consumption During Pregnancy With Child Growth. JAMA Netw Open. 2022 10 03; 5(10):e2239609.JAMA Netw Open2022-10-03T00:00:002022Association of Maternal Caffeine Consumption During Pregnancy With Child Growth.36603130Nguyen TDT, Wang Y, Bui TN, Lazcano R, Ingram DR, Yi M, Vakulabharanam V, Luo L, Pina MA, Karakas C, Li M, Kettner NM, Somaiah N, Hougton PJ, Mawlawi O, Lazar AJ, Hunt KK, Keyomarsi KCancer researchSequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time. Cancer Res. 2023 03 15; 83(6):939-955.Cancer Res2023-03-15T00:00:002023Sequential Targeting of Retinoblastoma and DNA Synthesis Pathways Is a Therapeutic Strategy for Sarcomas That Can Be Monitored in Real Time.36153033Gurewich D, Kressin N, Bokhour BG, Linsky AM, Dichter ME, Hunt KJ, Fix GM, Niles BLBMJ openRandomised controlled trial evaluating the effects of screening and referral for social determinants of health on Veterans' outcomes: protocol. BMJ Open. 2022 09 23; 12(9):e058972.BMJ Open2022-09-23T00:00:002022Randomised controlled trial evaluating the effects of screening and referral for social determinants of health on Veterans' outcomes: protocol.36085392Traweek RS, Martin AN, Rajkot NF, Guadagnolo BA, Bishop AJ, Lazar AJ, Keung EZ, Torres KE, Hunt KK, Feig BW, Roland CL, Scally CPAnnals of surgical oncologyRe-excision After Unplanned Excision of Soft Tissue Sarcoma is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease. Ann Surg Oncol. 2022 Sep 09.Ann Surg Oncol2022-09-09T00:00:002022Re-excision After Unplanned Excision of Soft Tissue Sarcoma is Associated with High Morbidity and Limited Pathologic Identification of Residual Disease.36653664Hunt KK, Suman VJ, Wingate HF, Leitch AM, Unzeitig G, Boughey JC, Meric-Bernstam F, Ellis MJ, Olson JAnnals of surgical oncologyLocal-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer. Ann Surg Oncol. 2023 Apr; 30(4):2111-2118.Ann Surg Oncol2023-01-18T00:00:002023Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer.36115928Erstad DJ, Chiang YJ, Witt RG, Cope B, Nassif EF, Scally CP, Torres KE, Feig BW, Hunt KK, Bishop AJ, Guadagnolo BA, Roland CL, Keung EZAnnals of surgical oncologyClinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma. Ann Surg Oncol. 2022 Sep 17.Ann Surg Oncol2022-09-17T00:00:002022Clinical Impact of External Beam Radiotherapy for Surgically Resected Primary Retroperitoneal Liposarcoma.Authorship 10629811036723723Witt RG, Voss RK, Chiang YJ, Nguyen S, Scally CP, Lin PP, Torres KE, Moon BS, Satcher RL, Hunt KK, Bird JE, Feig BW, Lewis VO, Roland CL, Keung EZAnnals of surgical oncologyPractice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership. Ann Surg Oncol. 2023 Jun; 30(6):3668-3676.Ann Surg Oncol2023-02-01T00:00:002023Practice Pattern Variability in the Management of Regional Lymph Node Metastasis in Extremity and Trunk Soft Tissue Sarcoma: A Survey of the Society of Surgical Oncology and Musculoskeletal Tumor Society Membership.Authorship 1064525836831368Panthi B, Adrada BE, Candelaria RP, Guirguis MS, Yam C, Boge M, Chen H, Hunt KK, Huo L, Hwang KP, Korkut A, Lane DL, Le-Petross HC, Leung JWT, Litton JK, Mohamed RM, Musall BC, Pashapoor S, Patel MM, Perez F, Son JB, Thompson A, Valero V, Wei P, White J, Xu Z, Pinsky L, Tripathy D, Yang W, Ma J, Rauch GMCancersAssessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI. Cancers (Basel). 2023 Feb 06; 15(4).Cancers (Basel)2023-02-06T00:00:002023Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI.Authorship 10669001136977292Boughey JC, Rosenkranz KM, Ballman KV, McCall L, Haffty BG, Cuttino LW, Kubicky CD, Le-Petross HT, Giuliano AE, Van Zee KJ, Hunt KK, Hahn OM, Carey LA, Partridge AHJournal of clinical oncology : official journal of the American Society of Clinical OncologyLocal Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance). J Clin Oncol. 2023 06 10; 41(17):3184-3193.J Clin Oncol2023-03-28T00:00:002023Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance).Authorship 1068631737074700Alabi O, Beriwal S, Gallini JW, Cui X, Jasien C, Brewster L, Hunt KJ, Massarweh NNJAMA surgeryAssociation of Health Care Utilization and Access to Care With Vascular Assessment Before Major Lower Extremity Amputation Among US Veterans. JAMA Surg. 2023 06 01; 158(6):e230479.JAMA Surg2023-06-01T00:00:002023Association of Health Care Utilization and Access to Care With Vascular Assessment Before Major Lower Extremity Amputation Among US Veterans.Authorship 1069618837202308Zaveri S, Lillemoe HA, Teshome M, Reyna CR, Vreeland TJ, Francescatti AB, Zheng L, Hunt KK, Katz MHG, Kilgore LJSurgeryOperative standards for sentinel lymph node biopsy and axillary lymphadenectomy for breast cancer: review of the American College of Surgeons commission on cancer standards 5.3 and 5.4. Surgery. 2023 09; 174(3):717-721.Surgery2023-05-16T00:00:002023Operative standards for sentinel lymph node biopsy and axillary lymphadenectomy for breast cancer: review of the American College of Surgeons commission on cancer standards 5.3 and 5.4.Authorship 10736351237384539Navarro-Yepes J, Kettner NM, Rao X, Bishop CS, Bui TN, Wingate HF, Singareeka Raghavendra A, Wang Y, Wang J, Sahin AA, Meric-Bernstam F, Hunt KK, Damodaran S, Tripathy D, Keyomarsi KCancer researchAbemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast Cancers. Cancer Res. 2023 10 02; 83(19):3264-3283.Cancer Res2023-10-02T00:00:002023Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor-Positive Metastatic Breast Cancers.Authorship 107496711Authorship 1074872637478956Novick K, Chadha M, Daroui P, Freedman G, Gao W, Hunt K, Park C, Rewari A, Suh W, Walker E, Wong J, Harris EEInternational journal of radiation oncology, biology, physicsAmerican Radium Society Appropriate Use Criteria Postmastectomy Radiation Therapy: Executive Summary of Clinical Topics. Int J Radiat Oncol Biol Phys. 2024 Feb 01; 118(2):458-465.Int J Radiat Oncol Biol Phys2023-07-20T00:00:002023American Radium Society Appropriate Use Criteria Postmastectomy Radiation Therapy: Executive Summary of Clinical Topics.37458948Zaveri S, Everidge S, FitzSullivan E, Hwang R, Smith BD, Lin H, Shen Y, Lucci A, Teshome M, Sun SX, Hunt KK, Kuerer HMAnnals of surgical oncologyExtremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection. Ann Surg Oncol. 2023 Nov; 30(12):7015-7025.Ann Surg Oncol2023-07-17T00:00:002023Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection.Authorship 10788137Authorship 1079084437670121Farley C, Bassett R, Meric-Bernstam F, Bedrosian I, Caudle A, DeSnyder S, Hunt K, Kuerer H, Singh P, Sun S, Tamirisa N, Teshome M, Hwang RFAnnals of surgical oncologyTo Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer? Ann Surg Oncol. 2023 Dec; 30(13):8327-8334.Ann Surg Oncol2023-09-05T00:00:002023To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer?37736254Gouda MA, Janku F, Somaiah N, Hunt KK, Yedururi S, Subbiah VOncoscienceMulti-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery. Oncoscience. 2023; 10:38-43.Oncoscience2023-09-20T00:00:002023Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery.Authorship 1080265937796181Lulla AR, Akli S, Karakas C, Caruso JA, Warma LD, Fowlkes NW, Rao X, Wang J, Hunt KK, Watowich SS, Keyomarsi KMolecular cancer therapeuticsNeutrophil elastase remodels mammary tumors to facilitate lung metastasis. Mol Cancer Ther. 2023 Oct 05.Mol Cancer Ther2023-10-05T00:00:002023Neutrophil elastase remodels mammary tumors to facilitate lung metastasis.Authorship 108093825Authorship 1081282537821977Allen CG, Sterba K, Norman S, Jackson A, Hunt KJ, McMahon L, Judge DPImplementation science communicationsUse of a multi-phased approach to identify and address facilitators and barriers to the implementation of a population-wide genomic screening program. Implement Sci Commun. 2023 Oct 11; 4(1):122.Implement Sci Commun2023-10-11T00:00:002023Use of a multi-phased approach to identify and address facilitators and barriers to the implementation of a population-wide genomic screening program.37835523Xu Z, Rauch DE, Mohamed RM, Pashapoor S, Zhou Z, Panthi B, Son JB, Hwang KP, Musall BC, Adrada BE, Candelaria RP, Leung JWT, Le-Petross HTC, Lane DL, Perez F, White J, Clayborn A, Reed B, Chen H, Sun J, Wei P, Thompson A, Korkut A, Huo L, Hunt KK, Litton JK, Valero V, Tripathy D, Yang W, Yam C, Ma JCancersDeep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer. Cancers (Basel). 2023 Oct 02; 15(19).Cancers (Basel)2023-10-02T00:00:002023Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer.Authorship 1082713637880516Thomas KK, Francescatti AB, Vreeland TJ, Teshome MK, Morris AM, Hunt KK, Katz MHG, Villano AMAnnals of surgical oncologyStandardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6. Ann Surg Oncol. 2024 Jan; 31(1):6-9.Ann Surg Oncol2023-10-26T00:00:002023Standardization of Colon Resection for Cancer: An Overview of the American College of Surgeons Commission on Cancer Standard 5.6.Authorship 10832965Authorship 1083114737942694Wen CC, Baker N, Paul R, Hill E, Hunt K, Li H, Gray K, Neelon BStatistics in medicineA Bayesian zero-inflated beta-binomial model for longitudinal data with group-specific changepoints. Stat Med. 2024 01 15; 43(1):125-140.Stat Med2023-11-09T00:00:002023A Bayesian zero-inflated beta-binomial model for longitudinal data with group-specific changepoints.37941561Panthi B, Mohamed RM, Adrada BE, Boge M, Candelaria RP, Chen H, Hunt KK, Huo L, Hwang KP, Korkut A, Lane DL, Le-Petross HC, Leung JWT, Litton JK, Pashapoor S, Perez F, Son JB, Sun J, Thompson A, Tripathy D, Valero V, Wei P, White J, Xu Z, Yang W, Zhou Z, Yam C, Rauch GM, Ma JFrontiers in oncologyLongitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer. Front Oncol. 2023; 13:1264259.Front Oncol2023-10-24T00:00:002023Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer.Authorship 10839019Authorship 1083734537948938Medeiros LJ, Marques-Piubelli ML, Sangiorgio VFI, Ruiz-Cordero R, Vega F, Feldman AL, Chapman JR, Clemens MW, Hunt KK, Evans MG, Khoo C, Lade S, Silberman M, Morkowski J, Pina EM, Mills DC, Bates CM, Magno WB, Sohani AR, Sieling BA, O'Donoghue JM, Bacon CM, Patani N, Televantou D, Turner SD, Johnson L, MacNeill F, Wotherspoon AC, Iyer SP, Malpica LE, Patel KP, Xu J, Miranda RNModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncCorrigendum to "Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship." [Modern Pathology 34 (2021) 2154-2167]. Mod Pathol. 2023 Dec; 36(12):100355.Mod Pathol2023-11-09T00:00:002023Corrigendum to "Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship." [Modern Pathology 34 (2021) 2154-2167].37973647Woodfin AA, Yam C, Teshome M, Kuerer HM, Hunt KK, Meric-Bernstam F, Schaverien M, Barcenas CH, Sun SXAnnals of surgical oncologyAxillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer. Ann Surg Oncol. 2024 Feb; 31(2):974-980.Ann Surg Oncol2023-11-16T00:00:002023Axillary Nodal Metastases Conversion and Perioperative Complications with Neoadjuvant Pembrolizumab Therapy in Triple-Negative Breast Cancer.Authorship 10856812038083160Zhou Z, Adrada BE, Candelaria RP, Elshafeey NA, Boge M, Mohamed RM, Pashapoor S, Sun J, Xu Z, Panthi B, Son JB, Guirguis MS, Patel MM, Whitman GJ, Moseley TW, Scoggins ME, White JB, Litton JK, Valero V, Hunt KK, Tripathy D, Yang W, Wei P, Yam C, Pagel MD, Rauch GM, Ma JAnnual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International ConferencePredicting pathological complete response to neoadjuvant systemic therapy for triple-negative breast cancers using deep learning on multiparametric MRIs. Annu Int Conf IEEE Eng Med Biol Soc. 2023 07; 2023:1-4.Annu Int Conf IEEE Eng Med Biol Soc2023-07-01T00:00:002023Predicting pathological complete response to neoadjuvant systemic therapy for triple-negative breast cancers using deep learning on multiparametric MRIs.Authorship 1086378338162957Carlson KA, Checka C, Hunt KK, Jung J, Bridges C, Singh P, Refinetti A, Moseley T, Perez F, Mayo C, Tamirisa NThe breast journalEvaluation of a Surgical Navigation System for Localization and Excision of Nonpalpable Lesions in Breast and Axillary Surgery. Breast J. 2023; 2023:9993852.Breast J2023-12-23T00:00:002023Evaluation of a Surgical Navigation System for Localization and Excision of Nonpalpable Lesions in Breast and Axillary Surgery.Authorship 10870572638236590Ma CX, Suman VJ, Sanati S, Vij K, Anurag M, Leitch AM, Unzeitig GW, Hoog J, Fernandez-Martinez A, Fan C, Gibbs RA, Watson MA, Dockter TJ, Hahn O, Guenther JM, Caudle A, Crouch E, Tiersten A, Mita M, Razaq W, Hieken TJ, Wang Y, Rimawi MF, Weiss A, Winer EP, Hunt KK, Perou CM, Ellis MJ, Partridge AH, Carey LAJAMA oncologyEndocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial. JAMA Oncol. 2024 Mar 01; 10(3):362-371.JAMA Oncol2024-03-01T00:00:002024Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial.Authorship 1087600638248552Malek AM, Wilson DA, Turan TN, Mateus J, Lackland DT, Hunt KJInternational journal of environmental research and public healthHypertensive Disorders of Pregnancy and Pre-Pregnancy Hypertension with Subsequent Incident Venous Thromboembolic Events. Int J Environ Res Public Health. 2024 Jan 12; 21(1).Int J Environ Res Public Health2024-01-12T00:00:002024Hypertensive Disorders of Pregnancy and Pre-Pregnancy Hypertension with Subsequent Incident Venous Thromboembolic Events.Authorship 1088165938294179Musall BC, Rauch DE, Mohamed RMM, Panthi B, Boge M, Candelaria RP, Chen H, Guirguis MS, Hunt KK, Huo L, Hwang KP, Korkut A, Litton JK, Moseley TW, Pashapoor S, Patel MM, Reed BJ, Scoggins ME, Son JB, Tripathy D, Valero V, Wei P, White JB, Whitman GJ, Xu Z, Yang WT, Yam C, Adrada BE, Ma JJournal of magnetic resonance imaging : JMRIDiffusion Tensor Imaging for Characterizing Changes in Triple-Negative Breast Cancer During Neoadjuvant Systemic Therapy. J Magn Reson Imaging. 2024 Jan 31.J Magn Reson Imaging2024-01-31T00:00:002024Diffusion Tensor Imaging for Characterizing Changes in Triple-Negative Breast Cancer During Neoadjuvant Systemic Therapy.Authorship 10883832Authorship 10883057Authorship 1088679338320161Smith BL, Hunt KK, Carr D, Blumencranz PW, Hwang ES, Gadd MA, Stone K, Dyess DL, Dodge D, Valente S, Dekhne N, Clark P, Lee MC, Samiian L, Lesnikoski BA, Clark L, Smith KP, Chang M, Harris DK, Schlossberg B, Ferrer J, Wapnir ILNEJM evidenceIntraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery. NEJM Evid. 2023 Jul; 2(7):EVIDoa2200333.NEJM Evid2023-04-27T00:00:002023Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery.38307509Thomas MK, Kalivas B, Zhang J, Marsden J, Mauldin PD, Moran WP, Hunt K, Heincelman MSouthern medical journalEffect of Delirium on Interhospital Transfer Outcomes. South Med J. 2024 Feb; 117(2):108-114.South Med J2024-02-01T00:00:002024Effect of Delirium on Interhospital Transfer Outcomes.38339245Adesoye T, Tripathy D, Hunt KK, Keyomarsi KCancersExploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics. Cancers (Basel). 2024 Jan 24; 16(3).Cancers (Basel)2024-01-24T00:00:002024Exploring Novel Frontiers: Leveraging STAT3 Signaling for Advanced Cancer Therapeutics.Authorship 10888541338351182Roland CL, Nassif Haddad EF, Keung EZ, Wang WL, Lazar AJ, Lin H, Chelvanambi M, Parra ER, Wani K, Guadagnolo BA, Bishop AJ, Burton EM, Hunt KK, Torres KE, Feig BW, Scally CP, Lewis VO, Bird JE, Ratan R, Araujo D, Zarzour MA, Patel S, Benjamin R, Conley AP, Livingston JA, Ravi V, Tawbi HA, Lin PP, Moon BS, Satcher RL, Mujtaba B, Witt RG, Traweek RS, Cope B, Lazcano R, Wu CC, Zhou X, Mohammad MM, Chu RA, Zhang J, Damania A, Sahasrabhojane P, Tate T, Callahan K, Nguyen S, Ingram D, Morey R, Crosby S, Mathew G, Duncan S, Lima CF, Blay JY, Fridman WH, Shaw K, Wistuba I, Futreal A, Ajami N, Wargo JA, Somaiah NNature cancerA randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nat Cancer. 2024 Feb 13.Nat Cancer2024-02-13T00:00:002024A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma.Authorship 10893751438396039Traweek RS, Lyu HG, Witt RG, Snyder RA, Nassif EF, Krijgh DD, Smith JM, Tilney GS, Feng C, Chiang YJ, Torres KE, Roubaud MJ, Scally CP, Hunt KK, Keung EZ, Mericli AF, Roland CLAnnals of surgical oncologyHigh Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma. Ann Surg Oncol. 2024 Feb 23.Ann Surg Oncol2024-02-23T00:00:002024High Community-Level Social Vulnerability is Associated with Worse Recurrence-Free Survival (RFS) After Resection of Extremity and Truncal Soft Tissue Sarcoma.Authorship 1089610838412359Clemens MW, Myckatyn T, Di Napoli A, Feldman AL, Jaffe ES, Haymaker CL, Horwitz SM, Hunt KK, Kadin ME, McCarthy CM, Miranda RN, Prince HM, Santanelli di Pompeo F, Holmes SD, Phillips LGPlastic and reconstructive surgeryBreast Implant Associated Anaplastic Large Cell Lymphoma: Evidence-Based Consensus Conference Statement From The American Association of Plastic Surgeons. Plast Reconstr Surg. 2024 Feb 27.Plast Reconstr Surg2024-02-27T00:00:002024Breast Implant Associated Anaplastic Large Cell Lymphoma: Evidence-Based Consensus Conference Statement From The American Association of Plastic Surgeons.Authorship 1090299638451836Marques-Piubelli ML, Lyapichev KA, Fnu A, Adrada B, Stewart J, Hunt KK, Clemens MW, Iyer S, Wu Y, El Hussein S, Xu J, Ok CY, Li S, M Pierson D, Ferrufino-Schmidt MC, Nahmod KA, Yoga A, Hunsicker L, Evans MG, Resetkova E, Qiu L, Khanlari M, Garces SA, Bueso-Ramos CE, Medeiros LJ, Miranda RNThe American journal of surgical pathologyThe Spectrum of Non-neoplastic Changes Associated With Breast Implants: Histopathology, Imaging, and Clinical Significance. Am J Surg Pathol. 2024 Mar 04.Am J Surg Pathol2024-03-04T00:00:002024The Spectrum of Non-neoplastic Changes Associated With Breast Implants: Histopathology, Imaging, and Clinical Significance.Authorship 1090545538470708Wilson DA, Mateus J, Ash E, Turan TN, Hunt KJ, Malek AMHealthcare (Basel, Switzerland)The Association of Hypertensive Disorders of Pregnancy with Infant Mortality, Preterm Delivery, and Small for Gestational Age. Healthcare (Basel). 2024 Mar 06; 12(5).Healthcare (Basel)2024-03-06T00:00:002024The Association of Hypertensive Disorders of Pregnancy with Infant Mortality, Preterm Delivery, and Small for Gestational Age.true1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor19801315Smith GL, Xu Y, Shih YC, Giordano SH, Smith BD, Hunt KK, Strom EA, Perkins GH, Hortobagyi GN, Buchholz TAJournal of the American College of SurgeonsBreast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. J Am Coll Surg. 2009 Oct; 209(4):425-433.e2.J Am Coll Surg2009-08-20T00:00:002009Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States.19844788Ellis MJ, Lin L, Crowder R, Tao Y, Hoog J, Snider J, Davies S, DeSchryver K, Evans DB, Steinseifer J, Bandaru R, Liu W, Gardner H, Semiglazov V, Watson M, Hunt K, Olson J, Baselga JBreast cancer research and treatmentPhosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer. Breast Cancer Res Treat. 2010 Jan; 119(2):379-90.Breast Cancer Res Treat2010-01-01T00:00:002010Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer.21555689Ellis MJ, Suman VJ, Hoog J, Lin L, Snider J, Prat A, Parker JS, Luo J, DeSchryver K, Allred DC, Esserman LJ, Unzeitig GW, Margenthaler J, Babiera GV, Marcom PK, Guenther JM, Watson MA, Leitch M, Hunt K, Olson JAJournal of clinical oncology : official journal of the American Society of Clinical OncologyRandomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031. J Clin Oncol. 2011 Jun 10; 29(17):2342-9.J Clin Oncol2011-05-09T00:00:002011Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031.24239210Buzdar AU, Suman VJ, Meric-Bernstam F, Leitch AM, Ellis MJ, Boughey JC, Unzeitig G, Royce M, McCall LM, Ewer MS, Hunt KK, American College of Surgeons Oncology Group investigatorsThe Lancet. OncologyFluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial. Lancet Oncol. 2013 Dec; 14(13):1317-25.Lancet Oncol2013-11-13T00:00:002013Fluorouracil, epirubicin, and cyclophosphamide (FEC-75) followed by paclitaxel plus trastuzumab versus paclitaxel plus trastuzumab followed by FEC-75 plus trastuzumab as neoadjuvant treatment for patients with HER2-positive breast cancer (Z1041): a randomised, controlled, phase 3 trial.24268788Smith GL, Jiang J, Buchholz TA, Xu Y, Hoffman KE, Giordano SH, Hunt KK, Smith BDInternational journal of radiation oncology, biology, physicsBenefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation. Int J Radiat Oncol Biol Phys. 2014 Feb 01; 88(2):274-84.Int J Radiat Oncol Biol Phys2013-11-21T00:00:002013Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation.11859211Yared MA, Middleton LP, Smith TL, Kim HW, Ross MI, Hunt KK, Sahin AAThe American journal of surgical pathologyRecommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol. 2002 Mar; 26(3):377-82.Am J Surg Pathol2002-03-01T00:00:002002Recommendations for sentinel lymph node processing in breast cancer.24736987Haynes AB, Bloom ES, Bedrosian I, Kuerer HM, Hwang RF, Munsell MF, Chemaly RF, Graviss LS, Caudle AS, Hunt KK, Tereffe W, Shaitelman SF, Babiera GVAnnals of surgical oncologyTiming of infectious complications following breast-conserving therapy with catheter-based accelerated partial breast irradiation. Ann Surg Oncol. 2014 Aug; 21(8):2512-6.Ann Surg Oncol2014-04-16T00:00:002014Timing of infectious complications following breast-conserving therapy with catheter-based accelerated partial breast irradiation.24912900Eberth JM, Xu Y, Smith GL, Shen Y, Jiang J, Buchholz TA, Hunt KK, Black DM, Giordano SH, Whitman GJ, Yang W, Shen C, Elting L, Smith BDJournal of clinical oncology : official journal of the American Society of Clinical OncologySurgeon influence on use of needle biopsy in patients with breast cancer: a national medicare study. J Clin Oncol. 2014 Jul 20; 32(21):2206-16.J Clin Oncol2014-06-09T00:00:002014Surgeon influence on use of needle biopsy in patients with breast cancer: a national medicare study.